A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.
Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)
The transference of a part of or an entire liver from one human or animal to another.
Devices for simulating the activities of the liver. They often consist of a hybrid between both biological and artificial materials.
Pathological processes of the LIVER.
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)
Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
Tumors or cancer of the LIVER.
Elimination of toxic or biologically active substances from body fluids by interaction with a sorbent medium. The types of media include absorbents, adsorbents, ion-exchange materials, and complexing agents. Detoxification can be extracorporeal (hemodialysis, hemofiltration, hemoperfusion, plasmapheresis), or occur inside the body (enterosorption, peritoneal dialysis).
Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.
Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, and chemicals from the environment.
Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions.
Repair or renewal of hepatic tissue.
A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS.
Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
Galactosamine is a type of amino monosaccharide that is a key component of many glycosaminoglycans, and is commonly found in animal tissues, often used in research and pharmaceutical applications for its role in cellular metabolism and synthesis of various biological molecules.
Excision of all or part of the liver. (Dorland, 28th ed)
The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.
Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough.
A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series.
A bile pigment that is a degradation product of HEME.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4)
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
The circulation of BLOOD through the LIVER.
Elevated level of AMMONIA in the blood. It is a sign of defective CATABOLISM of AMINO ACIDS or ammonia to UREA.
Poisoning from ingestion of mushrooms, primarily from, but not restricted to, toxic varieties.
INFLAMMATION of the LIVER.
An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2.
A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.
Liver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Elements of limited time intervals, contributing to particular results or situations.
FIBROSIS of the hepatic parenchyma due to chronic excess ALCOHOL DRINKING.
Diversion of blood flow through a circuit located outside the body but continuous with the bodily circulation.
A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.
A short thick vein formed by union of the superior mesenteric vein and the splenic vein.
Devices intended to replace non-functioning organs. They may be temporary or permanent. Since they are intended always to function as the natural organs they are replacing, they should be differentiated from PROSTHESES AND IMPLANTS and specific types of prostheses which, though also replacements for body parts, are frequently cosmetic (EYE, ARTIFICIAL) as well as functional (ARTIFICIAL LIMBS).
Accidental or deliberate use of a medication or street drug in excess of normal dosage.
Extracts of liver tissue containing uncharacterized specific factors with specific activities; a soluble thermostable fraction of mammalian liver is used in the treatment of pernicious anemia.
A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.
Experimentally induced tumors of the LIVER.
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
A colorless alkaline gas. It is formed in the body during decomposition of organic materials during a large number of metabolically important reactions. Note that the aqueous form of ammonia is referred to as AMMONIUM HYDROXIDE.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
INFLAMMATION of the LIVER due to ALCOHOL ABUSE. It is characterized by NECROSIS of HEPATOCYTES, infiltration by NEUTROPHILS, and deposit of MALLORY BODIES. Depending on its severity, the inflammatory lesion may be reversible or progress to LIVER CIRRHOSIS.
The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
The circulation in a portion of the body of one individual of blood supplied from another individual.
A type I keratin found associated with KERATIN-8 in simple, or predominately single layered, internal epithelia.
Solitary or multiple collections of PUS within the liver as a result of infection by bacteria, protozoa, or other agents.
A combination of congenital heart defects consisting of three key features including ATRIAL SEPTAL DEFECTS; PULMONARY STENOSIS; and RIGHT VENTRICULAR HYPERTROPHY.
INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS.
INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
A condition of substandard growth or diminished capacity to maintain normal function.
Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).
A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1.
Veins which drain the liver.
Water-soluble proteins found in egg whites, blood, lymph, and other tissues and fluids. They coagulate upon heating.
Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
Disease having a short and relatively severe course.
A group of disorders which have in common elevations of tyrosine in the blood and urine secondary to an enzyme deficiency. Type I tyrosinemia features episodic weakness, self-mutilation, hepatic necrosis, renal tubular injury, and seizures and is caused by a deficiency of the enzyme fumarylacetoacetase. Type II tyrosinemia features INTELLECTUAL DISABILITY, painful corneal ulcers, and keratoses of the palms and plantar surfaces and is caused by a deficiency of the enzyme TYROSINE TRANSAMINASE. Type III tyrosinemia features INTELLECTUAL DISABILITY and is caused by a deficiency of the enzyme 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE. (Menkes, Textbook of Child Neurology, 5th ed, pp42-3)
A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed)
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
A genus of fungi of the family Agaricaceae, order Agaricales; most species are poisonous.
Pressure within the cranial cavity. It is influenced by brain mass, the circulatory system, CSF dynamics, and skull rigidity.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Non-cadaveric providers of organs for transplant to related or non-related recipients.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D).
Increased pressure within the cranial vault. This may result from several conditions, including HYDROCEPHALUS; BRAIN EDEMA; intracranial masses; severe systemic HYPERTENSION; PSEUDOTUMOR CEREBRI; and other disorders.
Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions.
The channels that collect and transport the bile secretion from the BILE CANALICULI, the smallest branch of the BILIARY TRACT in the LIVER, through the bile ductules, the bile ducts out the liver, and to the GALLBLADDER for storage.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.
An autosomal dominant porphyria that is due to a deficiency of FERROCHELATASE (heme synthetase) in both the LIVER and the BONE MARROW, the last enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features include mainly neurological symptoms, rarely cutaneous lesions, and elevated levels of protoporphyrin and COPROPORPHYRINS in the feces.
A branch of the celiac artery that distributes to the stomach, pancreas, duodenum, liver, gallbladder, and greater omentum.
Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).
A rare central nervous system demyelinating condition affecting children and young adults. Pathologic findings include a large, sharply defined, asymmetric focus of myelin destruction that may involve an entire lobe or cerebral hemisphere. The clinical course tends to be progressive and includes dementia, cortical blindness, cortical deafness, spastic hemiplegia, and pseudobulbar palsy. Concentric sclerosis of Balo is differentiated from diffuse cerebral sclerosis of Schilder by the pathologic finding of alternating bands of destruction and preservation of myelin in concentric rings. Alpers' Syndrome refers to a heterogeneous group of diseases that feature progressive cerebral deterioration and liver disease. (From Adams et al., Principles of Neurology, 6th ed, p914; Dev Neurosci 1991;13(4-5):267-73)
Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS.
The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum.
Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)
Prospective patient listings for appointments or treatments.
A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.
The pathological process occurring in cells that are dying from irreparable injuries. It is caused by the progressive, uncontrolled action of degradative ENZYMES, leading to MITOCHONDRIAL SWELLING, nuclear flocculation, and cell lysis. It is distinct it from APOPTOSIS, which is a normal, regulated cellular process.
Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.
The BILE DUCTS and the GALLBLADDER.
FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cirrhosis involves the destruction of small intra-hepatic bile ducts and bile secretion. Secondary biliary cirrhosis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.
Surgical portasystemic shunt between the portal vein and inferior vena cava.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
A group of diseases related to a deficiency of the enzyme ARGININOSUCCINATE SYNTHASE which causes an elevation of serum levels of CITRULLINE. In neonates, clinical manifestations include lethargy, hypotonia, and SEIZURES. Milder forms also occur. Childhood and adult forms may present with recurrent episodes of intermittent weakness, lethargy, ATAXIA, behavioral changes, and DYSARTHRIA. (From Menkes, Textbook of Child Neurology, 5th ed, p49)
Glycogen stored in the liver. (Dorland, 28th ed)
Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA).
Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
Accumulation or retention of free fluid within the peritoneal cavity.
An antidepressive agent that has also been used in the treatment of movement disorders. The mechanism of action is not well understood.
INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.
A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.
Progressive destruction or the absence of all or part of the extrahepatic BILE DUCTS, resulting in the complete obstruction of BILE flow. Usually, biliary atresia is found in infants and accounts for one third of the neonatal cholestatic JAUNDICE.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
Imino acids are organic compounds containing a nitrogen atom in their structure, classified as derivatives of amino acids, where the carbon atom adjacent to the carboxyl group is bonded to a nitrogen atom instead of a hydrogen atom, forming a characteristic imino functional group.
Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL).
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.
A condition in which the hepatic venous outflow is obstructed anywhere from the small HEPATIC VEINS to the junction of the INFERIOR VENA CAVA and the RIGHT ATRIUM. Usually the blockage is extrahepatic and caused by blood clots (THROMBUS) or fibrous webs. Parenchymal FIBROSIS is uncommon.
Passages within the liver for the conveyance of bile. Includes right and left hepatic ducts even though these may join outside the liver to form the common hepatic duct.
The measurement of an organ in volume, mass, or heaviness.
Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose).
Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding.
The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
The N-acetyl derivative of CYSTEINE. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates.
An enzyme that catalyses three sequential METHYLATION reactions for conversion of phosphatidylethanolamine to PHOSPHATIDYLCHOLINE.
A process of selective diffusion through a membrane. It is usually used to separate low-molecular-weight solutes which diffuse through the membrane from the colloidal and high-molecular-weight solutes which do not. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
A serine protease that is the complex of COMPLEMENT C3B and COMPLEMENT FACTOR BB. It cleaves multiple COMPLEMENT C3 into COMPLEMENT C3A (anaphylatoxin) and COMPLEMENT C3B in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY.
Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use.
The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life.
One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.
System established by the World Health Organization and the International Committee on Thrombosis and Hemostasis for monitoring and reporting blood coagulation tests. Under this system, results are standardized using the International Sensitivity Index for the particular test reagent/instrument combination used.
An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.
Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6)
Amino acids containing an aromatic side chain.
INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water.
A tricarbocyanine dye that is used diagnostically in liver function tests and to determine blood volume and cardiac output.
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
Failure of equipment to perform to standard. The failure may be due to defects or improper use.
A disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed)
A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli.
A condition characterized by an abnormal increase of BILIRUBIN in the blood, which may result in JAUNDICE. Bilirubin, a breakdown product of HEME, is normally excreted in the BILE or further catabolized before excretion in the urine.
Treatment process involving the injection of fluid into an organ or tissue.
The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM.
A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION.
Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients.
Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.
Drugs that are used to reduce body temperature in fever.
Transference of cells within an individual, between individuals of the same species, or between individuals of different species.
An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic.
The return of a sign, symptom, or disease after a remission.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
Substances that are energetically unstable and can produce a sudden expansion of the material, called an explosion, which is accompanied by heat, pressure and noise. Other things which have been described as explosive that are not included here are explosive action of laser heating, human performance, sudden epidemiological outbreaks, or fast cell growth.
Heart failure caused by abnormal myocardial contraction during SYSTOLE leading to defective cardiac emptying.
INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
The administrative procedures involved with acquiring TISSUES or organs for TRANSPLANTATION through various programs, systems, or organizations. These procedures include obtaining consent from TISSUE DONORS and arranging for transportation of donated tissues and organs, after TISSUE HARVESTING, to HOSPITALS for processing and transplantation.
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)
A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery.
Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)
The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)
Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
Inbred C57BL mice are a strain of laboratory mice that have been produced by many generations of brother-sister matings, resulting in a high degree of genetic uniformity and homozygosity, making them widely used for biomedical research, including studies on genetics, immunology, cancer, and neuroscience.
Operation for biliary atresia by anastomosis of the bile ducts into the jejunum or duodenum.
A type of surgical portasystemic shunt to reduce portal hypertension with associated complications of esophageal varices and ascites. It is performed percutaneously through the jugular vein and involves the creation of an intrahepatic shunt between the hepatic vein and portal vein. The channel is maintained by a metallic stent. The procedure can be performed in patients who have failed sclerotherapy and is an additional option to the surgical techniques of portocaval, mesocaval, and splenorenal shunts. It takes one to three hours to perform. (JAMA 1995;273(23):1824-30)
A mitochondrial enzyme found in a wide variety of cells and tissues. It is the final enzyme in the 8-enzyme biosynthetic pathway of HEME. Ferrochelatase catalyzes ferrous insertion into protoporphyrin IX to form protoheme or heme. Deficiency in this enzyme results in ERYTHROPOIETIC PROTOPORPHYRIA.
Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS.
An infant during the first month after birth.
Surgical venous shunt between the portal and systemic circulation to effect decompression of the portal circulation. It is performed primarily in the treatment of bleeding esophageal varices resulting from portal hypertension. Types of shunt include portacaval, splenorenal, mesocaval, splenocaval, left gastric-caval (coronary-caval), portarenal, umbilicorenal, and umbilicocaval.
The rate dynamics in chemical or physical systems.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
Agents counteracting or neutralizing the action of POISONS.
An alpha-globulin found in the plasma of man and other vertebrates. It is apparently synthesized in the liver and carries vitamin D and its metabolites through the circulation and mediates the response of tissue. It is also known as group-specific component (Gc). Gc subtypes are used to determine specific phenotypes and gene frequencies. These data are employed in the classification of population groups, paternity investigations, and in forensic medicine.
A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides.
Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones.
Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.
Malfunction of implantation shunts, valves, etc., and prosthesis loosening, migration, and breaking.
Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both.
Inbred BALB/c mice are a strain of laboratory mice that have been selectively bred to be genetically identical to each other, making them useful for scientific research and experiments due to their consistent genetic background and predictable responses to various stimuli or treatments.
Criteria and standards used for the determination of the appropriateness of the inclusion of patients with specific conditions in proposed treatment plans and the criteria used for the inclusion of subjects in various clinical trials and other research protocols.
Antibodies elicited in a different species from which the antigen originated. These antibodies are directed against a wide variety of interspecies-specific antigens, the best known of which are Forssman, Hanganutziu-Deicher (H-D), and Paul-Bunnell (P-B). Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of infection and latent infectious states as well as in cancer classification.
Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed)
The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation.
Extracorporeal ULTRAFILTRATION technique without HEMODIALYSIS for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function.
The venous trunk which receives blood from the lower extremities and from the pelvic and abdominal organs.
Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.
Specialized phagocytic cells of the MONONUCLEAR PHAGOCYTE SYSTEM found on the luminal surface of the hepatic sinusoids. They filter bacteria and small foreign proteins out of the blood, and dispose of worn out red blood cells.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi).
A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease.
Genetically developed small pigs for use in biomedical research. There are several strains - Yucatan miniature, Sinclair miniature, and Minnesota miniature.
A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.
Advanced and highly specialized care provided to medical or surgical patients whose conditions are life-threatening and require comprehensive care and constant monitoring. It is usually administered in specially equipped units of a health care facility.
A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism.

Hepatosplanchnic haemodynamics and renal blood flow and function in rats with liver failure. (1/587)

BACKGROUND: Massive liver necrosis, characteristic of acute liver failure, may affect hepatosplanchnic haemodynamics, and contribute to the alterations in renal haemodynamics and function. AIMS: To investigate the relation between hepatosplanchnic haemodynamics, including portal systemic shunting, and renal blood flow and function in rats with acute liver failure. METHODS: Liver failure was induced in male Wistar rats by intraperitoneal injection of 1.1 g/kg of D(+)-galactosamine hydrochloride. The parameters assessed included; systemic, hepatosplanchnic, and renal blood flow (57Co microsphere method); portal-systemic shunting and intrarenal shunting (consecutive intrasplenic, intraportal, or renal arterial injections of 99mTc methylene diphosphonate and 99mTc albumin microspheres); arterial blood pressure and portal pressure; renal function; and liver function (liver function tests and 14C aminopyrine breath test). RESULTS: Progressive liver dysfunction was accompanied by the development of a hyperdynamic circulation, a highly significant decrease in renal blood flow and function, and an increase in intrarenal shunting 36, 42, and 48 hours after administration of D-galactosamine. The alterations in renal blood flow and function were accompanied by significant increases in portal pressure, portal venous inflow, and intrahepatic portal systemic shunting in galactosamine treated rats compared with controls. There was a significant correlation between changes in renal blood flow and changes in portal pressure, intrahepatic portal systemic shunting, and deterioration in liver function (r = 0.8, p < 0.0001). CONCLUSIONS: The results of this study suggest that both increased intrahepatic portal systemic shunting and hepatocyte impairment may contribute to alterations in renal haemodynamics and function.  (+info)

Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching system. (2/587)

An adenovirus vector AxCALNFasL was constructed in order to transduce a gene for rat Fas-ligand, requiring co-expression of Cre recombinase for its expression. In the cosmid cassette, pAxCALNFasL, a stuffer DNA fragment flanked with two loxP sequences was placed between the promoter and Fas-ligand cDNA to prevent its expression in transfected 293 cells. COS-7 cells infected with AxCALNFasL alone did not induce apoptosis in cocultivated Jurkat cells, but the cells treated with AxCALNFasL and AxCANCre (an adenovirus expressing Cre recombinase with the CAG promoter) did. BALB/c mice injected with 10(9) plaque-forming units of AxCALNFasL and with different doses of AxCANCre, developed lethal acute liver failure. The number of the apoptotic hepatocytes increased dramatically with increased doses of injected AxCANCre, indicating that the level of transgene expression in the rodent liver appeared to be adjustable. Based on these observations, we conclude that vectors expressing a gene to produce cytotoxic substances can be constructed by the use of a Cre-mediated switching system. Our system also demonstrated that efficient expression of the toxic gene in the rodent liver was achievable by co-infection of adenovirus vectors carrying the target gene and Cre recombinase.  (+info)

Anorexia nervosa with severe liver dysfunction and subsequent critical complications. (3/587)

A twenty-year-old woman with anorexia nervosa (body mass index=11) suffered from severe liver dysfunction (aspartate aminotransferase 5,000 IU/l, alanine aminotransferase 3,980 IU/l, prothrombin time 32%), hypoglycemia (serum glucose 27 mg/dl), and pancreatic dysfunction (amylase 820 IU/l, lipase 558 IU/l). She fell into a depressive state with irritability, which was not improved by intravenous glucose. Despite treatment with plasmapheresis for the liver dysfunction, she subsequently developed pulmonary edema, acute renal failure, gastrointestinal bleeding, and disseminated intravascular coagulation. Hemodialysis, mechanical ventilation and drug therapy including prednisolone, prostaglandin E1, and branched-chain amino acid, improved her critical condition. In this case, malnutrition may have been the cause for the liver dysfunction and subsequent complications.  (+info)

Review article: liver support systems in acute hepatic failure. (4/587)

The treatment of acute hepatic failure has developed rapidly over the last 40 years, reducing morbidity and mortality from this syndrome. Whilst this has been partly attributed to significant improvements in the specialist medical management of these patients, advances in surgical techniques and pharmaceutical developments have led to the establishment of successful liver transplantation programmes, which have improved mortality significantly. This review will examine the clinical impact of alternative methods that have been used to provide extra-corporeal hepatic support. Non-biological, bio- logical and hybrid hepatic extra-corporeal support will be explored, offering a comprehensive historical overview and an appraisal of present and future advances.  (+info)

Hepatocyte transplantation in acute liver failure. (5/587)

The majority of patients with acute liver failure (ALF) die waiting for orthotopic liver transplantation (OLT). No other treatment modality is shown to improve survival. This study was conducted to assess the safety and feasibility of hepatocyte transplantation (HT) and subsequent engraftment and function of donor cells. Functional and structural integrity of cryopreserved and thawed human hepatocytes were assessed by their morphological characteristics, induction of P-4501A1 transcription, and survival in vivo by xenotransplantation into rats. Five patients with severe ALF underwent intrasplenic (4 patients) and/or intrahepatic (2 patients) HT through angiography under cyclosporine immunosuppression. All patients had grade III to IV encephalopathy and factor V levels less than 0.5 U/mL, were ventilator and dialysis dependent, and were not OLT candidates. Three of the 5 patients who survived 48 hours after HT had substantial improvement in encephalopathy scores, arterial ammonia levels, and prothrombin times. Clinical improvement was paralleled by an increase in aminopyrine and caffeine clearances. All 3 patients lived substantially longer than expected based on clinical experience after HT (12, 28, and 52 days) but eventually died. Postmortem examination showed the presence of transplanted hepatocytes in liver and spleen by light microscopy and fluorescent in situ hybridization (FISH). Cryopreserved and thawed human hepatocytes can be transplanted into recipients with ALF with some acceptable but definite complications. Engraftment of donor hepatocytes was proven by histological examination and FISH by both transjugular biopsy and at autopsy. Improvement in brain edema, encephalopathy grade, and clearance of antipyrine and caffeine suggested function, albeit with a 24- to 72-hour delay posttransplantation.  (+info)

Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. (6/587)

Because of a critical shortage in suitable organs, many patients with terminal liver disease die each year before liver transplantation can be performed. Transplantation of isolated hepatocytes has been proposed for the temporary metabolic support of patients awaiting liver transplantation or spontaneous reversion of their liver disease. A major limitation of this form of therapy is the present inability to isolate an adequate number of transplantable hepatocytes. A highly differentiated cell line, NKNT-3, was generated by retroviral transfer in normal primary adult human hepatocytes of an immortalizing gene that can be subsequently and completely excised by Cre/Lox site-specific recombination. When transplanted into the spleen of rats under transient immunosuppression, reversibly immortalized NKNT-3 cells provided life-saving metabolic support during acute liver failure induced by 90% hepatectomy.  (+info)

Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. (7/587)

Acute liver failure (ALF) is an uncommon condition associated with high morbidity and mortality. We performed a retrospective analysis of patients evaluated for ALF. The aim of our study is to determine the clinical features and outcome of such patients and to assess the validity of King's College Hospital (KCH) prognostic criteria. One hundred seventy-seven patients were evaluated for ALF during a period of 13 years. Mean age was 39 years, and 63% were women. The causes included viral hepatitis (31%), acetaminophen toxicity (19%), idiosyncratic drug reactions (12%), miscellaneous causes (11%), and an indeterminate group (28%). Twenty-five patients (14%) recovered with medical therapy (group I), 65 patients (37%) died without orthotopic liver transplantation (OLT; group II), and 87 patients (49%) underwent OLT (group III). Patients in group II were older and often had advanced encephalopathy, whereas those in group I had less hyperbilirubinemia and often had hyperacute failure. KCH criteria had high specificity and positive predictive value but low negative predictive value for a poor outcome. We conclude that early prognostication is needed in patients with ALF to assist decision making regarding OLT. The fulfillment of KCH criteria usually predicts a poor outcome, but a lack of fulfillment does not predict survival.  (+info)

Extracorporeal perfusion for the treatment of acute liver failure. (8/587)

OBJECTIVE AND SUMMARY BACKGROUND DATA: Because of the shortage of available donor organs, death rates from liver failure remain high. Therefore, several temporary liver-assisting therapies have been developed. This article reviews various approaches to temporary liver support as well as immunologic and metabolic developments toward a solution for this problem. METHODS: A literature review was performed using Medline and additional library searches to obtain further references. Only articles with a well-defined aim of study and methodology and a clear description of the outcome of the experiments were included. CONCLUSIONS: Renewed interest has developed in old and new methods for an extracorporeal approach to the treatment of acute liver failure. Although temporary clinical improvement has been established, further research is needed to achieve a successful long-term clinical outcome. New developments in the field of genetic modification and tissue engineering await clinical application in the near future.  (+info)

Acute liver failure is a sudden and severe loss of liver function that occurs within a few days or weeks. It can be caused by various factors such as drug-induced liver injury, viral hepatitis, or metabolic disorders. In acute liver failure, the liver cannot perform its vital functions, including protein synthesis, detoxification, and metabolism of carbohydrates, fats, and proteins.

The symptoms of acute liver failure include jaundice (yellowing of the skin and eyes), coagulopathy (bleeding disorders), hepatic encephalopathy (neurological symptoms such as confusion, disorientation, and coma), and elevated levels of liver enzymes in the blood. Acute liver failure is a medical emergency that requires immediate hospitalization and treatment, which may include medications, supportive care, and liver transplantation.

Liver failure is a serious condition in which the liver is no longer able to perform its normal functions, such as removing toxins and waste products from the blood, producing bile to help digest food, and regulating blood clotting. This can lead to a buildup of toxins in the body, jaundice (yellowing of the skin and eyes), fluid accumulation in the abdomen, and an increased risk of bleeding. Liver failure can be acute (sudden) or chronic (developing over time). Acute liver failure is often caused by medication toxicity, viral hepatitis, or other sudden illnesses. Chronic liver failure is most commonly caused by long-term damage from conditions such as cirrhosis, hepatitis, alcohol abuse, and non-alcoholic fatty liver disease.

It's important to note that Liver Failure is a life threatening condition and need immediate medical attention.

Liver transplantation is a surgical procedure in which a diseased or failing liver is replaced with a healthy one from a deceased donor or, less commonly, a portion of a liver from a living donor. The goal of the procedure is to restore normal liver function and improve the patient's overall health and quality of life.

Liver transplantation may be recommended for individuals with end-stage liver disease, acute liver failure, certain genetic liver disorders, or liver cancers that cannot be treated effectively with other therapies. The procedure involves complex surgery to remove the diseased liver and implant the new one, followed by a period of recovery and close medical monitoring to ensure proper function and minimize the risk of complications.

The success of liver transplantation has improved significantly in recent years due to advances in surgical techniques, immunosuppressive medications, and post-transplant care. However, it remains a major operation with significant risks and challenges, including the need for lifelong immunosuppression to prevent rejection of the new liver, as well as potential complications such as infection, bleeding, and organ failure.

An artificial liver is not a actual organ replacement but a device designed to perform some of the functions of a liver in patients with liver failure. These devices can be divided into two types: bioartificial and non-bioartificial. Non-bioartificial devices, such as hemodialysis machines and molecular adsorbent recirculating system (MARS), use physical and chemical processes to remove toxins from the blood. Bioartificial livers, on the other hand, contain living cells, usually hepatocytes, which can perform more advanced liver functions such as synthesizing proteins and drugs metabolism.

It's important to note that currently there is no FDA approved artificial liver device available for use in clinical practice. However, research and development of these devices are ongoing with the hope that they may provide a bridge to transplantation or recovery for patients with acute liver failure.

Liver diseases refer to a wide range of conditions that affect the normal functioning of the liver. The liver is a vital organ responsible for various critical functions such as detoxification, protein synthesis, and production of biochemicals necessary for digestion.

Liver diseases can be categorized into acute and chronic forms. Acute liver disease comes on rapidly and can be caused by factors like viral infections (hepatitis A, B, C, D, E), drug-induced liver injury, or exposure to toxic substances. Chronic liver disease develops slowly over time, often due to long-term exposure to harmful agents or inherent disorders of the liver.

Common examples of liver diseases include hepatitis, cirrhosis (scarring of the liver tissue), fatty liver disease, alcoholic liver disease, autoimmune liver diseases, genetic/hereditary liver disorders (like Wilson's disease and hemochromatosis), and liver cancers. Symptoms may vary widely depending on the type and stage of the disease but could include jaundice, abdominal pain, fatigue, loss of appetite, nausea, and weight loss.

Early diagnosis and treatment are essential to prevent progression and potential complications associated with liver diseases.

The liver is a large, solid organ located in the upper right portion of the abdomen, beneath the diaphragm and above the stomach. It plays a vital role in several bodily functions, including:

1. Metabolism: The liver helps to metabolize carbohydrates, fats, and proteins from the food we eat into energy and nutrients that our bodies can use.
2. Detoxification: The liver detoxifies harmful substances in the body by breaking them down into less toxic forms or excreting them through bile.
3. Synthesis: The liver synthesizes important proteins, such as albumin and clotting factors, that are necessary for proper bodily function.
4. Storage: The liver stores glucose, vitamins, and minerals that can be released when the body needs them.
5. Bile production: The liver produces bile, a digestive juice that helps to break down fats in the small intestine.
6. Immune function: The liver plays a role in the immune system by filtering out bacteria and other harmful substances from the blood.

Overall, the liver is an essential organ that plays a critical role in maintaining overall health and well-being.

Heart failure is a pathophysiological state in which the heart is unable to pump sufficient blood to meet the metabolic demands of the body or do so only at the expense of elevated filling pressures. It can be caused by various cardiac disorders, including coronary artery disease, hypertension, valvular heart disease, cardiomyopathy, and arrhythmias. Symptoms may include shortness of breath, fatigue, and fluid retention. Heart failure is often classified based on the ejection fraction (EF), which is the percentage of blood that is pumped out of the left ventricle during each contraction. A reduced EF (less than 40%) is indicative of heart failure with reduced ejection fraction (HFrEF), while a preserved EF (greater than or equal to 50%) is indicative of heart failure with preserved ejection fraction (HFpEF). There is also a category of heart failure with mid-range ejection fraction (HFmrEF) for those with an EF between 40-49%.

Hepatic encephalopathy (HE) is a neuropsychiatric syndrome associated with liver dysfunction and/or portosystemic shunting. It results from the accumulation of toxic substances, such as ammonia and inflammatory mediators, which are normally metabolized by the liver. HE can present with a wide range of symptoms, including changes in sleep-wake cycle, altered mental status, confusion, disorientation, asterixis (flapping tremor), and in severe cases, coma. The diagnosis is based on clinical evaluation, neuropsychological testing, and exclusion of other causes of cognitive impairment. Treatment typically involves addressing the underlying liver dysfunction, reducing ammonia production through dietary modifications and medications, and preventing further episodes with lactulose or rifaximin therapy.

Liver cirrhosis is a chronic, progressive disease characterized by the replacement of normal liver tissue with scarred (fibrotic) tissue, leading to loss of function. The scarring is caused by long-term damage from various sources such as hepatitis, alcohol abuse, nonalcoholic fatty liver disease, and other causes. As the disease advances, it can lead to complications like portal hypertension, fluid accumulation in the abdomen (ascites), impaired brain function (hepatic encephalopathy), and increased risk of liver cancer. It is generally irreversible, but early detection and treatment of underlying causes may help slow down its progression.

Liver neoplasms refer to abnormal growths in the liver that can be benign or malignant. Benign liver neoplasms are non-cancerous tumors that do not spread to other parts of the body, while malignant liver neoplasms are cancerous tumors that can invade and destroy surrounding tissue and spread to other organs.

Liver neoplasms can be primary, meaning they originate in the liver, or secondary, meaning they have metastasized (spread) to the liver from another part of the body. Primary liver neoplasms can be further classified into different types based on their cell of origin and behavior, including hepatocellular carcinoma, cholangiocarcinoma, and hepatic hemangioma.

The diagnosis of liver neoplasms typically involves a combination of imaging studies, such as ultrasound, CT scan, or MRI, and biopsy to confirm the type and stage of the tumor. Treatment options depend on the type and extent of the neoplasm and may include surgery, radiation therapy, chemotherapy, or liver transplantation.

"Sorption detoxification" is not a widely recognized or established medical term. However, the word "sorption" refers to various processes that result in the accumulation of a substance at an interface between two phases, such as absorption (taking up a substance into a liquid or solid), adsorption (accumulation of molecules on the surface of a material), and ion exchange.

In some alternative medicine or detoxification contexts, "sorption detoxification" might refer to the use of substances that can bind to or absorb toxins in the body, facilitating their removal through excretion. However, there is limited scientific evidence supporting the effectiveness of such approaches, and they are not considered mainstream medical treatments for drug addiction, poisoning, or other medical conditions.

Therefore, it's essential to consult with a licensed healthcare professional before pursuing any detoxification or treatment regimen that involves "sorption detoxification" or similar unconventional methods.

End-stage liver disease (ESLD) is a term used to describe advanced and irreversible liver damage, usually caused by chronic liver conditions such as cirrhosis, hepatitis, or alcoholic liver disease. At this stage, the liver can no longer function properly, leading to a range of serious complications.

The symptoms of ESLD may include:

* Jaundice (yellowing of the skin and eyes)
* Ascites (accumulation of fluid in the abdomen)
* Encephalopathy (confusion, drowsiness, or coma caused by the buildup of toxins in the brain)
* Bleeding from the gastrointestinal tract
* Infections
* Kidney failure

Treatment for ESLD typically focuses on managing symptoms and preventing complications. In some cases, a liver transplant may be necessary to improve survival. However, due to the shortage of available donor livers, many people with ESLD are not eligible for transplantation. The prognosis for individuals with ESLD is generally poor, with a median survival time of less than one year.

Acetaminophen is a medication used to relieve pain and reduce fever. It is a commonly used over-the-counter drug and is also available in prescription-strength formulations. Acetaminophen works by inhibiting the production of prostaglandins, chemicals in the body that cause inflammation and trigger pain signals.

Acetaminophen is available in many different forms, including tablets, capsules, liquids, and suppositories. It is often found in combination with other medications, such as cough and cold products, sleep aids, and opioid pain relievers.

While acetaminophen is generally considered safe when used as directed, it can cause serious liver damage or even death if taken in excessive amounts. It is important to follow the dosing instructions carefully and avoid taking more than the recommended dose, especially if you are also taking other medications that contain acetaminophen.

If you have any questions about using acetaminophen or are concerned about potential side effects, it is always best to consult with a healthcare professional.

Drug-Induced Liver Injury (DILI) is a medical term that refers to liver damage or injury caused by the use of medications or drugs. This condition can vary in severity, from mild abnormalities in liver function tests to severe liver failure, which may require a liver transplant.

The exact mechanism of DILI can differ depending on the drug involved, but it generally occurs when the liver metabolizes the drug into toxic compounds that damage liver cells. This can happen through various pathways, including direct toxicity to liver cells, immune-mediated reactions, or metabolic idiosyncrasies.

Symptoms of DILI may include jaundice (yellowing of the skin and eyes), fatigue, abdominal pain, nausea, vomiting, loss of appetite, and dark urine. In severe cases, it can lead to complications such as ascites, encephalopathy, and bleeding disorders.

The diagnosis of DILI is often challenging because it requires the exclusion of other potential causes of liver injury. Liver function tests, imaging studies, and sometimes liver biopsies may be necessary to confirm the diagnosis. Treatment typically involves discontinuing the offending drug and providing supportive care until the liver recovers. In some cases, medications that protect the liver or promote its healing may be used.

Liver function tests (LFTs) are a group of blood tests that are used to assess the functioning and health of the liver. These tests measure the levels of various enzymes, proteins, and waste products that are produced or metabolized by the liver. Some common LFTs include:

1. Alanine aminotransferase (ALT): An enzyme found primarily in the liver, ALT is released into the bloodstream in response to liver cell damage. Elevated levels of ALT may indicate liver injury or disease.
2. Aspartate aminotransferase (AST): Another enzyme found in various tissues, including the liver, heart, and muscles. Like ALT, AST is released into the bloodstream following tissue damage. High AST levels can be a sign of liver damage or other medical conditions.
3. Alkaline phosphatase (ALP): An enzyme found in several organs, including the liver, bile ducts, and bones. Elevated ALP levels may indicate a blockage in the bile ducts, liver disease, or bone disorders.
4. Gamma-glutamyl transferase (GGT): An enzyme found mainly in the liver, pancreas, and biliary system. Increased GGT levels can suggest liver disease, alcohol consumption, or the use of certain medications.
5. Bilirubin: A yellowish pigment produced when hemoglobin from red blood cells is broken down. Bilirubin is processed by the liver and excreted through bile. High bilirubin levels can indicate liver dysfunction, bile duct obstruction, or certain types of anemia.
6. Albumin: A protein produced by the liver that helps maintain fluid balance in the body and transports various substances in the blood. Low albumin levels may suggest liver damage, malnutrition, or kidney disease.
7. Total protein: A measure of all proteins present in the blood, including albumin and other types of proteins produced by the liver. Decreased total protein levels can indicate liver dysfunction or other medical conditions.

These tests are often ordered together as part of a routine health checkup or when evaluating symptoms related to liver function or disease. The results should be interpreted in conjunction with clinical findings, medical history, and other diagnostic tests.

Liver regeneration is the ability of the liver to restore its original mass and function after injury or surgical resection. This complex process involves the proliferation and differentiation of mature hepatocytes, as well as the activation and transdifferentiation of various types of stem and progenitor cells located in the liver. The mechanisms that regulate liver regeneration include a variety of growth factors, hormones, and cytokines, which act in a coordinated manner to ensure the restoration of normal liver architecture and function. Liver regeneration is essential for the survival of individuals who have undergone partial hepatectomy or who have suffered liver damage due to various causes, such as viral hepatitis, alcohol abuse, or drug-induced liver injury.

Analgesics, non-narcotic are a class of medications used to relieve pain that do not contain narcotics or opioids. They work by blocking the transmission of pain signals in the nervous system or by reducing inflammation and swelling. Examples of non-narcotic analgesics include acetaminophen (Tylenol), ibuprofen (Advil, Motrin), naproxen (Aleve), and aspirin. These medications are often used to treat mild to moderate pain, such as headaches, menstrual cramps, muscle aches, and arthritis symptoms. They can be obtained over-the-counter or by prescription, depending on the dosage and formulation. It is important to follow the recommended dosages and usage instructions carefully to avoid adverse effects.

Fatty liver, also known as hepatic steatosis, is a medical condition characterized by the abnormal accumulation of fat in the liver. The liver's primary function is to process nutrients, filter blood, and fight infections, among other tasks. When excess fat builds up in the liver cells, it can impair liver function and lead to inflammation, scarring, and even liver failure if left untreated.

Fatty liver can be caused by various factors, including alcohol consumption, obesity, nonalcoholic fatty liver disease (NAFLD), viral hepatitis, and certain medications or medical conditions. NAFLD is the most common cause of fatty liver in the United States and other developed countries, affecting up to 25% of the population.

Symptoms of fatty liver may include fatigue, weakness, weight loss, loss of appetite, nausea, abdominal pain or discomfort, and jaundice (yellowing of the skin and eyes). However, many people with fatty liver do not experience any symptoms, making it essential to diagnose and manage the condition through regular check-ups and blood tests.

Treatment for fatty liver depends on the underlying cause. Lifestyle changes such as weight loss, exercise, and dietary modifications are often recommended for people with NAFLD or alcohol-related fatty liver disease. Medications may also be prescribed to manage related conditions such as diabetes, high cholesterol, or metabolic syndrome. In severe cases of liver damage, a liver transplant may be necessary.

Galactosamine is not a medical condition but a chemical compound. Medically, it might be referred to in the context of certain medical tests or treatments. Here's the scientific definition:

Galactosamine is an amino sugar, a type of monosaccharide (simple sugar) that contains a functional amino group (-NH2) as well as a hydroxyl group (-OH). More specifically, galactosamine is a derivative of galactose, with the chemical formula C6H13NO5. It is an important component of many glycosaminoglycans (GAGs), which are complex carbohydrates found in animal tissues, particularly in connective tissue and cartilage.

In some medical applications, galactosamine has been used as a building block for the synthesis of GAG analogs or as a component of substrates for enzyme assays. It is also used in research to study various biological processes, such as cell growth and differentiation.

Hepatectomy is a surgical procedure that involves the removal of part or all of the liver. This procedure can be performed for various reasons, such as removing cancerous or non-cancerous tumors, treating liver trauma, or donating a portion of the liver to another person in need of a transplant (live donor hepatectomy). The extent of the hepatectomy depends on the medical condition and overall health of the patient. It is a complex procedure that requires significant expertise and experience from the surgical team due to the liver's unique anatomy, blood supply, and regenerative capabilities.

Hepatocytes are the predominant type of cells in the liver, accounting for about 80% of its cytoplasmic mass. They play a key role in protein synthesis, protein storage, transformation of carbohydrates, synthesis of cholesterol, bile salts and phospholipids, detoxification, modification, and excretion of exogenous and endogenous substances, initiation of formation and secretion of bile, and enzyme production. Hepatocytes are essential for the maintenance of homeostasis in the body.

Microsomes, liver refers to a subcellular fraction of liver cells (hepatocytes) that are obtained during tissue homogenization and subsequent centrifugation. These microsomal fractions are rich in membranous structures known as the endoplasmic reticulum (ER), particularly the rough ER. They are involved in various important cellular processes, most notably the metabolism of xenobiotics (foreign substances) including drugs, toxins, and carcinogens.

The liver microsomes contain a variety of enzymes, such as cytochrome P450 monooxygenases, that are crucial for phase I drug metabolism. These enzymes help in the oxidation, reduction, or hydrolysis of xenobiotics, making them more water-soluble and facilitating their excretion from the body. Additionally, liver microsomes also host other enzymes involved in phase II conjugation reactions, where the metabolites from phase I are further modified by adding polar molecules like glucuronic acid, sulfate, or acetyl groups.

In summary, liver microsomes are a subcellular fraction of liver cells that play a significant role in the metabolism and detoxification of xenobiotics, contributing to the overall protection and maintenance of cellular homeostasis within the body.

Treatment failure is a term used in medicine to describe the situation when a prescribed treatment or intervention is not achieving the desired therapeutic goals or objectives. This may occur due to various reasons, such as:

1. Development of drug resistance by the pathogen or disease being treated.
2. Inadequate dosage or frequency of the medication.
3. Poor adherence or compliance to the treatment regimen by the patient.
4. The presence of underlying conditions or comorbidities that may affect the efficacy of the treatment.
5. The severity or progression of the disease despite appropriate treatment.

When treatment failure occurs, healthcare providers may need to reassess the patient's condition and modify the treatment plan accordingly, which may include adjusting the dosage, changing the medication, adding new medications, or considering alternative treatments.

Bilirubin is a yellowish pigment that is produced by the liver when it breaks down old red blood cells. It is a normal byproduct of hemoglobin metabolism and is usually conjugated (made water-soluble) in the liver before being excreted through the bile into the digestive system. Elevated levels of bilirubin can cause jaundice, a yellowing of the skin and eyes. Increased bilirubin levels may indicate liver disease or other medical conditions such as gallstones or hemolysis. It is also measured to assess liver function and to help diagnose various liver disorders.

A fatal outcome is a term used in medical context to describe a situation where a disease, injury, or illness results in the death of an individual. It is the most severe and unfortunate possible outcome of any medical condition, and is often used as a measure of the severity and prognosis of various diseases and injuries. In clinical trials and research, fatal outcome may be used as an endpoint to evaluate the effectiveness and safety of different treatments or interventions.

I'd be happy to help! However, I believe there might be a slight misunderstanding in your question. Mitochondria are organelles found in the cells of all complex living organisms, including humans, while the liver is a large, solid organ located in the upper right portion of the abdomen. They don't have a medical definition together. I can certainly provide you with separate definitions for each:

1. Mitochondria: These are double-membrane-bound cellular organelles that generate most of the chemical energy needed to power the cell's biochemical reactions. Commonly known as the "powerhouse of the cell," mitochondria convert organic substrates, such as glucose, fatty acids, and amino acids, into adenosine triphosphate (ATP) through a process called oxidative phosphorylation. Mitochondria are dynamic structures that can change their shape, size, and number through fission (division) and fusion (merging) processes. They play essential roles in various cellular functions, including calcium signaling, apoptosis (programmed cell death), and the regulation of cellular metabolism.

2. Liver: The liver is a large, lobulated organ that lies mainly in the upper right portion of the abdominal cavity, just below the diaphragm. It plays a crucial role in various physiological functions, such as detoxification, protein synthesis, metabolism, and nutrient storage. The liver is responsible for removing toxins from the bloodstream, producing bile to aid in digestion, regulating glucose levels, synthesizing plasma proteins, and storing glycogen, vitamins, and minerals. It also contributes to the metabolism of carbohydrates, lipids, and amino acids, helping maintain energy homeostasis in the body.

I hope this clarifies any confusion! If you have any further questions or need more information, please don't hesitate to ask.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Liver circulation, also known as hepatic circulation, refers to the blood flow through the liver. The liver receives blood from two sources: the hepatic artery and the portal vein.

The hepatic artery delivers oxygenated blood from the heart to the liver, accounting for about 25% of the liver's blood supply. The remaining 75% comes from the portal vein, which carries nutrient-rich, deoxygenated blood from the gastrointestinal tract, spleen, pancreas, and gallbladder to the liver.

In the liver, these two sources of blood mix in the sinusoids, small vessels with large spaces between the endothelial cells that line them. This allows for efficient exchange of substances between the blood and the hepatocytes (liver cells). The blood then leaves the liver through the hepatic veins, which merge into the inferior vena cava and return the blood to the heart.

The unique dual blood supply and extensive sinusoidal network in the liver enable it to perform various critical functions, such as detoxification, metabolism, synthesis, storage, and secretion of numerous substances, maintaining body homeostasis.

Hyperammonemia is a medical condition characterized by an excessively high level of ammonia (a toxic byproduct of protein metabolism) in the blood. This can lead to serious neurological symptoms and complications, as ammonia is highly toxic to the brain. Hyperammonemia can be caused by various underlying conditions, including liver disease, genetic disorders that affect ammonia metabolism, certain medications, and infections. It is important to diagnose and treat hyperammonemia promptly to prevent long-term neurological damage or even death. Treatment typically involves addressing the underlying cause of the condition, as well as providing supportive care such as administering medications that help remove ammonia from the blood.

Mushroom poisoning refers to the adverse health effects that occur after ingesting toxic mushrooms. These effects can range from mild gastrointestinal symptoms like nausea, vomiting, and diarrhea, to severe neurological and systemic reactions, including hallucinations, organ failure, and even death in serious cases. The severity of the poisoning depends on several factors, including the type and amount of toxic mushroom consumed, the age and health status of the individual, and the time elapsed between ingestion and medical treatment. It is crucial to seek immediate medical attention if mushroom poisoning is suspected, as some symptoms may not appear until several hours or days after consumption, and delays in treatment can lead to more severe outcomes.

Hepatitis is a medical condition characterized by inflammation of the liver, often resulting in damage to liver cells. It can be caused by various factors, including viral infections (such as Hepatitis A, B, C, D, and E), alcohol abuse, toxins, medications, and autoimmune disorders. Symptoms may include jaundice, fatigue, abdominal pain, loss of appetite, nausea, vomiting, and dark urine. The severity of the disease can range from mild illness to severe, life-threatening conditions, such as liver failure or cirrhosis.

Alanine transaminase (ALT) is a type of enzyme found primarily in the cells of the liver and, to a lesser extent, in the cells of other tissues such as the heart, muscles, and kidneys. Its primary function is to catalyze the reversible transfer of an amino group from alanine to another alpha-keto acid, usually pyruvate, to form pyruvate and another amino acid, usually glutamate. This process is known as the transamination reaction.

When liver cells are damaged or destroyed due to various reasons such as hepatitis, alcohol abuse, nonalcoholic fatty liver disease, or drug-induced liver injury, ALT is released into the bloodstream. Therefore, measuring the level of ALT in the blood is a useful diagnostic tool for evaluating liver function and detecting liver damage. Normal ALT levels vary depending on the laboratory, but typically range from 7 to 56 units per liter (U/L) for men and 6 to 45 U/L for women. Elevated ALT levels may indicate liver injury or disease, although other factors such as muscle damage or heart disease can also cause elevations in ALT.

Multiple Organ Failure (MOF) is a severe condition characterized by the dysfunction or failure of more than one organ system in the body. It often occurs as a result of serious illness, trauma, or infection, such as sepsis. The organs that commonly fail include the lungs, kidneys, liver, and heart. This condition can lead to significant morbidity and mortality if not promptly diagnosed and treated.

The definition of MOF has evolved over time, but a widely accepted one is the "Sequential Organ Failure Assessment" (SOFA) score, which evaluates six organ systems: respiratory, coagulation, liver, cardiovascular, renal, and neurologic. A SOFA score of 10 or more indicates MOF, and a higher score is associated with worse outcomes.

MOF can be classified as primary or secondary. Primary MOF occurs when the initial insult directly causes organ dysfunction, such as in severe trauma or septic shock. Secondary MOF occurs when the initial injury or illness has been controlled, but organ dysfunction develops later due to ongoing inflammation and other factors.

Early recognition and aggressive management of MOF are crucial for improving outcomes. Treatment typically involves supportive care, such as mechanical ventilation, dialysis, and medication to support cardiovascular function. In some cases, surgery or other interventions may be necessary to address the underlying cause of organ dysfunction.

Alcoholic liver disease (ALD) is a term that encompasses a spectrum of liver disorders caused by excessive alcohol consumption. The three main stages of ALD are:

1. Fatty Liver: This is the earliest stage of ALD, characterized by the accumulation of fat droplets within liver cells (hepatocytes). It's often reversible with abstinence from alcohol.

2. Alcoholic Hepatitis: This is a more severe form of ALD, characterized by inflammation and damage to the liver cells. It can range from mild to severe, and severe cases can lead to liver failure. Symptoms may include jaundice, abdominal pain, and fever.

3. Cirrhosis: This is the most advanced stage of ALD, characterized by widespread scarring (fibrosis) and nodular transformation of the liver. It's irreversible and can lead to complications such as liver failure, portal hypertension, and increased risk of liver cancer.

The development and progression of ALD are influenced by various factors, including the amount and duration of alcohol consumption, genetic predisposition, nutritional status, and co-existing viral hepatitis or other liver diseases. Abstaining from alcohol is the most effective way to prevent and manage ALD.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Alcoholic Liver Cirrhosis is a medical condition characterized by irreversible scarring (fibrosis) and damage to the liver caused by excessive consumption of alcohol over an extended period. The liver's normal structure and function are progressively impaired as healthy liver tissue is replaced by scarred tissue, leading to the formation of nodules (regenerative noduli).

The condition typically develops after years of heavy drinking, with a higher risk for those who consume more than 60 grams of pure alcohol daily. The damage caused by alcoholic liver cirrhosis can be life-threatening and may result in complications such as:

1. Ascites (accumulation of fluid in the abdomen)
2. Encephalopathy (neurological dysfunction due to liver failure)
3. Esophageal varices (dilated veins in the esophagus that can rupture and bleed)
4. Hepatorenal syndrome (kidney failure caused by liver disease)
5. Increased susceptibility to infections
6. Liver cancer (hepatocellular carcinoma)
7. Portal hypertension (increased blood pressure in the portal vein that supplies blood to the liver)

Abstaining from alcohol and managing underlying medical conditions are crucial for slowing down or halting disease progression. Treatment may involve medications, dietary changes, and supportive care to address complications. In severe cases, a liver transplant might be necessary.

Extracorporeal circulation (ECC) is a term used in medicine to describe the process of temporarily taking over the functions of the heart and lungs by using a machine. This allows the surgeon to perform certain types of surgery, such as open-heart surgery, on a still and bloodless operating field.

During ECC, the patient's blood is circulated outside the body through a pump and oxygenator. The pump helps to maintain blood flow and pressure, while the oxygenator adds oxygen to the blood and removes carbon dioxide. This allows the surgeon to stop the heart and arrest its motion, making it easier to perform delicate procedures on the heart and surrounding structures.

Extracorporeal circulation is a complex and high-risk procedure that requires careful monitoring and management by a team of healthcare professionals. It carries risks such as bleeding, infection, and injury to blood vessels or organs. However, when performed correctly, it can be a life-saving measure for patients undergoing certain types of surgery.

Autoimmune hepatitis is a chronic (long-term) disease in which the body's immune system mistakenly attacks the liver, leading to inflammation and damage. This results in decreased liver function over time if not treated. The exact cause of autoimmune hepatitis is unknown, but it is believed to be associated with genetic factors and exposure to certain environmental triggers, such as viral infections or medications.

There are two main types of autoimmune hepatitis:

1. Type 1 (classic) autoimmune hepatitis: This form can affect both adults and children, and it is more common in women than men. People with this type may also have other autoimmune disorders, such as rheumatoid arthritis, thyroid disease, or ulcerative colitis.
2. Type 2 autoimmune hepatitis: This form primarily affects children and young women. It is less common than type 1 and tends to be more severe. People with this type may also have other autoimmune disorders, such as celiac disease or chronic candidiasis.

Symptoms of autoimmune hepatitis can vary widely, from mild to severe. They may include fatigue, loss of appetite, nausea, vomiting, abdominal pain, joint pain, jaundice (yellowing of the skin and eyes), dark urine, and light-colored stools.

Diagnosis typically involves blood tests, imaging studies, and sometimes a liver biopsy to assess the extent of damage. Treatment usually includes medications that suppress the immune system, such as corticosteroids and immunosuppressants, which can help reduce inflammation and slow or stop liver damage. In some cases, lifestyle changes and supportive care may also be necessary.

The portal vein is the large venous trunk that carries blood from the gastrointestinal tract, spleen, pancreas, and gallbladder to the liver. It is formed by the union of the superior mesenteric vein (draining the small intestine and a portion of the large intestine) and the splenic vein (draining the spleen and pancreas). The portal vein then divides into right and left branches within the liver, where the blood flows through the sinusoids and gets enriched with oxygen and nutrients before being drained by the hepatic veins into the inferior vena cava. This unique arrangement allows the liver to process and detoxify the absorbed nutrients, remove waste products, and regulate metabolic homeostasis.

Artificial organs are medical devices that are implanted in the human body to replace the function of a damaged, diseased, or failing organ. These devices can be made from a variety of materials, including metals, plastics, and synthetic biomaterials. They are designed to mimic the structure and function of natural organs as closely as possible, with the goal of improving the patient's quality of life and extending their lifespan.

Some examples of artificial organs include:

1. Artificial heart: A device that is implanted in the chest to replace the function of a failing heart. It can be used as a temporary or permanent solution for patients with end-stage heart failure.
2. Artificial pancreas: A device that is used to treat type 1 diabetes by regulating blood sugar levels. It consists of an insulin pump and a continuous glucose monitor, which work together to deliver insulin automatically based on the patient's needs.
3. Artificial kidney: A device that filters waste products from the blood, similar to a natural kidney. It can be used as a temporary or permanent solution for patients with end-stage renal disease.
4. Artificial lung: A device that helps patients with respiratory failure breathe by exchanging oxygen and carbon dioxide in the blood.
5. Artificial bladder: A device that is implanted in the body to help patients with bladder dysfunction urinate.
6. Artificial eyes: Prosthetic devices that are used to replace a missing or damaged eye, providing cosmetic and sometimes functional benefits.

It's important to note that while artificial organs can significantly improve the quality of life for many patients, they are not without risks. Complications such as infection, rejection, and device failure can occur, and ongoing medical care is necessary to monitor and manage these risks.

A drug overdose occurs when a person ingests, inhales, or absorbs through the skin a toxic amount of a drug or combination of drugs. This can result in a variety of symptoms, depending on the type of drug involved. In some cases, an overdose can be fatal.

An overdose can occur accidentally, for example if a person mistakenly takes too much of a medication or if a child accidentally ingests a medication that was left within their reach. An overdose can also occur intentionally, such as when a person takes too much of a drug to attempt suicide or to achieve a desired high.

The symptoms of a drug overdose can vary widely depending on the type of drug involved. Some common symptoms of a drug overdose may include:

* Nausea and vomiting
* Abdominal pain
* Dizziness or confusion
* Difficulty breathing
* Seizures
* Unconsciousness
* Rapid heart rate or low blood pressure

If you suspect that someone has overdosed on a drug, it is important to seek medical help immediately. Call your local poison control center or emergency number (such as 911 in the United States) for assistance. If possible, try to provide the medical personnel with as much information as you can about the person and the drug(s) involved. This can help them to provide appropriate treatment more quickly.

Liver extracts are preparations made from animal livers, often from cows or pigs, that contain various nutrients, vitamins, and minerals found in liver tissue. They have been used historically in medicine as a source of nutrition and to treat certain medical conditions.

Liver extracts contain high levels of vitamin B12, iron, and other essential nutrients. They were once commonly prescribed to treat anemia, pernicious anemia (a type of anemia caused by vitamin B12 deficiency), and other conditions related to malnutrition. However, with the advent of more modern treatments and better methods for addressing nutritional deficiencies, liver extracts are less commonly used in modern medicine.

It's important to note that while liver extracts can be a good source of nutrition, they should not be used as a substitute for a balanced diet. Moreover, individuals with certain medical conditions, such as liver disease or hemochromatosis (a condition characterized by excessive iron absorption), should avoid liver extracts or use them only under the supervision of a healthcare provider.

Hepatolenticular degeneration, also known as Wilson's disease, is a rare genetic disorder of copper metabolism. It is characterized by the accumulation of copper in various organs, particularly the liver and brain. This leads to progressive damage and impairment of their functions.

The medical definition of Hepatolenticular degeneration (Wilson's disease) is:

A genetic disorder caused by a mutation in the ATP7B gene, resulting in impaired biliary excretion of copper and its accumulation within hepatocytes. This causes liver damage, which can manifest as acute hepatitis, cirrhosis, or fulminant hepatic failure. Additionally, excess copper is released into the bloodstream and deposited in various tissues, including the basal ganglia of the brain, leading to neurological symptoms such as tremors, rigidity, dysarthria, and behavioral changes. Other features include Kayser-Fleischer rings (copper deposition in the cornea), splenomegaly, and hemolytic anemia. Early diagnosis and treatment with copper-chelating agents can significantly improve outcomes and prevent complications.

Experimental liver neoplasms refer to abnormal growths or tumors in the liver that are intentionally created or manipulated in a laboratory setting for the purpose of studying their development, progression, and potential treatment options. These experimental models can be established using various methods such as chemical induction, genetic modification, or transplantation of cancerous cells or tissues. The goal of this research is to advance our understanding of liver cancer biology and develop novel therapies for liver neoplasms in humans. It's important to note that these experiments are conducted under strict ethical guidelines and regulations to minimize harm and ensure the humane treatment of animals involved in such studies.

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in adults. It originates from the hepatocytes, which are the main functional cells of the liver. This type of cancer is often associated with chronic liver diseases such as cirrhosis caused by hepatitis B or C virus infection, alcohol abuse, non-alcoholic fatty liver disease (NAFLD), and aflatoxin exposure.

The symptoms of HCC can vary but may include unexplained weight loss, lack of appetite, abdominal pain or swelling, jaundice, and fatigue. The diagnosis of HCC typically involves imaging tests such as ultrasound, CT scan, or MRI, as well as blood tests to measure alpha-fetoprotein (AFP) levels. Treatment options for Hepatocellular carcinoma depend on the stage and extent of the cancer, as well as the patient's overall health and liver function. Treatment options may include surgery, radiation therapy, chemotherapy, targeted therapy, or liver transplantation.

Prognosis is a medical term that refers to the prediction of the likely outcome or course of a disease, including the chances of recovery or recurrence, based on the patient's symptoms, medical history, physical examination, and diagnostic tests. It is an important aspect of clinical decision-making and patient communication, as it helps doctors and patients make informed decisions about treatment options, set realistic expectations, and plan for future care.

Prognosis can be expressed in various ways, such as percentages, categories (e.g., good, fair, poor), or survival rates, depending on the nature of the disease and the available evidence. However, it is important to note that prognosis is not an exact science and may vary depending on individual factors, such as age, overall health status, and response to treatment. Therefore, it should be used as a guide rather than a definitive forecast.

Ammonia is a colorless, pungent-smelling gas with the chemical formula NH3. It is a compound of nitrogen and hydrogen and is a basic compound, meaning it has a pH greater than 7. Ammonia is naturally found in the environment and is produced by the breakdown of organic matter, such as animal waste and decomposing plants. In the medical field, ammonia is most commonly discussed in relation to its role in human metabolism and its potential toxicity.

In the body, ammonia is produced as a byproduct of protein metabolism and is typically converted to urea in the liver and excreted in the urine. However, if the liver is not functioning properly or if there is an excess of protein in the diet, ammonia can accumulate in the blood and cause a condition called hyperammonemia. Hyperammonemia can lead to serious neurological symptoms, such as confusion, seizures, and coma, and is treated by lowering the level of ammonia in the blood through medications, dietary changes, and dialysis.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Alcoholic hepatitis is a medical condition characterized by inflammation and damage to the liver caused by excessive alcohol consumption. It is a type of hepatitis that specifically results from alcohol abuse, rather than from viral infections or other causes. The condition can vary in severity, and long-term heavy drinking increases the risk of developing alcoholic hepatitis.

The inflammation in alcoholic hepatitis can lead to symptoms such as jaundice (yellowing of the skin and eyes), abdominal pain, nausea, vomiting, loss of appetite, and fever. In severe cases, it can cause liver failure, which may be life-threatening. Treatment typically involves alcohol abstinence, supportive care, and medications to manage symptoms and prevent further liver damage. In some cases, hospitalization and more intensive treatments may be necessary.

Chronic kidney failure, also known as chronic kidney disease (CKD) stage 5 or end-stage renal disease (ESRD), is a permanent loss of kidney function that occurs gradually over a period of months to years. It is defined as a glomerular filtration rate (GFR) of less than 15 ml/min, which means the kidneys are filtering waste and excess fluids at less than 15% of their normal capacity.

CKD can be caused by various underlying conditions such as diabetes, hypertension, glomerulonephritis, polycystic kidney disease, and recurrent kidney infections. Over time, the damage to the kidneys can lead to a buildup of waste products and fluids in the body, which can cause a range of symptoms including fatigue, weakness, shortness of breath, nausea, vomiting, and confusion.

Treatment for chronic kidney failure typically involves managing the underlying condition, making lifestyle changes such as following a healthy diet, and receiving supportive care such as dialysis or a kidney transplant to replace lost kidney function.

Cross circulation is a medical procedure in which blood from one person (the donor) is circulated through the body of another person (the recipient) by connecting their cardiovascular systems. This technique was first developed and used in open-heart surgery during the 1950s, before the invention of heart-lung machines.

In cross circulation, the donor's and recipient's circulatory systems are connected through anastomoses (surgical connections) between their blood vessels. The most common configuration involved connecting the donor's femoral artery to the recipient's aorta and the donor's femoral vein to the recipient's vena cava. This allowed the donor's heart to pump oxygenated blood to both the donor and the recipient during the surgery.

Cross circulation was used as a temporary measure to maintain the recipient's circulation and oxygenation while their own heart was stopped and repaired during open-heart surgery. However, this technique had several limitations and risks, including potential complications for the donor (such as bleeding, infection, or reactions to the recipient's blood) and ethical concerns related to using one person as a "human bridge" to save another.

With the development of more advanced and safer heart-lung machines in the early 1960s, cross circulation became obsolete in cardiac surgery. Nowadays, it is rarely used and mainly of historical interest.

Keratin-18 is a type I cytoskeletal keratin protein that is primarily expressed in simple epithelial cells, such as those found in the gastrointestinal tract, liver, and skin. It forms intermediate filaments, which are structural proteins that provide support and stability to the cell. Keratin-18 has been identified as a sensitive and specific marker for apoptosis (programmed cell death), making it useful in research and diagnosis of various diseases, including liver disease and cancer.

A liver abscess is a localized collection of pus within the liver tissue caused by an infection. It can result from various sources such as bacterial or amebic infections that spread through the bloodstream, bile ducts, or directly from nearby organs. The abscess may cause symptoms like fever, pain in the upper right abdomen, nausea, vomiting, and weight loss. If left untreated, a liver abscess can lead to serious complications, including sepsis and organ failure. Diagnosis typically involves imaging tests like ultrasound or CT scan, followed by drainage of the pus and antibiotic treatment.

Tetralogy of Fallot is a congenital heart defect that consists of four cardiac abnormalities: ventricular septal defect (a hole between the right and left ventricles), pulmonary stenosis (narrowing of the pulmonary valve and outflow tract), overriding aorta (the aorta is positioned over both ventricles instead of just the left one), and right ventricular hypertrophy (thickening of the right ventricular muscle). This condition results in insufficient oxygenation of the blood, causing cyanosis (bluish discoloration of the skin and mucous membranes) and other symptoms such as shortness of breath, fatigue, and poor growth. Treatment typically involves surgical repair, usually done during infancy or early childhood.

Chronic Hepatitis B is a persistent infection of the liver caused by the hepatitis B virus (HBV), which can lead to chronic inflammation and scarring of the liver over time. It is defined as the presence of hepatitis B surface antigen (HBsAg) in the blood for more than six months.

The infection can be asymptomatic or may cause nonspecific symptoms such as fatigue, loss of appetite, nausea, and joint pain. A small percentage of people with chronic HBV infection may develop serious complications, including cirrhosis, liver failure, and liver cancer. Treatment options for chronic hepatitis B include antiviral medications that can help to suppress the virus and reduce the risk of liver damage. Vaccination is available to prevent hepatitis B infection.

Prothrombin time (PT) is a medical laboratory test that measures the time it takes for blood to clot. It's often used to evaluate the functioning of the extrinsic and common pathways of the coagulation system, which is responsible for blood clotting. Specifically, PT measures how long it takes for prothrombin (a protein produced by the liver) to be converted into thrombin, an enzyme that converts fibrinogen into fibrin and helps form a clot.

Prolonged PT may indicate a bleeding disorder or a deficiency in coagulation factors, such as vitamin K deficiency or the use of anticoagulant medications like warfarin. It's important to note that PT is often reported with an international normalized ratio (INR), which allows for standardization and comparison of results across different laboratories and reagent types.

Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease. The virus is transmitted through contact with infected blood, semen, and other bodily fluids. It can also be passed from an infected mother to her baby at birth.

Acute hepatitis B infection lasts for a few weeks to several months and often causes no symptoms. However, some people may experience mild to severe flu-like symptoms, yellowing of the skin and eyes (jaundice), dark urine, and fatigue. Most adults with acute hepatitis B recover completely and develop lifelong immunity to the virus.

Chronic hepatitis B infection can lead to serious liver damage, including cirrhosis and liver cancer. People with chronic hepatitis B may experience long-term symptoms such as fatigue, joint pain, and depression. They are also at risk for developing liver failure and liver cancer.

Prevention measures include vaccination, safe sex practices, avoiding sharing needles or other drug injection equipment, and covering wounds and skin rashes. There is no specific treatment for acute hepatitis B, but chronic hepatitis B can be treated with antiviral medications to slow the progression of liver damage.

"Failure to Thrive" is a medical term used to describe a condition in infants and children who are not growing and gaining weight as expected. It is typically defined as significant deviation from normal growth patterns, such as poor weight gain or loss, slow increase in length/height, and delayed developmental milestones. The condition can have various causes, including medical, psychological, social, and environmental factors. Early identification and intervention are crucial to address the underlying cause and promote healthy growth and development.

Cholestasis is a medical condition characterized by the interruption or reduction of bile flow from the liver to the small intestine. Bile is a digestive fluid produced by the liver that helps in the breakdown and absorption of fats. When the flow of bile is blocked or reduced, it can lead to an accumulation of bile components, such as bilirubin, in the blood, which can cause jaundice, itching, and other symptoms.

Cholestasis can be caused by various factors, including liver diseases (such as hepatitis, cirrhosis, or cancer), gallstones, alcohol abuse, certain medications, pregnancy, and genetic disorders. Depending on the underlying cause, cholestasis may be acute or chronic, and it can range from mild to severe in its symptoms and consequences. Treatment for cholestasis typically involves addressing the underlying cause and managing the symptoms with supportive care.

Transaminases, also known as aminotransferases, are a group of enzymes found in various tissues of the body, particularly in the liver, heart, muscle, and kidneys. They play a crucial role in the metabolism of amino acids, the building blocks of proteins.

There are two major types of transaminases: aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Both enzymes are normally present in low concentrations in the bloodstream. However, when tissues that contain these enzymes are damaged or injured, such as during liver disease or muscle damage, the levels of AST and ALT in the blood may significantly increase.

Measurement of serum transaminase levels is a common laboratory test used to assess liver function and detect liver injury or damage. Increased levels of these enzymes in the blood can indicate conditions such as hepatitis, liver cirrhosis, drug-induced liver injury, heart attack, and muscle disorders. It's important to note that while elevated transaminase levels may suggest liver disease, they do not specify the type or cause of the condition, and further diagnostic tests are often required for accurate diagnosis and treatment.

The hepatic veins are blood vessels that carry oxygen-depleted blood from the liver back to the heart. There are typically three major hepatic veins - right, middle, and left - that originate from the posterior aspect of the liver and drain into the inferior vena cava just below the diaphragm. These veins are responsible for returning the majority of the blood flow from the gastrointestinal tract and spleen to the heart. It's important to note that the hepatic veins do not have valves, which can make them susceptible to a condition called Budd-Chiari syndrome, where blood clots form in the veins and obstruct the flow of blood from the liver.

Albumins are a type of protein found in various biological fluids, including blood plasma. The most well-known albumin is serum albumin, which is produced by the liver and is the most abundant protein in blood plasma. Serum albumin plays several important roles in the body, such as maintaining oncotic pressure (which helps to regulate fluid balance in the body), transporting various substances (such as hormones, fatty acids, and drugs), and acting as an antioxidant.

Albumins are soluble in water and have a molecular weight ranging from 65,000 to 69,000 daltons. They are composed of a single polypeptide chain that contains approximately 585 amino acid residues. The structure of albumin is characterized by a high proportion of alpha-helices and beta-sheets, which give it a stable, folded conformation.

In addition to their role in human physiology, albumins are also used as diagnostic markers in medicine. For example, low serum albumin levels may indicate liver disease, malnutrition, or inflammation, while high levels may be seen in dehydration or certain types of kidney disease. Albumins may also be used as a replacement therapy in patients with severe protein loss, such as those with nephrotic syndrome or burn injuries.

Hepatorenal syndrome (HRS) is a serious complication that primarily affects people with advanced liver disease, particularly those with cirrhosis. It's characterized by functional renal failure in the absence of structural kidney damage. This means that the kidneys stop working properly, but if they were to be removed and examined, there would be no obvious physical reason for their failure.

The medical definition of hepatorenal syndrome includes specific diagnostic criteria:

1. Presence of liver cirrhosis or fulminant hepatic failure.
2. Evidence of impaired liver function, such as ascites (accumulation of fluid in the abdomen) and elevated levels of bilirubin in the blood.
3. Functional renal failure, defined as a serum creatinine level greater than 1.5 mg/dL or a doubling of the baseline creatinine to a level above 1.5 mg/dL in patients with previously normal renal function.
4. Absence of structural kidney damage, confirmed by a normal urinalysis (no protein or red blood cells in the urine), a high urine sodium concentration (greater than 10 mEq/L), and a low fractional excretion of sodium (less than 1%).
5. No alternative explanation for renal failure, such as sepsis, hypovolemia, or use of nephrotoxic medications.

Hepatorenal syndrome is further divided into two types:

- Type 1 HRS: This form is characterized by a rapid and severe decline in kidney function, with a doubling of the serum creatinine to a level greater than 2.5 mg/dL within two weeks. Type 1 HRS has a poor prognosis, with a median survival time of about two weeks if left untreated.
- Type 2 HRS: This form is characterized by a more gradual and modest decline in kidney function, with a serum creatinine level persistently above 1.5 mg/dL. Type 2 HRS has a better prognosis than type 1, but it still significantly worsens the overall survival of patients with liver cirrhosis.

Hepatorenal syndrome is a serious complication of liver cirrhosis and other forms of advanced liver disease. It requires prompt recognition and treatment to improve outcomes and prevent further deterioration of kidney function.

A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.

Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.

It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

Postoperative complications refer to any unfavorable condition or event that occurs during the recovery period after a surgical procedure. These complications can vary in severity and may include, but are not limited to:

1. Infection: This can occur at the site of the incision or inside the body, such as pneumonia or urinary tract infection.
2. Bleeding: Excessive bleeding (hemorrhage) can lead to a drop in blood pressure and may require further surgical intervention.
3. Blood clots: These can form in the deep veins of the legs (deep vein thrombosis) and can potentially travel to the lungs (pulmonary embolism).
4. Wound dehiscence: This is when the surgical wound opens up, which can lead to infection and further complications.
5. Pulmonary issues: These include atelectasis (collapsed lung), pneumonia, or respiratory failure.
6. Cardiovascular problems: These include abnormal heart rhythms (arrhythmias), heart attack, or stroke.
7. Renal failure: This can occur due to various reasons such as dehydration, blood loss, or the use of certain medications.
8. Pain management issues: Inadequate pain control can lead to increased stress, anxiety, and decreased mobility.
9. Nausea and vomiting: These can be caused by anesthesia, opioid pain medication, or other factors.
10. Delirium: This is a state of confusion and disorientation that can occur in the elderly or those with certain medical conditions.

Prompt identification and management of these complications are crucial to ensure the best possible outcome for the patient.

An acute disease is a medical condition that has a rapid onset, develops quickly, and tends to be short in duration. Acute diseases can range from minor illnesses such as a common cold or flu, to more severe conditions such as pneumonia, meningitis, or a heart attack. These types of diseases often have clear symptoms that are easy to identify, and they may require immediate medical attention or treatment.

Acute diseases are typically caused by an external agent or factor, such as a bacterial or viral infection, a toxin, or an injury. They can also be the result of a sudden worsening of an existing chronic condition. In general, acute diseases are distinct from chronic diseases, which are long-term medical conditions that develop slowly over time and may require ongoing management and treatment.

Examples of acute diseases include:

* Acute bronchitis: a sudden inflammation of the airways in the lungs, often caused by a viral infection.
* Appendicitis: an inflammation of the appendix that can cause severe pain and requires surgical removal.
* Gastroenteritis: an inflammation of the stomach and intestines, often caused by a viral or bacterial infection.
* Migraine headaches: intense headaches that can last for hours or days, and are often accompanied by nausea, vomiting, and sensitivity to light and sound.
* Myocardial infarction (heart attack): a sudden blockage of blood flow to the heart muscle, often caused by a buildup of plaque in the coronary arteries.
* Pneumonia: an infection of the lungs that can cause coughing, chest pain, and difficulty breathing.
* Sinusitis: an inflammation of the sinuses, often caused by a viral or bacterial infection.

It's important to note that while some acute diseases may resolve on their own with rest and supportive care, others may require medical intervention or treatment to prevent complications and promote recovery. If you are experiencing symptoms of an acute disease, it is always best to seek medical attention to ensure proper diagnosis and treatment.

Tyrosinemia is a rare genetic disorder that affects the way the body metabolizes the amino acid tyrosine, which is found in many protein-containing foods. There are three types of tyrosinemia, but type I, also known as hepatorenal tyrosinemia or Hawkins' syndrome, is the most severe and common form.

Tyrosinemia type I is caused by a deficiency of the enzyme fumarylacetoacetase, which is necessary for the breakdown of tyrosine in the body. As a result, toxic intermediates accumulate and can cause damage to the liver, kidneys, and nervous system. Symptoms of tyrosinemia type I may include failure to thrive, vomiting, diarrhea, abdominal pain, jaundice, and mental developmental delays.

If left untreated, tyrosinemia type I can lead to serious complications such as liver cirrhosis, liver cancer, kidney damage, and neurological problems. Treatment typically involves a low-tyrosine diet, medication to reduce tyrosine production, and sometimes liver transplantation. Early diagnosis and treatment are essential for improving outcomes in individuals with tyrosinemia type I.

Carbon tetrachloride is a colorless, heavy, and nonflammable liquid with a mild ether-like odor. Its chemical formula is CCl4. It was previously used as a solvent and refrigerant, but its use has been largely phased out due to its toxicity and ozone-depleting properties.

Inhalation, ingestion, or skin contact with carbon tetrachloride can cause harmful health effects. Short-term exposure can lead to symptoms such as dizziness, headache, nausea, and vomiting. Long-term exposure has been linked to liver and kidney damage, as well as an increased risk of cancer.

Carbon tetrachloride is also a potent greenhouse gas and contributes to climate change. Its production and use are regulated by international agreements aimed at protecting human health and the environment.

Survival analysis is a branch of statistics that deals with the analysis of time to event data. It is used to estimate the time it takes for a certain event of interest to occur, such as death, disease recurrence, or treatment failure. The event of interest is called the "failure" event, and survival analysis estimates the probability of not experiencing the failure event until a certain point in time, also known as the "survival" probability.

Survival analysis can provide important information about the effectiveness of treatments, the prognosis of patients, and the identification of risk factors associated with the event of interest. It can handle censored data, which is common in medical research where some participants may drop out or be lost to follow-up before the event of interest occurs.

Survival analysis typically involves estimating the survival function, which describes the probability of surviving beyond a certain time point, as well as hazard functions, which describe the instantaneous rate of failure at a given time point. Other important concepts in survival analysis include median survival times, restricted mean survival times, and various statistical tests to compare survival curves between groups.

Medical survival rate is a statistical measure used to determine the percentage of patients who are still alive for a specific period of time after their diagnosis or treatment for a certain condition or disease. It is often expressed as a five-year survival rate, which refers to the proportion of people who are alive five years after their diagnosis. Survival rates can be affected by many factors, including the stage of the disease at diagnosis, the patient's age and overall health, the effectiveness of treatment, and other health conditions that the patient may have. It is important to note that survival rates are statistical estimates and do not necessarily predict an individual patient's prognosis.

"Amanita" is a genus of fungi that includes several species commonly known as mushrooms. Some of these species are edible and considered delicacies, while others are highly toxic and can cause serious illness or death if ingested. The most famous toxic species is Amanita phalloides, also known as the "death cap" mushroom.

Here is a medical definition of "Amanita":

"A genus of fungi in the family Amanitaceae, characterized by the production of large fruiting bodies with a universal veil that often leaves a skirt-like ring on the stipe and a volva at the base. Some species are edible and highly prized, while others are poisonous and can cause severe gastrointestinal symptoms, liver damage, or even death. Examples of toxic Amanita species include A. phalloides (the 'death cap'), A. virosa (the 'destroying angel'), and A. muscaria (the 'fly agaric')."

(Source: Medscape Medical Dictionary)

Intracranial pressure (ICP) is the pressure inside the skull and is typically measured in millimeters of mercury (mmHg). It's the measurement of the pressure exerted by the cerebrospinal fluid (CSF), blood, and brain tissue within the confined space of the skull.

Normal ICP ranges from 5 to 15 mmHg in adults when lying down. Intracranial pressure may increase due to various reasons such as bleeding in the brain, swelling of the brain, increased production or decreased absorption of CSF, and brain tumors. Elevated ICP is a serious medical emergency that can lead to brain damage or even death if not promptly treated. Symptoms of high ICP may include severe headache, vomiting, altered consciousness, and visual changes.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

A living donor is a person who voluntarily donates an organ or part of an organ to another person while they are still alive. This can include donations such as a kidney, liver lobe, lung, or portion of the pancreas or intestines. The donor and recipient typically undergo medical evaluation and compatibility testing to ensure the best possible outcome for the transplantation procedure. Living donation is regulated by laws and ethical guidelines to ensure that donors are fully informed and making a voluntary decision.

A biological marker, often referred to as a biomarker, is a measurable indicator that reflects the presence or severity of a disease state, or a response to a therapeutic intervention. Biomarkers can be found in various materials such as blood, tissues, or bodily fluids, and they can take many forms, including molecular, histologic, radiographic, or physiological measurements.

In the context of medical research and clinical practice, biomarkers are used for a variety of purposes, such as:

1. Diagnosis: Biomarkers can help diagnose a disease by indicating the presence or absence of a particular condition. For example, prostate-specific antigen (PSA) is a biomarker used to detect prostate cancer.
2. Monitoring: Biomarkers can be used to monitor the progression or regression of a disease over time. For instance, hemoglobin A1c (HbA1c) levels are monitored in diabetes patients to assess long-term blood glucose control.
3. Predicting: Biomarkers can help predict the likelihood of developing a particular disease or the risk of a negative outcome. For example, the presence of certain genetic mutations can indicate an increased risk for breast cancer.
4. Response to treatment: Biomarkers can be used to evaluate the effectiveness of a specific treatment by measuring changes in the biomarker levels before and after the intervention. This is particularly useful in personalized medicine, where treatments are tailored to individual patients based on their unique biomarker profiles.

It's important to note that for a biomarker to be considered clinically valid and useful, it must undergo rigorous validation through well-designed studies, including demonstrating sensitivity, specificity, reproducibility, and clinical relevance.

Viral hepatitis in humans refers to inflammation of the liver caused by infection with viruses that primarily target the liver. There are five main types of human viral hepatitis, designated as Hepatitis A, B, C, D, and E virus (HAV, HBV, HCV, HDV, and HEV). These viruses can cause a range of illnesses, from acute self-limiting hepatitis to chronic hepatitis, which can lead to cirrhosis and liver cancer.

1. Hepatitis A virus (HAV) is typically spread through the fecal-oral route, often through contaminated food or water. It usually results in an acute self-limiting infection, but rarely can cause chronic hepatitis in individuals with weakened immune systems.
2. Hepatitis B virus (HBV) is primarily transmitted through contact with infected blood, semen, and other bodily fluids. It can lead to both acute and chronic hepatitis, which may result in cirrhosis and liver cancer if left untreated.
3. Hepatitis C virus (HCV) is predominantly spread through exposure to infected blood, such as through sharing needles or receiving contaminated blood transfusions. Chronic hepatitis C is common, and it can lead to serious liver complications like cirrhosis and liver cancer if not treated.
4. Hepatitis D virus (HDV) is an incomplete virus that requires the presence of HBV for its replication. HDV infection occurs only in individuals already infected with HBV, leading to more severe liver disease compared to HBV monoinfection.
5. Hepatitis E virus (HEV) is primarily transmitted through the fecal-oral route, often through contaminated food or water. It usually results in an acute self-limiting infection but can cause chronic hepatitis in pregnant women and individuals with weakened immune systems.

Prevention measures include vaccination for HAV and HBV, safe sex practices, avoiding sharing needles, and ensuring proper hygiene and sanitation to prevent fecal-oral transmission.

Intracranial hypertension is a medical condition characterized by an increased pressure within the skull (intracranial space) that contains the brain, cerebrospinal fluid (CSF), and blood. Normally, the pressure inside the skull is carefully regulated to maintain a balance between the formation and absorption of CSF. However, when the production of CSF exceeds its absorption or when there is an obstruction in the flow of CSF, the pressure inside the skull can rise, leading to intracranial hypertension.

The symptoms of intracranial hypertension may include severe headaches, nausea, vomiting, visual disturbances such as blurred vision or double vision, and papilledema (swelling of the optic nerve disc). In some cases, intracranial hypertension can lead to serious complications such as vision loss, brain herniation, and even death if left untreated.

Intracranial hypertension can be idiopathic, meaning that there is no identifiable cause, or secondary to other underlying medical conditions such as brain tumors, meningitis, hydrocephalus, or certain medications. The diagnosis of intracranial hypertension typically involves a combination of clinical evaluation, imaging studies (such as MRI or CT scans), and lumbar puncture to measure the pressure inside the skull and assess the CSF composition. Treatment options may include medications to reduce CSF production, surgery to relieve pressure on the brain, or shunting procedures to drain excess CSF from the intracranial space.

Plasma exchange, also known as plasmapheresis, is a medical procedure where the liquid portion of the blood (plasma) is separated from the blood cells. The plasma, which may contain harmful substances such as antibodies, clotting factors, or toxins, is then removed and replaced with fresh plasma or a plasma substitute. This process helps to remove the harmful substances from the blood and allows the body to replenish its own plasma with normal components. Plasma exchange is used in the treatment of various medical conditions including autoimmune diseases, poisonings, and certain types of kidney diseases.

Bile ducts are tubular structures that carry bile from the liver to the gallbladder for storage or directly to the small intestine to aid in digestion. There are two types of bile ducts: intrahepatic and extrahepatic. Intrahepatic bile ducts are located within the liver and drain bile from liver cells, while extrahepatic bile ducts are outside the liver and include the common hepatic duct, cystic duct, and common bile duct. These ducts can become obstructed or inflamed, leading to various medical conditions such as cholestasis, cholecystitis, and gallstones.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

Acute kidney injury (AKI), also known as acute renal failure, is a rapid loss of kidney function that occurs over a few hours or days. It is defined as an increase in the serum creatinine level by 0.3 mg/dL within 48 hours or an increase in the creatinine level to more than 1.5 times baseline, which is known or presumed to have occurred within the prior 7 days, or a urine volume of less than 0.5 mL/kg per hour for six hours.

AKI can be caused by a variety of conditions, including decreased blood flow to the kidneys, obstruction of the urinary tract, exposure to toxic substances, and certain medications. Symptoms of AKI may include decreased urine output, fluid retention, electrolyte imbalances, and metabolic acidosis. Treatment typically involves addressing the underlying cause of the injury and providing supportive care, such as dialysis, to help maintain kidney function until the injury resolves.

Erythropoietic Protoporphyria (EPP) is a rare inherited disorder of porphyrin metabolism. It results from a deficiency in the ferrochelatase enzyme, which normally catalyzes the insertion of iron into protoporphyrin to form heme. This deficiency leads to an accumulation of protoporphyrin, particularly in red blood cells and plasma.

The accumulated protoporphyrin is sensitive to light, particularly wavelengths between 400-410 nm (blue light). When exposed to this light, the protoporphyrin molecules absorb the light energy and transfer it to molecular oxygen, leading to the formation of highly reactive singlet oxygen. This reaction causes oxidative damage to surrounding tissues, resulting in the symptoms of EPP.

The main symptom is severe, painful burn-like reactions on exposed skin after sunlight exposure, often accompanied by swelling and itching. These symptoms can occur within minutes of sun exposure and can last for several days. Chronic skin changes such as scarring and milia can also occur over time.

EPP is usually diagnosed through the measurement of porphyrins in the blood or stool, and genetic testing can confirm the diagnosis. Treatment typically involves avoiding sunlight exposure, using sun protection measures, and in some cases, oral beta-carotene or cysteine supplements to reduce symptoms. In severe cases, heme arginate or afamelanotide may be used.

The hepatic artery is a branch of the celiac trunk or abdominal aorta that supplies oxygenated blood to the liver. It typically divides into two main branches, the right and left hepatic arteries, which further divide into smaller vessels to supply different regions of the liver. The hepatic artery also gives off branches to supply other organs such as the gallbladder, pancreas, and duodenum.

It's worth noting that there is significant variability in the anatomy of the hepatic artery, with some individuals having additional branches or variations in the origin of the vessel. This variability can have implications for surgical procedures involving the liver and surrounding organs.

Intrahepatic cholestasis is a medical condition characterized by the interruption or reduction of bile flow within the liver. Bile is a digestive fluid produced by the liver that helps in the absorption of fats and fat-soluble vitamins. Intrahepatic cholestasis occurs when there is a problem with the transport of bile components inside the liver cells (hepatocytes). This can lead to an accumulation of bile acids, bilirubin, and other substances in the liver, which can cause damage to liver cells and result in symptoms such as jaundice, itching, and dark urine.

Intrahepatic cholestasis can be caused by various factors, including medications, alcohol abuse, hepatitis viruses, autoimmune disorders, genetic defects, and cancer. Depending on the underlying cause, intrahepatic cholestasis can be acute or chronic, and it can range from mild to severe. Treatment typically involves addressing the underlying cause of the condition, as well as providing supportive care to manage symptoms and prevent complications.

Diffuse cerebral sclerosis of Schilder, also known as Schilder's disease, is a rare inflammatory demyelinating disorder of the central nervous system. It primarily affects children and young adults, but can occur at any age. The condition is characterized by widespread destruction of the myelin sheath, which surrounds and protects nerve fibers in the brain.

The hallmark feature of Schilder's disease is the presence of multiple, large, symmetrical lesions in the white matter of both cerebral hemispheres. These lesions are typically located in the parieto-occipital regions of the brain and can extend to involve other areas as well.

The symptoms of Schilder's disease vary depending on the location and extent of the lesions, but may include:

* Progressive intellectual decline
* Seizures
* Visual disturbances
* Weakness or paralysis on one side of the body (hemiparesis)
* Loss of sensation in various parts of the body
* Speech difficulties
* Behavioral changes, such as irritability, mood swings, and depression

The exact cause of Schilder's disease is not known, but it is believed to be an autoimmune disorder, in which the body's own immune system mistakenly attacks the myelin sheath. There is no cure for Schilder's disease, and treatment typically involves corticosteroids or other immunosuppressive therapies to reduce inflammation and slow the progression of the disease. Despite treatment, many patients with Schilder's disease experience significant disability and may require long-term care.

Experimental liver cirrhosis refers to a controlled research setting where various factors and substances are intentionally introduced to induce liver cirrhosis in animals or cell cultures. The purpose is to study the mechanisms, progression, potential treatments, and prevention strategies for liver cirrhosis. This could involve administering chemicals, drugs, alcohol, viruses, or manipulating genes associated with liver damage and fibrosis. It's important to note that results from experimental models may not directly translate to human conditions, but they can provide valuable insights into disease pathophysiology and therapeutic development.

Hepatitis B virus (HBV) is a DNA virus that belongs to the Hepadnaviridae family and causes the infectious disease known as hepatitis B. This virus primarily targets the liver, where it can lead to inflammation and damage of the liver tissue. The infection can range from acute to chronic, with chronic hepatitis B increasing the risk of developing serious liver complications such as cirrhosis and liver cancer.

The Hepatitis B virus has a complex life cycle, involving both nuclear and cytoplasmic phases. It enters hepatocytes (liver cells) via binding to specific receptors and is taken up by endocytosis. The viral DNA is released into the nucleus, where it is converted into a covalently closed circular DNA (cccDNA) form, which serves as the template for viral transcription.

HBV transcribes several RNAs, including pregenomic RNA (pgRNA), which is used as a template for reverse transcription during virion assembly. The pgRNA is encapsidated into core particles along with the viral polymerase and undergoes reverse transcription to generate new viral DNA. This process occurs within the cytoplasm of the hepatocyte, resulting in the formation of immature virions containing partially double-stranded DNA.

These immature virions are then enveloped by host cell membranes containing HBV envelope proteins (known as surface antigens) to form mature virions that can be secreted from the hepatocyte and infect other cells. The virus can also integrate into the host genome, which may contribute to the development of hepatocellular carcinoma in chronic cases.

Hepatitis B is primarily transmitted through exposure to infected blood or bodily fluids containing the virus, such as through sexual contact, sharing needles, or from mother to child during childbirth. Prevention strategies include vaccination, safe sex practices, and avoiding needle-sharing behaviors. Treatment for hepatitis B typically involves antiviral medications that can help suppress viral replication and reduce the risk of liver damage.

A chronic disease is a long-term medical condition that often progresses slowly over a period of years and requires ongoing management and care. These diseases are typically not fully curable, but symptoms can be managed to improve quality of life. Common chronic diseases include heart disease, stroke, cancer, diabetes, arthritis, and COPD (chronic obstructive pulmonary disease). They are often associated with advanced age, although they can also affect children and younger adults. Chronic diseases can have significant impacts on individuals' physical, emotional, and social well-being, as well as on healthcare systems and society at large.

A waiting list, in the context of healthcare and medicine, refers to a list of patients who are awaiting a particular medical service or procedure, such as surgery, consultation with a specialist, or therapy. These lists are often established when the demand for certain services exceeds the immediate supply of resources, including physician time, hospital beds, or specialized equipment.

Patients on waiting lists are typically ranked based on factors like the severity of their condition, the urgency of their need for treatment, and the date they were placed on the list. The goal is to ensure that those with the most pressing medical needs receive care as soon as possible, while also providing a fair and transparent system for allocating limited resources.

However, it's important to note that extended waiting times can have negative consequences for patients, including worsening of symptoms, decreased quality of life, and potential complications. As such, healthcare systems strive to minimize wait times through various strategies, such as increasing resource allocation, improving efficiency, and implementing alternative service delivery models.

Jaundice is a medical condition characterized by the yellowing of the skin, sclera (whites of the eyes), and mucous membranes due to an excess of bilirubin in the bloodstream. Bilirubin is a yellow-orange pigment produced when hemoglobin from red blood cells is broken down. Normally, bilirubin is processed by the liver and excreted through bile into the digestive system. However, if there's an issue with bilirubin metabolism or elimination, it can accumulate in the body, leading to jaundice.

Jaundice can be a symptom of various underlying conditions, such as liver diseases (hepatitis, cirrhosis), gallbladder issues (gallstones, tumors), or blood disorders (hemolysis). It is essential to consult a healthcare professional if jaundice is observed, as it may indicate a severe health problem requiring prompt medical attention.

Necrosis is the premature death of cells or tissues due to damage or injury, such as from infection, trauma, infarction (lack of blood supply), or toxic substances. It's a pathological process that results in the uncontrolled and passive degradation of cellular components, ultimately leading to the release of intracellular contents into the extracellular space. This can cause local inflammation and may lead to further tissue damage if not treated promptly.

There are different types of necrosis, including coagulative, liquefactive, caseous, fat, fibrinoid, and gangrenous necrosis, each with distinct histological features depending on the underlying cause and the affected tissues or organs.

Portal hypertension is a medical condition characterized by an increased pressure in the portal vein, which is the large blood vessel that carries blood from the intestines, spleen, and pancreas to the liver. Normal portal venous pressure is approximately 5-10 mmHg. Portal hypertension is defined as a portal venous pressure greater than 10 mmHg.

The most common cause of portal hypertension is cirrhosis of the liver, which leads to scarring and narrowing of the small blood vessels in the liver, resulting in increased resistance to blood flow. Other causes include blood clots in the portal vein, inflammation of the liver or bile ducts, and invasive tumors that block the flow of blood through the liver.

Portal hypertension can lead to a number of complications, including the development of abnormal blood vessels (varices) in the esophagus, stomach, and intestines, which are prone to bleeding. Ascites, or the accumulation of fluid in the abdominal cavity, is another common complication of portal hypertension. Other potential complications include encephalopathy, which is a condition characterized by confusion, disorientation, and other neurological symptoms, and an increased risk of bacterial infections.

Treatment of portal hypertension depends on the underlying cause and the severity of the condition. Medications to reduce pressure in the portal vein, such as beta blockers or nitrates, may be used. Endoscopic procedures to band or inject varices can help prevent bleeding. In severe cases, surgery or liver transplantation may be necessary.

The biliary tract is a system of ducts that transport bile from the liver to the gallbladder and then to the small intestine. Bile is a digestive fluid produced by the liver that helps in the breakdown and absorption of fats in the small intestine. The main components of the biliary tract are:

1. Intrahepatic bile ducts: These are the smaller branches of bile ducts located within the liver that collect bile from the liver cells or hepatocytes.
2. Gallbladder: A small pear-shaped organ located beneath the liver, which stores and concentrates bile received from the intrahepatic bile ducts. The gallbladder releases bile into the small intestine when food is ingested, particularly fats, to aid digestion.
3. Common hepatic duct: This is a duct that forms by the union of the right and left hepatic ducts, which carry bile from the right and left lobes of the liver, respectively.
4. Cystic duct: A short duct that connects the gallbladder to the common hepatic duct, forming the beginning of the common bile duct.
5. Common bile duct: This is a larger duct formed by the union of the common hepatic duct and the cystic duct. It carries bile from the liver and gallbladder into the small intestine.
6. Pancreatic duct: A separate duct that originates from the pancreas, a gland located near the liver and stomach. The pancreatic duct joins the common bile duct just before they both enter the duodenum, the first part of the small intestine.
7. Ampulla of Vater: This is the dilated portion where the common bile duct and the pancreatic duct join together and empty their contents into the duodenum through a shared opening called the papilla of Vater.

Disorders related to the biliary tract include gallstones, cholecystitis (inflammation of the gallbladder), bile duct stones, bile duct strictures or obstructions, and primary sclerosing cholangitis, among others.

Biliary cirrhosis is a specific type of liver cirrhosis that results from chronic inflammation and scarring of the bile ducts, leading to impaired bile flow, liver damage, and fibrosis. It can be further classified into primary biliary cholangitis (PBC) and secondary biliary cirrhosis. PBC is an autoimmune disease, while secondary biliary cirrhosis is often associated with chronic gallstones, biliary tract obstruction, or recurrent pyogenic cholangitis. Symptoms may include fatigue, itching, jaundice, and abdominal discomfort. Diagnosis typically involves blood tests, imaging studies, and sometimes liver biopsy. Treatment focuses on managing symptoms, slowing disease progression, and preventing complications.

A portacaval shunt is a surgical procedure that creates an alternate pathway for blood flow between the portal vein and the inferior vena cava. The portal vein carries blood from the gastrointestinal tract, liver, spleen, and pancreas to the liver. In certain medical conditions, such as severe liver disease or portal hypertension, the blood pressure in the portal vein becomes abnormally high, which can lead to serious complications like variceal bleeding.

In a surgical portacaval shunt procedure, a surgeon creates a connection between the portal vein and the inferior vena cava, allowing a portion of the blood from the portal vein to bypass the liver and flow directly into the systemic circulation. This helps reduce the pressure in the portal vein and prevent complications associated with portal hypertension.

There are different types of portacaval shunts, including:

1. Direct portacaval shunt: In this procedure, the surgeon directly connects the portal vein to the inferior vena cava.
2. Side-to-side portacaval shunt: Here, the surgeon creates an anastomosis (connection) between a side branch of the portal vein and the inferior vena cava.
3. H-type shunt: This involves creating two separate connections between the portal vein and the inferior vena cava, forming an "H" shape.

It is important to note that while portacaval shunts can be effective in managing complications of portal hypertension, they may also have potential risks and side effects, such as worsening liver function, encephalopathy, or heart failure. Therefore, the decision to perform a portacaval shunt should be made carefully, considering the individual patient's medical condition and overall health.

Messenger RNA (mRNA) is a type of RNA (ribonucleic acid) that carries genetic information copied from DNA in the form of a series of three-base code "words," each of which specifies a particular amino acid. This information is used by the cell's machinery to construct proteins, a process known as translation. After being transcribed from DNA, mRNA travels out of the nucleus to the ribosomes in the cytoplasm where protein synthesis occurs. Once the protein has been synthesized, the mRNA may be degraded and recycled. Post-transcriptional modifications can also occur to mRNA, such as alternative splicing and addition of a 5' cap and a poly(A) tail, which can affect its stability, localization, and translation efficiency.

Citrullinemia is a rare inherited metabolic disorder characterized by the body's inability to properly process and eliminate certain toxic byproducts that are generated during the breakdown of proteins. This condition results from a deficiency of the enzyme argininosuccinate synthetase, which is required for the normal functioning of the urea cycle. The urea cycle is a series of biochemical reactions that occur in the liver and help to convert ammonia, a toxic substance, into urea, which can then be excreted by the kidneys.

There are two main types of citrullinemia: type I (also known as classic citrullinemia) and type II (also known as citrullinemia type II or adult-onset citrullinemia). Type I is typically more severe and can present in newborns with symptoms such as poor feeding, vomiting, seizures, and developmental delays. If left untreated, it can lead to serious complications, including intellectual disability, coma, and even death.

Type II citrullinemia, on the other hand, tends to present later in life, often in adulthood, and may cause symptoms such as confusion, seizures, and neurological problems. It is important to note that some individuals with type II citrullinemia may never develop any symptoms at all.

Treatment for citrullinemia typically involves a combination of dietary restrictions, supplements, and medications to help manage the buildup of toxic byproducts in the body. In severe cases, liver transplantation may be considered as a last resort.

Liver glycogen is the reserve form of glucose stored in hepatocytes (liver cells) for the maintenance of normal blood sugar levels. It is a polysaccharide, a complex carbohydrate, that is broken down into glucose molecules when blood glucose levels are low. This process helps to maintain the body's energy needs between meals and during periods of fasting or exercise. The amount of glycogen stored in the liver can vary depending on factors such as meal consumption, activity level, and insulin regulation.

"Swine" is a common term used to refer to even-toed ungulates of the family Suidae, including domestic pigs and wild boars. However, in a medical context, "swine" often appears in the phrase "swine flu," which is a strain of influenza virus that typically infects pigs but can also cause illness in humans. The 2009 H1N1 pandemic was caused by a new strain of swine-origin influenza A virus, which was commonly referred to as "swine flu." It's important to note that this virus is not transmitted through eating cooked pork products; it spreads from person to person, mainly through respiratory droplets produced when an infected person coughs or sneezes.

A kidney, in medical terms, is one of two bean-shaped organs located in the lower back region of the body. They are essential for maintaining homeostasis within the body by performing several crucial functions such as:

1. Regulation of water and electrolyte balance: Kidneys help regulate the amount of water and various electrolytes like sodium, potassium, and calcium in the bloodstream to maintain a stable internal environment.

2. Excretion of waste products: They filter waste products from the blood, including urea (a byproduct of protein metabolism), creatinine (a breakdown product of muscle tissue), and other harmful substances that result from normal cellular functions or external sources like medications and toxins.

3. Endocrine function: Kidneys produce several hormones with important roles in the body, such as erythropoietin (stimulates red blood cell production), renin (regulates blood pressure), and calcitriol (activated form of vitamin D that helps regulate calcium homeostasis).

4. pH balance regulation: Kidneys maintain the proper acid-base balance in the body by excreting either hydrogen ions or bicarbonate ions, depending on whether the blood is too acidic or too alkaline.

5. Blood pressure control: The kidneys play a significant role in regulating blood pressure through the renin-angiotensin-aldosterone system (RAAS), which constricts blood vessels and promotes sodium and water retention to increase blood volume and, consequently, blood pressure.

Anatomically, each kidney is approximately 10-12 cm long, 5-7 cm wide, and 3 cm thick, with a weight of about 120-170 grams. They are surrounded by a protective layer of fat and connected to the urinary system through the renal pelvis, ureters, bladder, and urethra.

The Predictive Value of Tests, specifically the Positive Predictive Value (PPV) and Negative Predictive Value (NPV), are measures used in diagnostic tests to determine the probability that a positive or negative test result is correct.

Positive Predictive Value (PPV) is the proportion of patients with a positive test result who actually have the disease. It is calculated as the number of true positives divided by the total number of positive results (true positives + false positives). A higher PPV indicates that a positive test result is more likely to be a true positive, and therefore the disease is more likely to be present.

Negative Predictive Value (NPV) is the proportion of patients with a negative test result who do not have the disease. It is calculated as the number of true negatives divided by the total number of negative results (true negatives + false negatives). A higher NPV indicates that a negative test result is more likely to be a true negative, and therefore the disease is less likely to be present.

The predictive value of tests depends on the prevalence of the disease in the population being tested, as well as the sensitivity and specificity of the test. A test with high sensitivity and specificity will generally have higher predictive values than a test with low sensitivity and specificity. However, even a highly sensitive and specific test can have low predictive values if the prevalence of the disease is low in the population being tested.

Ascites is an abnormal accumulation of fluid in the peritoneal cavity, which is the space between the lining of the abdominal wall and the organs within it. This buildup of fluid can cause the belly to swell and become distended. Ascites can be caused by various medical conditions, including liver cirrhosis, cancer, heart failure, and kidney disease. The accumulation of fluid in the peritoneal cavity can lead to complications such as infection, reduced mobility, and difficulty breathing. Treatment for ascites depends on the underlying cause and may include diuretics, paracentesis (a procedure to remove excess fluid from the abdomen), or treatment of the underlying medical condition.

Deanol, also known as dimethylaminoethanol or DMAE, is a naturally occurring compound that is found in small amounts in certain foods, such as anchovies and sardines. It is also available as a dietary supplement. Deanol is a precursor to choline, which is a nutrient that is essential for the synthesis of the neurotransmitter acetylcholine.

Deanol has been studied for its potential effects on various aspects of mental and physical health. Some proponents of deanol claim that it can improve memory, concentration, and intelligence, as well as reduce symptoms of attention deficit hyperactivity disorder (ADHD) and Alzheimer's disease. However, there is limited scientific evidence to support these claims, and more research is needed to confirm the potential benefits of deanol.

It is important to note that deanol can have side effects, including headache, dizziness, insomnia, and increased blood pressure. It may also interact with certain medications, so it is important to speak with a healthcare provider before taking deanol or any other dietary supplement.

Chronic hepatitis is a type of liver inflammation that lasts for more than six months and can lead to scarring of the liver (cirrhosis), liver failure, and even liver cancer in some cases. It can be caused by various factors, including viral infections such as Hepatitis B and C, autoimmune disorders, alcohol abuse, and non-alcoholic fatty liver disease. The symptoms of chronic hepatitis may include fatigue, loss of appetite, nausea, vomiting, abdominal pain, joint pain, dark urine, and jaundice (yellowing of the skin and eyes). Treatment for chronic hepatitis depends on the underlying cause and may include antiviral medications, immunosuppressive drugs, or lifestyle changes.

"Wistar rats" are a strain of albino rats that are widely used in laboratory research. They were developed at the Wistar Institute in Philadelphia, USA, and were first introduced in 1906. Wistar rats are outbred, which means that they are genetically diverse and do not have a fixed set of genetic characteristics like inbred strains.

Wistar rats are commonly used as animal models in biomedical research because of their size, ease of handling, and relatively low cost. They are used in a wide range of research areas, including toxicology, pharmacology, nutrition, cancer, cardiovascular disease, and behavioral studies. Wistar rats are also used in safety testing of drugs, medical devices, and other products.

Wistar rats are typically larger than many other rat strains, with males weighing between 500-700 grams and females weighing between 250-350 grams. They have a lifespan of approximately 2-3 years. Wistar rats are also known for their docile and friendly nature, making them easy to handle and work with in the laboratory setting.

Biliary atresia is a rare, progressive liver disease in infants and children, characterized by the inflammation, fibrosis, and obstruction of the bile ducts. This results in the impaired flow of bile from the liver to the intestine, leading to cholestasis (accumulation of bile in the liver), jaundice (yellowing of the skin and eyes), and eventually liver cirrhosis and failure if left untreated.

The exact cause of biliary atresia is not known, but it is believed to be a combination of genetic and environmental factors. It can occur as an isolated condition or in association with other congenital anomalies. The diagnosis of biliary atresia is typically made through imaging studies, such as ultrasound and cholangiography, and confirmed by liver biopsy.

The standard treatment for biliary atresia is a surgical procedure called the Kasai portoenterostomy, which aims to restore bile flow from the liver to the intestine. In this procedure, the damaged bile ducts are removed and replaced with a loop of intestine that is connected directly to the liver. The success of the Kasai procedure depends on several factors, including the age at diagnosis and surgery, the extent of liver damage, and the skill and experience of the surgeon.

Despite successful Kasai surgery, many children with biliary atresia will eventually develop cirrhosis and require liver transplantation. The prognosis for children with biliary atresia has improved significantly over the past few decades due to earlier diagnosis, advances in surgical techniques, and better postoperative care. However, it remains a challenging condition that requires close monitoring and multidisciplinary management by pediatric hepatologists, surgeons, and other healthcare professionals.

Disease progression is the worsening or advancement of a medical condition over time. It refers to the natural course of a disease, including its development, the severity of symptoms and complications, and the impact on the patient's overall health and quality of life. Understanding disease progression is important for developing appropriate treatment plans, monitoring response to therapy, and predicting outcomes.

The rate of disease progression can vary widely depending on the type of medical condition, individual patient factors, and the effectiveness of treatment. Some diseases may progress rapidly over a short period of time, while others may progress more slowly over many years. In some cases, disease progression may be slowed or even halted with appropriate medical interventions, while in other cases, the progression may be inevitable and irreversible.

In clinical practice, healthcare providers closely monitor disease progression through regular assessments, imaging studies, and laboratory tests. This information is used to guide treatment decisions and adjust care plans as needed to optimize patient outcomes and improve quality of life.

Imino acids are organic compounds that contain a nitrogen atom as part of an amide-like structure. They are structurally similar to amino acids, which contain a carboxyl group and an amino group, but instead of the amino group, imino acids have a structural unit known as an imine or Schiff base, which is a carbon-nitrogen double bond with a hydrogen atom attached to the nitrogen atom.

One example of an imino acid is proline, which is a cyclic imino acid that plays important roles in protein structure and function. Proline is unique among the 20 standard amino acids because its side chain is linked to the nitrogen atom of the backbone, forming a ring-like structure. This structural feature gives proline unique properties, such as restricted rotation around the bond between the nitrogen and alpha carbon atoms, which can affect protein folding and stability.

Other imino acids may be formed through chemical reactions or enzymatic processes, and they can play important roles in various biological pathways, including the biosynthesis of amino acids, nucleotides, and other biomolecules. However, imino acids are not typically considered to be part of the standard set of 20 amino acids that make up proteins.

Esophageal varices and gastric varices are abnormal, enlarged veins in the lower part of the esophagus (the tube that connects the throat to the stomach) and in the stomach lining, respectively. They occur as a result of increased pressure in the portal vein, which is the large blood vessel that carries blood from the digestive organs to the liver. This condition is known as portal hypertension.

Esophageal varices are more common than gastric varices and tend to be more symptomatic. They can cause bleeding, which can be life-threatening if not treated promptly. Gastric varices may also bleed, but they are often asymptomatic until they rupture.

The most common causes of esophageal and gastric varices are cirrhosis (scarring of the liver) and portal hypertension due to other liver diseases such as schistosomiasis or Budd-Chiari syndrome. Treatment options for esophageal and gastric varices include medications to reduce bleeding, endoscopic therapies to treat active bleeding or prevent recurrent bleeding, and surgical procedures to relieve portal hypertension.

Sprague-Dawley rats are a strain of albino laboratory rats that are widely used in scientific research. They were first developed by researchers H.H. Sprague and R.C. Dawley in the early 20th century, and have since become one of the most commonly used rat strains in biomedical research due to their relatively large size, ease of handling, and consistent genetic background.

Sprague-Dawley rats are outbred, which means that they are genetically diverse and do not suffer from the same limitations as inbred strains, which can have reduced fertility and increased susceptibility to certain diseases. They are also characterized by their docile nature and low levels of aggression, making them easier to handle and study than some other rat strains.

These rats are used in a wide variety of research areas, including toxicology, pharmacology, nutrition, cancer, and behavioral studies. Because they are genetically diverse, Sprague-Dawley rats can be used to model a range of human diseases and conditions, making them an important tool in the development of new drugs and therapies.

Blood coagulation disorders, also known as bleeding disorders or clotting disorders, refer to a group of medical conditions that affect the body's ability to form blood clots properly. Normally, when a blood vessel is injured, the body's coagulation system works to form a clot to stop the bleeding and promote healing.

In blood coagulation disorders, there can be either an increased tendency to bleed due to problems with the formation of clots (hemorrhagic disorder), or an increased tendency for clots to form inappropriately even without injury, leading to blockages in the blood vessels (thrombotic disorder).

Examples of hemorrhagic disorders include:

1. Hemophilia - a genetic disorder that affects the ability to form clots due to deficiencies in clotting factors VIII or IX.
2. Von Willebrand disease - another genetic disorder caused by a deficiency or abnormality of the von Willebrand factor, which helps platelets stick together to form a clot.
3. Liver diseases - can lead to decreased production of coagulation factors, increasing the risk of bleeding.
4. Disseminated intravascular coagulation (DIC) - a serious condition where clotting and bleeding occur simultaneously due to widespread activation of the coagulation system.

Examples of thrombotic disorders include:

1. Factor V Leiden mutation - a genetic disorder that increases the risk of inappropriate blood clot formation.
2. Antithrombin III deficiency - a genetic disorder that impairs the body's ability to break down clots, increasing the risk of thrombosis.
3. Protein C or S deficiencies - genetic disorders that lead to an increased risk of thrombosis due to impaired regulation of the coagulation system.
4. Antiphospholipid syndrome (APS) - an autoimmune disorder where the body produces antibodies against its own clotting factors, increasing the risk of thrombosis.

Treatment for blood coagulation disorders depends on the specific diagnosis and may include medications to manage bleeding or prevent clots, as well as lifestyle changes and monitoring to reduce the risk of complications.

Budd-Chiari syndrome is a rare condition characterized by the obstruction of the hepatic veins, which are the blood vessels that carry blood from the liver to the heart. This obstruction can be caused by blood clots, tumors, or other abnormalities, and it can lead to a backflow of blood in the liver, resulting in various symptoms such as abdominal pain, swelling, and liver enlargement. In severe cases, Budd-Chiari syndrome can cause liver failure and other complications if left untreated. The diagnosis of this condition typically involves imaging tests such as ultrasound, CT scan, or MRI, and treatment may include anticoagulation therapy, thrombolytic therapy, or surgical intervention to remove the obstruction.

Intrahepatic bile ducts are the small tubular structures inside the liver that collect bile from the liver cells (hepatocytes). Bile is a digestive fluid produced by the liver that helps in the absorption of fats and fat-soluble vitamins from food. The intrahepatic bile ducts merge to form larger ducts, which eventually exit the liver and join with the cystic duct from the gallbladder to form the common bile duct. The common bile duct then empties into the duodenum, the first part of the small intestine, where bile aids in digestion. Intrahepatic bile ducts can become obstructed or damaged due to various conditions such as gallstones, tumors, or inflammation, leading to complications like jaundice, liver damage, and infection.

Organ size refers to the volume or physical measurement of an organ in the body of an individual. It can be described in terms of length, width, and height or by using specialized techniques such as imaging studies (like CT scans or MRIs) to determine the volume. The size of an organ can vary depending on factors such as age, sex, body size, and overall health status. Changes in organ size may indicate various medical conditions, including growths, inflammation, or atrophy.

Hemoperfusion is a medical procedure that involves passing a patient's blood through an external device to remove toxic substances or excess therapeutic drugs. In this process, the patient's blood is circulated outside the body, where it passes through a cartridge containing adsorbent material (such as activated charcoal or synthetic resins). These materials bind to and eliminate harmful molecules from the blood, which are then discarded.

Hemoperfusion can be used in various clinical situations, such as:

1. Drug overdoses: To remove toxic levels of drugs that cannot be effectively eliminated by conventional methods like dialysis.
2. Poisoning: To eliminate harmful toxins from the bloodstream in cases of acute poisoning or envenomation.
3. Liver failure: In patients with liver dysfunction, hemoperfusion can help remove waste products and toxins that the damaged liver cannot process effectively.
4. Septicemia: To eliminate bacterial toxins from the bloodstream in severe cases of sepsis or septic shock.

It is important to note that hemoperfusion is not a common procedure and is typically reserved for specific, life-threatening situations where other treatment options have been exhausted. The use of this technique requires specialized equipment, trained medical personnel, and close monitoring of the patient's clinical status during and after the procedure.

"Inbred strains of rats" are genetically identical rodents that have been produced through many generations of brother-sister mating. This results in a high degree of homozygosity, where the genes at any particular locus in the genome are identical in all members of the strain.

Inbred strains of rats are widely used in biomedical research because they provide a consistent and reproducible genetic background for studying various biological phenomena, including the effects of drugs, environmental factors, and genetic mutations on health and disease. Additionally, inbred strains can be used to create genetically modified models of human diseases by introducing specific mutations into their genomes.

Some commonly used inbred strains of rats include the Wistar Kyoto (WKY), Sprague-Dawley (SD), and Fischer 344 (F344) rat strains. Each strain has its own unique genetic characteristics, making them suitable for different types of research.

Graft survival, in medical terms, refers to the success of a transplanted tissue or organ in continuing to function and integrate with the recipient's body over time. It is the opposite of graft rejection, which occurs when the recipient's immune system recognizes the transplanted tissue as foreign and attacks it, leading to its failure.

Graft survival depends on various factors, including the compatibility between the donor and recipient, the type and location of the graft, the use of immunosuppressive drugs to prevent rejection, and the overall health of the recipient. A successful graft survival implies that the transplanted tissue or organ has been accepted by the recipient's body and is functioning properly, providing the necessary physiological support for the recipient's survival and improved quality of life.

A "knockout" mouse is a genetically engineered mouse in which one or more genes have been deleted or "knocked out" using molecular biology techniques. This allows researchers to study the function of specific genes and their role in various biological processes, as well as potential associations with human diseases. The mice are generated by introducing targeted DNA modifications into embryonic stem cells, which are then used to create a live animal. Knockout mice have been widely used in biomedical research to investigate gene function, disease mechanisms, and potential therapeutic targets.

Acetylcysteine is a medication that is used for its antioxidant effects and to help loosen thick mucus in the lungs. It is commonly used to treat conditions such as chronic bronchitis, emphysema, and cystic fibrosis. Acetylcysteine is also known by the brand names Mucomyst and Accolate. It works by thinning and breaking down mucus in the airways, making it easier to cough up and clear the airways. Additionally, acetylcysteine is an antioxidant that helps to protect cells from damage caused by free radicals. It is available as a oral tablet, liquid, or inhaled medication.

Phosphatidylethanolamine N-Methyltransferase (PEMT) is an enzyme that plays a role in the synthesis of phosphatidylcholine, a major phospholipid component of cell membranes. The enzyme catalyzes the transfer of methyl groups from S-adenosylmethionine to phosphatidylethanolamine, converting it into phosphatidylcholine in a three-step methylation process. This enzyme is found primarily in the endoplasmic reticulum and mitochondria of cells and has implications in lipid metabolism, liver function, and inflammation. Genetic variations and altered expression levels of PEMT have been associated with various diseases, including non-alcoholic fatty liver disease, cardiovascular disease, and neurological disorders.

Dialysis is a medical treatment that is used to remove waste and excess fluid from the blood when the kidneys are no longer able to perform these functions effectively. This life-sustaining procedure uses a specialized machine, called a dialyzer or artificial kidney, to filter the blood outside of the body and return clean, chemically balanced blood back into the body.

There are two main types of dialysis: hemodialysis and peritoneal dialysis.

1. Hemodialysis: In this method, a patient's blood is passed through an external filter (dialyzer) that removes waste products, toxins, and excess fluids. The cleaned blood is then returned to the body with the help of a specialized machine. Hemodialysis typically requires access to a large vein, often created by a surgical procedure called an arteriovenous (AV) fistula or graft. Hemodialysis sessions usually last for about 3-5 hours and are performed three times a week in a clinical setting, such as a dialysis center or hospital.
2. Peritoneal Dialysis: This method uses the lining of the patient's own abdomen (peritoneum) as a natural filter to clean the blood. A sterile dialysate solution is introduced into the peritoneal cavity via a permanently implanted catheter. The solution absorbs waste products and excess fluids from the blood vessels lining the peritoneum through a process called diffusion. After a dwell time, usually several hours, the used dialysate is drained out and replaced with fresh dialysate. This process is known as an exchange and is typically repeated multiple times throughout the day or night, depending on the specific type of peritoneal dialysis (continuous ambulatory peritoneal dialysis or automated peritoneal dialysis).

Both methods have their advantages and disadvantages, and the choice between them depends on various factors, such as a patient's overall health, lifestyle, and personal preferences. Dialysis is a life-saving treatment for people with end-stage kidney disease or severe kidney dysfunction, allowing them to maintain their quality of life and extend their lifespan until a kidney transplant becomes available or their kidney function improves.

Antiviral agents are a class of medications that are designed to treat infections caused by viruses. Unlike antibiotics, which target bacteria, antiviral agents interfere with the replication and infection mechanisms of viruses, either by inhibiting their ability to replicate or by modulating the host's immune response to the virus.

Antiviral agents are used to treat a variety of viral infections, including influenza, herpes simplex virus (HSV) infections, human immunodeficiency virus (HIV) infection, hepatitis B and C, and respiratory syncytial virus (RSV) infections.

These medications can be administered orally, intravenously, or topically, depending on the type of viral infection being treated. Some antiviral agents are also used for prophylaxis, or prevention, of certain viral infections.

It is important to note that antiviral agents are not effective against all types of viruses and may have significant side effects. Therefore, it is essential to consult with a healthcare professional before starting any antiviral therapy.

Complement C3 Convertase, Alternative Pathway is a complex enzyme composed of the proteins C3b and Bb. It plays a crucial role in the alternative pathway of the complement system, which is a part of the innate immune system that helps to defend the body against invading pathogens.

The alternative pathway is continuously activated at a low level, and C3 Convertase is responsible for amplifying this activation. It does so by cleaving the complement component C3 into C3a and C3b. The C3b then binds to the surface of the pathogen and can form additional C3 Convertases, leading to a positive feedback loop that results in the rapid accumulation of complement components on the surface of the pathogen.

This accumulation of complement components helps to mark the pathogen for destruction by other immune cells, such as neutrophils and macrophages. Additionally, the cleavage products C3a and C5a generated during this process can act as anaphylatoxins, inducing inflammation and attracting more immune cells to the site of infection.

Regulation of Complement C3 Convertase is critical to prevent damage to host tissues. Several regulatory proteins, such as factor H and decay-accelerating factor (DAF), help to limit the formation and activity of C3 Convertase on host cells and tissues. Dysregulation of the complement system, including the alternative pathway and Complement C3 Convertase, has been implicated in a variety of diseases, including autoimmune disorders, inflammatory diseases, and infectious diseases.

Plasmapheresis is a medical procedure where the liquid portion of the blood (plasma) is separated from the blood cells. The plasma, which may contain harmful substances such as antibodies or toxins, is then removed and replaced with fresh plasma or a plasma substitute. The remaining blood cells are mixed with the new plasma and returned to the body. This process is also known as therapeutic plasma exchange (TPE). It's used to treat various medical conditions including certain autoimmune diseases, poisonings, and neurological disorders.

Alpha-fetoprotein (AFP) is a protein produced by the yolk sac and the liver during fetal development. In adults, AFP is normally present in very low levels in the blood. However, abnormal production of AFP can occur in certain medical conditions, such as:

* Liver cancer or hepatocellular carcinoma (HCC)
* Germ cell tumors, including non-seminomatous testicular cancer and ovarian cancer
* Hepatitis or liver inflammation
* Certain types of benign liver disease, such as cirrhosis or hepatic adenomas

Elevated levels of AFP in the blood can be detected through a simple blood test. This test is often used as a tumor marker to help diagnose and monitor certain types of cancer, particularly HCC. However, it's important to note that an elevated AFP level alone is not enough to diagnose cancer, and further testing is usually needed to confirm the diagnosis. Additionally, some non-cancerous conditions can also cause elevated AFP levels, so it's important to interpret the test results in the context of the individual's medical history and other diagnostic tests.

Apoptosis is a programmed and controlled cell death process that occurs in multicellular organisms. It is a natural process that helps maintain tissue homeostasis by eliminating damaged, infected, or unwanted cells. During apoptosis, the cell undergoes a series of morphological changes, including cell shrinkage, chromatin condensation, and fragmentation into membrane-bound vesicles called apoptotic bodies. These bodies are then recognized and engulfed by neighboring cells or phagocytic cells, preventing an inflammatory response. Apoptosis is regulated by a complex network of intracellular signaling pathways that involve proteins such as caspases, Bcl-2 family members, and inhibitors of apoptosis (IAPs).

The International Normalized Ratio (INR) is a standardized measurement of the prothrombin time (PT), which is the time it takes for blood to clot. The INR is used to monitor and regulate the effects of anticoagulant medications, such as warfarin, that affect the blood's ability to clot.

The INR is calculated by dividing the patient's PT by a control value (the PT of normal, healthy blood), raised to the power of a sensitivity factor called the International Sensitivity Index (ISI). The ISI is specific to the thromboplastin reagent used in the PT assay.

The INR provides a consistent and comparable way to monitor anticoagulation therapy across different laboratories, regardless of the thromboplastin reagent used. This helps ensure that patients receive appropriate doses of anticoagulant medications and reduces the risk of bleeding or clotting complications.

In general, an INR range of 2.0 to 3.0 is recommended for most people taking anticoagulants for conditions such as atrial fibrillation, deep vein thrombosis, or pulmonary embolism. However, the target INR range may vary depending on individual patient factors and medical indications.

Graft rejection is an immune response that occurs when transplanted tissue or organ (the graft) is recognized as foreign by the recipient's immune system, leading to the activation of immune cells to attack and destroy the graft. This results in the failure of the transplant and the need for additional medical intervention or another transplant. There are three types of graft rejection: hyperacute, acute, and chronic. Hyperacute rejection occurs immediately or soon after transplantation due to pre-existing antibodies against the graft. Acute rejection typically occurs within weeks to months post-transplant and is characterized by the infiltration of T-cells into the graft. Chronic rejection, which can occur months to years after transplantation, is a slow and progressive process characterized by fibrosis and tissue damage due to ongoing immune responses against the graft.

Brain edema is a medical condition characterized by the abnormal accumulation of fluid in the brain, leading to an increase in intracranial pressure. This can result from various causes, such as traumatic brain injury, stroke, infection, brain tumors, or inflammation. The swelling of the brain can compress vital structures, impair blood flow, and cause neurological symptoms, which may range from mild headaches to severe cognitive impairment, seizures, coma, or even death if not treated promptly and effectively.

Aromatic amino acids are a specific type of amino acids that contain an aromatic ring in their side chain. The three aromatic amino acids are phenylalanine (Phe), tyrosine (Tyr), and tryptophan (Trp). These amino acids play important roles in various biological processes, including protein structure and function, neurotransmission, and enzyme catalysis.

The aromatic ring in these amino acids is composed of a planar six-membered carbon ring that contains alternating double bonds. This structure gives the side chains unique chemical properties, such as their ability to absorb ultraviolet light and participate in stacking interactions with other aromatic residues. These interactions can contribute to the stability and function of proteins and other biological molecules.

It's worth noting that while most amino acids are classified as either "hydrophobic" or "hydrophilic," depending on their chemical properties, aromatic amino acids exhibit characteristics of both groups. They can form hydrogen bonds with polar residues and also engage in hydrophobic interactions with nonpolar residues, making them versatile building blocks for protein structure and function.

Hepatitis A is a viral infection that specifically targets the liver, causing inflammation and impaired function. This disease is caused by the hepatitis A virus (HAV), which spreads primarily through the fecal-oral route, often due to poor sanitation and hygiene. Individuals can become infected by consuming food or water contaminated with HAV or by coming into direct contact with an infected person's stool.

The symptoms of hepatitis A may include fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay-colored bowel movements, joint pain, and jaundice (yellowing of the skin and eyes). However, in some cases, particularly in children under six years old, the infection may be asymptomatic.

While hepatitis A can be unpleasant and cause serious complications, it is rarely fatal and most people recover completely within a few months. Preventive measures include vaccination, practicing good hygiene, and avoiding potentially contaminated food and water.

Indocyanine green (ICG) is a sterile, water-soluble, tricarbocyanine dye that is used as a diagnostic agent in medical imaging. It is primarily used in ophthalmology for fluorescein angiography to examine blood flow in the retina and choroid, and in cardiac surgery to assess cardiac output and perfusion. When injected into the body, ICG binds to plasma proteins and fluoresces when exposed to near-infrared light, allowing for visualization of various tissues and structures. It is excreted primarily by the liver and has a half-life of approximately 3-4 minutes in the bloodstream.

Risk assessment in the medical context refers to the process of identifying, evaluating, and prioritizing risks to patients, healthcare workers, or the community related to healthcare delivery. It involves determining the likelihood and potential impact of adverse events or hazards, such as infectious diseases, medication errors, or medical devices failures, and implementing measures to mitigate or manage those risks. The goal of risk assessment is to promote safe and high-quality care by identifying areas for improvement and taking action to minimize harm.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

Equipment failure is a term used in the medical field to describe the malfunction or breakdown of medical equipment, devices, or systems that are essential for patient care. This can include simple devices like syringes and thermometers, as well as complex machines such as ventilators, infusion pumps, and imaging equipment.

Equipment failure can have serious consequences for patients, including delayed or inappropriate treatment, injury, or even death. It is therefore essential that medical equipment is properly maintained, tested, and repaired to ensure its safe and effective operation.

There are many potential causes of equipment failure, including:

* Wear and tear from frequent use
* Inadequate cleaning or disinfection
* Improper handling or storage
* Power supply issues
* Software glitches or bugs
* Mechanical failures or defects
* Human error or misuse

To prevent equipment failure, healthcare facilities should have established policies and procedures for the acquisition, maintenance, and disposal of medical equipment. Staff should be trained in the proper use and handling of equipment, and regular inspections and testing should be performed to identify and address any potential issues before they lead to failure.

Hemochromatosis is a medical condition characterized by excessive absorption and accumulation of iron in the body, resulting in damage to various organs. It's often referred to as "iron overload" disorder. There are two main types: primary (hereditary) and secondary (acquired). Primary hemochromatosis is caused by genetic mutations that lead to increased intestinal iron absorption, while secondary hemochromatosis can be the result of various conditions such as multiple blood transfusions, chronic liver disease, or certain types of anemia.

In both cases, the excess iron gets stored in body tissues, particularly in the liver, heart, and pancreas, which can cause organ damage and lead to complications like cirrhosis, liver failure, diabetes, heart problems, and skin discoloration. Early diagnosis and treatment through regular phlebotomy (blood removal) or chelation therapy can help manage the condition and prevent severe complications.

A Receiver Operating Characteristic (ROC) curve is a graphical representation used in medical decision-making and statistical analysis to illustrate the performance of a binary classifier system, such as a diagnostic test or a machine learning algorithm. It's a plot that shows the tradeoff between the true positive rate (sensitivity) and the false positive rate (1 - specificity) for different threshold settings.

The x-axis of an ROC curve represents the false positive rate (the proportion of negative cases incorrectly classified as positive), while the y-axis represents the true positive rate (the proportion of positive cases correctly classified as positive). Each point on the curve corresponds to a specific decision threshold, with higher points indicating better performance.

The area under the ROC curve (AUC) is a commonly used summary measure that reflects the overall performance of the classifier. An AUC value of 1 indicates perfect discrimination between positive and negative cases, while an AUC value of 0.5 suggests that the classifier performs no better than chance.

ROC curves are widely used in healthcare to evaluate diagnostic tests, predictive models, and screening tools for various medical conditions, helping clinicians make informed decisions about patient care based on the balance between sensitivity and specificity.

Hyperbilirubinemia is a medical condition characterized by an excessively high level of bilirubin in the bloodstream. Bilirubin is a yellowish pigment produced by the liver when it breaks down old red blood cells. Normally, bilirubin is conjugated (made water-soluble) in the liver and then excreted through the bile into the digestive system. However, if there is a problem with the liver's ability to process or excrete bilirubin, it can build up in the blood, leading to hyperbilirubinemia.

Hyperbilirubinemia can be classified as either unconjugated or conjugated, depending on whether the bilirubin is in its direct (conjugated) or indirect (unconjugated) form. Unconjugated hyperbilirubinemia can occur due to increased production of bilirubin (such as in hemolytic anemia), decreased uptake of bilirubin by the liver, or impaired conjugation of bilirubin in the liver. Conjugated hyperbilirubinemia, on the other hand, is usually caused by a problem with the excretion of conjugated bilirubin into the bile, such as in cholestatic liver diseases like hepatitis or cirrhosis.

Symptoms of hyperbilirubinemia can include jaundice (yellowing of the skin and eyes), dark urine, light-colored stools, itching, and fatigue. Treatment depends on the underlying cause of the condition and may involve medications, dietary changes, or surgery.

Perfusion, in medical terms, refers to the process of circulating blood through the body's organs and tissues to deliver oxygen and nutrients and remove waste products. It is a measure of the delivery of adequate blood flow to specific areas or tissues in the body. Perfusion can be assessed using various methods, including imaging techniques like computed tomography (CT) scans, magnetic resonance imaging (MRI), and perfusion scintigraphy.

Perfusion is critical for maintaining proper organ function and overall health. When perfusion is impaired or inadequate, it can lead to tissue hypoxia, acidosis, and cell death, which can result in organ dysfunction or failure. Conditions that can affect perfusion include cardiovascular disease, shock, trauma, and certain surgical procedures.

Hemodynamics is the study of how blood flows through the cardiovascular system, including the heart and the vascular network. It examines various factors that affect blood flow, such as blood volume, viscosity, vessel length and diameter, and pressure differences between different parts of the circulatory system. Hemodynamics also considers the impact of various physiological and pathological conditions on these variables, and how they in turn influence the function of vital organs and systems in the body. It is a critical area of study in fields such as cardiology, anesthesiology, and critical care medicine.

Cardiac output is a measure of the amount of blood that the heart pumps in one minute. It is calculated by multiplying the stroke volume (the amount of blood pumped by the left ventricle during each contraction) by the heart rate (the number of times the heart beats per minute). Low cardiac output refers to a condition in which the heart is not able to pump enough blood to meet the body's needs. This can occur due to various reasons such as heart failure, heart attack, or any other conditions that weaken the heart muscle. Symptoms of low cardiac output may include fatigue, shortness of breath, and decreased mental status. Treatment for low cardiac output depends on the underlying cause and may include medications, surgery, or medical devices to help support heart function.

Renal dialysis is a medical procedure that is used to artificially remove waste products, toxins, and excess fluids from the blood when the kidneys are no longer able to perform these functions effectively. This process is also known as hemodialysis.

During renal dialysis, the patient's blood is circulated through a special machine called a dialyzer or an artificial kidney, which contains a semi-permeable membrane that filters out waste products and excess fluids from the blood. The cleaned blood is then returned to the patient's body.

Renal dialysis is typically recommended for patients with advanced kidney disease or kidney failure, such as those with end-stage renal disease (ESRD). It is a life-sustaining treatment that helps to maintain the balance of fluids and electrolytes in the body, prevent the buildup of waste products and toxins, and control blood pressure.

There are two main types of renal dialysis: hemodialysis and peritoneal dialysis. Hemodialysis is the most common type and involves using a dialyzer to filter the blood outside the body. Peritoneal dialysis, on the other hand, involves placing a catheter in the abdomen and using the lining of the abdomen (peritoneum) as a natural filter to remove waste products and excess fluids from the body.

Overall, renal dialysis is an essential treatment option for patients with kidney failure, helping them to maintain their quality of life and prolong their survival.

A tissue donor is an individual who has agreed to allow organs and tissues to be removed from their body after death for the purpose of transplantation to restore the health or save the life of another person. The tissues that can be donated include corneas, heart valves, skin, bone, tendons, ligaments, veins, and cartilage. These tissues can enhance the quality of life for many recipients and are often used in reconstructive surgeries. It is important to note that tissue donation does not interfere with an open casket funeral or other cultural or religious practices related to death and grieving.

Aspartate aminotransferases (ASTs) are a group of enzymes found in various tissues throughout the body, including the heart, liver, and muscles. They play a crucial role in the metabolic process of transferring amino groups between different molecules.

In medical terms, AST is often used as a blood test to measure the level of this enzyme in the serum. Elevated levels of AST can indicate damage or injury to tissues that contain this enzyme, such as the liver or heart. For example, liver disease, including hepatitis and cirrhosis, can cause elevated AST levels due to damage to liver cells. Similarly, heart attacks can also result in increased AST levels due to damage to heart muscle tissue.

It is important to note that an AST test alone cannot diagnose a specific medical condition, but it can provide valuable information when used in conjunction with other diagnostic tests and clinical evaluation.

Antipyretics are medications that are used to reduce fever or prevent shivering. They work by inhibiting the production of prostaglandins, which are chemicals in the body that cause fever and inflammation. The most commonly used antipyretic is acetaminophen (also known as paracetamol), but other examples include aspirin and ibuprofen. Antipyretics are typically taken orally, but some forms can also be given rectally or intravenously. It's important to follow the dosage instructions carefully when taking antipyretics, as taking too much can cause liver damage or other serious side effects.

Cell transplantation is the process of transferring living cells from one part of the body to another or from one individual to another. In medicine, cell transplantation is often used as a treatment for various diseases and conditions, including neurodegenerative disorders, diabetes, and certain types of cancer. The goal of cell transplantation is to replace damaged or dysfunctional cells with healthy ones, thereby restoring normal function to the affected area.

In the context of medical research, cell transplantation may involve the use of stem cells, which are immature cells that have the ability to develop into many different types of specialized cells. Stem cell transplantation has shown promise in the treatment of a variety of conditions, including spinal cord injuries, stroke, and heart disease.

It is important to note that cell transplantation carries certain risks, such as immune rejection and infection. As such, it is typically reserved for cases where other treatments have failed or are unlikely to be effective.

Ursodeoxycholic acid (UDCA) is a naturally occurring bile acid that is used medically as a therapeutic agent. It is commonly used to treat gallstones, particularly cholesterol gallstones, and other conditions associated with abnormal liver function, such as primary biliary cholangitis (PBC). UDCA works by decreasing the amount of cholesterol in bile and protecting liver cells from damage. It is also known as ursodiol or Ursotan.

Recurrence, in a medical context, refers to the return of symptoms or signs of a disease after a period of improvement or remission. It indicates that the condition has not been fully eradicated and may require further treatment. Recurrence is often used to describe situations where a disease such as cancer comes back after initial treatment, but it can also apply to other medical conditions. The likelihood of recurrence varies depending on the type of disease and individual patient factors.

X-ray computed tomography (CT or CAT scan) is a medical imaging method that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional (tomographic) images (virtual "slices") of the body. These cross-sectional images can then be used to display detailed internal views of organs, bones, and soft tissues in the body.

The term "computed tomography" is used instead of "CT scan" or "CAT scan" because the machines take a series of X-ray measurements from different angles around the body and then use a computer to process these data to create detailed images of internal structures within the body.

CT scanning is a noninvasive, painless medical test that helps physicians diagnose and treat medical conditions. CT imaging provides detailed information about many types of tissue including lung, bone, soft tissue and blood vessels. CT examinations can be performed on every part of the body for a variety of reasons including diagnosis, surgical planning, and monitoring of therapeutic responses.

In computed tomography (CT), an X-ray source and detector rotate around the patient, measuring the X-ray attenuation at many different angles. A computer uses this data to construct a cross-sectional image by the process of reconstruction. This technique is called "tomography". The term "computed" refers to the use of a computer to reconstruct the images.

CT has become an important tool in medical imaging and diagnosis, allowing radiologists and other physicians to view detailed internal images of the body. It can help identify many different medical conditions including cancer, heart disease, lung nodules, liver tumors, and internal injuries from trauma. CT is also commonly used for guiding biopsies and other minimally invasive procedures.

In summary, X-ray computed tomography (CT or CAT scan) is a medical imaging technique that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional images of the body. It provides detailed internal views of organs, bones, and soft tissues in the body, allowing physicians to diagnose and treat medical conditions.

Explosive agents are substances or materials that can undergo rapid chemical reactions, leading to a sudden release of gas and heat, resulting in a large increase in pressure and volume. This rapid expansion creates an explosion, which can cause significant damage to surrounding structures and pose serious risks to human health and safety.

Explosive agents are typically classified into two main categories: low explosives and high explosives. Low explosives burn more slowly than high explosives and rely on the confinement of the material to build up pressure and cause an explosion. Examples of low explosives include black powder, smokeless powder, and certain types of pyrotechnics.

High explosives, on the other hand, decompose rapidly and can detonate with great speed and force. They are often used in military applications such as bombs, artillery shells, and demolitions. Examples of high explosives include TNT (trinitrotoluene), RDX (cyclotrimethylenetrinitramine), and PETN (pentaerythritol tetranitrate).

It is important to note that the handling, storage, and use of explosive agents require specialized training and strict safety protocols, as they can pose significant risks if not managed properly.

Heart failure, systolic is a type of heart failure in which the heart's lower chambers, the ventricles, are not able to contract with enough force to pump an adequate amount of blood throughout the body. This means that the heart cannot effectively pump oxygenated blood to meet the body's needs, leading to symptoms such as shortness of breath, fatigue, and fluid buildup in the lungs and other parts of the body.

Systolic heart failure is often caused by damage to the heart muscle, such as from a heart attack or long-standing high blood pressure. Over time, this damage can weaken the heart muscle and make it harder for the ventricles to contract with enough force to pump blood efficiently.

Treatment for systolic heart failure typically involves medications to help improve heart function, reduce symptoms, and prevent further damage to the heart. Lifestyle changes, such as following a healthy diet, getting regular exercise, and quitting smoking, can also help manage this condition. In some cases, more advanced treatments such as implantable devices or heart transplantation may be necessary.

Chronic Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that lasts for more than six months. This long-term infection can lead to scarring of the liver (cirrhosis), which can cause serious health problems, such as liver failure or liver cancer, in some individuals. The infection is usually asymptomatic until complications arise, but it can be detected through blood tests that identify antibodies to the virus or viral RNA. Chronic hepatitis C is typically managed with antiviral therapy, which can help clear the virus from the body and reduce the risk of liver damage.

A cohort study is a type of observational study in which a group of individuals who share a common characteristic or exposure are followed up over time to determine the incidence of a specific outcome or outcomes. The cohort, or group, is defined based on the exposure status (e.g., exposed vs. unexposed) and then monitored prospectively to assess for the development of new health events or conditions.

Cohort studies can be either prospective or retrospective in design. In a prospective cohort study, participants are enrolled and followed forward in time from the beginning of the study. In contrast, in a retrospective cohort study, researchers identify a cohort that has already been assembled through medical records, insurance claims, or other sources and then look back in time to assess exposure status and health outcomes.

Cohort studies are useful for establishing causality between an exposure and an outcome because they allow researchers to observe the temporal relationship between the two. They can also provide information on the incidence of a disease or condition in different populations, which can be used to inform public health policy and interventions. However, cohort studies can be expensive and time-consuming to conduct, and they may be subject to bias if participants are not representative of the population or if there is loss to follow-up.

Tissue and organ procurement is the process of obtaining viable tissues and organs from deceased or living donors for the purpose of transplantation, research, or education. This procedure is performed by trained medical professionals in a sterile environment, adhering to strict medical standards and ethical guidelines. The tissues and organs that can be procured include hearts, lungs, livers, kidneys, pancreases, intestines, corneas, skin, bones, tendons, and heart valves. The process involves a thorough medical evaluation of the donor, as well as consent from the donor or their next of kin. After procurement, the tissues and organs are preserved and transported to recipients in need.

Immunosuppressive agents are medications that decrease the activity of the immune system. They are often used to prevent the rejection of transplanted organs and to treat autoimmune diseases, where the immune system mistakenly attacks the body's own tissues. These drugs work by interfering with the immune system's normal responses, which helps to reduce inflammation and damage to tissues. However, because they suppress the immune system, people who take immunosuppressive agents are at increased risk for infections and other complications. Examples of immunosuppressive agents include corticosteroids, azathioprine, cyclophosphamide, mycophenolate mofetil, tacrolimus, and sirolimus.

The Kaplan-Meier estimate is a statistical method used to calculate the survival probability over time in a population. It is commonly used in medical research to analyze time-to-event data, such as the time until a patient experiences a specific event like disease progression or death. The Kaplan-Meier estimate takes into account censored data, which occurs when some individuals are lost to follow-up before experiencing the event of interest.

The method involves constructing a survival curve that shows the proportion of subjects still surviving at different time points. At each time point, the survival probability is calculated as the product of the conditional probabilities of surviving from one time point to the next. The Kaplan-Meier estimate provides an unbiased and consistent estimator of the survival function, even when censoring is present.

In summary, the Kaplan-Meier estimate is a crucial tool in medical research for analyzing time-to-event data and estimating survival probabilities over time while accounting for censored observations.

A reoperation is a surgical procedure that is performed again on a patient who has already undergone a previous operation for the same or related condition. Reoperations may be required due to various reasons, such as inadequate initial treatment, disease recurrence, infection, or complications from the first surgery. The nature and complexity of a reoperation can vary widely depending on the specific circumstances, but it often carries higher risks and potential complications compared to the original operation.

Respiratory insufficiency is a condition characterized by the inability of the respiratory system to maintain adequate gas exchange, resulting in an inadequate supply of oxygen and/or removal of carbon dioxide from the body. This can occur due to various causes, such as lung diseases (e.g., chronic obstructive pulmonary disease, pneumonia), neuromuscular disorders (e.g., muscular dystrophy, spinal cord injury), or other medical conditions that affect breathing mechanics and/or gas exchange.

Respiratory insufficiency can manifest as hypoxemia (low oxygen levels in the blood) and/or hypercapnia (high carbon dioxide levels in the blood). Symptoms of respiratory insufficiency may include shortness of breath, rapid breathing, fatigue, confusion, and in severe cases, loss of consciousness or even death. Treatment depends on the underlying cause and severity of the condition and may include oxygen therapy, mechanical ventilation, medications, and/or other supportive measures.

I believe there might be a misunderstanding in your question. "Dogs" is not a medical term or condition. It is the common name for a domesticated carnivore of the family Canidae, specifically the genus Canis, which includes wolves, foxes, and other extant and extinct species of mammals. Dogs are often kept as pets and companions, and they have been bred in a wide variety of forms and sizes for different purposes, such as hunting, herding, guarding, assisting police and military forces, and providing companionship and emotional support.

If you meant to ask about a specific medical condition or term related to dogs, please provide more context so I can give you an accurate answer.

Gastrointestinal (GI) hemorrhage is a term used to describe any bleeding that occurs in the gastrointestinal tract, which includes the esophagus, stomach, small intestine, large intestine, and rectum. The bleeding can range from mild to severe and can produce symptoms such as vomiting blood, passing black or tarry stools, or having low blood pressure.

GI hemorrhage can be classified as either upper or lower, depending on the location of the bleed. Upper GI hemorrhage refers to bleeding that occurs above the ligament of Treitz, which is a point in the small intestine where it becomes narrower and turns a corner. Common causes of upper GI hemorrhage include gastritis, ulcers, esophageal varices, and Mallory-Weiss tears.

Lower GI hemorrhage refers to bleeding that occurs below the ligament of Treitz. Common causes of lower GI hemorrhage include diverticulosis, colitis, inflammatory bowel disease, and vascular abnormalities such as angiodysplasia.

The diagnosis of GI hemorrhage is often made based on the patient's symptoms, medical history, physical examination, and diagnostic tests such as endoscopy, CT scan, or radionuclide scanning. Treatment depends on the severity and cause of the bleeding and may include medications, endoscopic procedures, surgery, or a combination of these approaches.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

A hepatic portoenterostomy, also known as Kasai procedure, is a surgical operation performed on infants with extrahepatic biliary atresia. This condition is characterized by the absence or abnormal formation of the bile ducts that carry bile from the liver to the small intestine, leading to obstruction and damage to the liver.

During a hepatic portoenterostomy, the surgeon creates an anastomosis (connection) between the portal vein, which brings blood to the liver, and a loop of intestine. This connection allows bile to flow directly from the liver into the intestine, bypassing the blocked or absent bile ducts. The goal of the procedure is to restore bile flow and prevent further damage to the liver.

The success of the procedure varies, but it can help improve the child's quality of life and delay or prevent the need for a liver transplant in some cases. However, many children with biliary atresia will eventually require a liver transplant as the disease progresses.

A Transjugular Intrahepatic Portosystemic Shunt (TIPS) is a medical procedure that creates an alternative pathway for blood flow from the portal vein to the hepatic vein within the liver. This shunt is composed of a stent, which is a small metal tube that is inserted into the liver using a long needle that is passed through a vein in the neck (jugular vein).

TIPS is typically used to treat complications of portal hypertension, such as variceal bleeding, ascites, and hepatic hydrothorax. By creating a shunt that bypasses the liver, TIPS reduces the pressure in the portal vein, which can help to alleviate these symptoms. However, because the shunt allows blood to bypass the liver, it can also impair liver function and lead to other complications, such as hepatic encephalopathy.

It is important to note that TIPS is a complex procedure that should only be performed by experienced interventional radiologists in a hospital setting with appropriate medical backup and monitoring capabilities.

Ferrochelatase is a medical/biochemical term that refers to an enzyme called Fe-chelatase or heme synthase. This enzyme plays a crucial role in the biosynthesis of heme, which is a vital component of hemoglobin, cytochromes, and other important biological molecules.

Ferrochelatase functions by catalyzing the insertion of ferrous iron (Fe2+) into protoporphyrin IX, the final step in heme biosynthesis. This enzyme is located within the inner mitochondrial membrane of cells and is widely expressed in various tissues, with particularly high levels found in erythroid precursor cells, liver, and brain.

Defects or mutations in the ferrochelatase gene can lead to a rare genetic disorder called erythropoietic protoporphyria (EPP), which is characterized by an accumulation of protoporphyrin IX in red blood cells, plasma, and other tissues. This accumulation results in photosensitivity, skin lesions, and potential complications such as liver dysfunction and gallstones.

Tumor Necrosis Factor-alpha (TNF-α) is a cytokine, a type of small signaling protein involved in immune response and inflammation. It is primarily produced by activated macrophages, although other cell types such as T-cells, natural killer cells, and mast cells can also produce it.

TNF-α plays a crucial role in the body's defense against infection and tissue injury by mediating inflammatory responses, activating immune cells, and inducing apoptosis (programmed cell death) in certain types of cells. It does this by binding to its receptors, TNFR1 and TNFR2, which are found on the surface of many cell types.

In addition to its role in the immune response, TNF-α has been implicated in the pathogenesis of several diseases, including autoimmune disorders such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis, as well as cancer, where it can promote tumor growth and metastasis.

Therapeutic agents that target TNF-α, such as infliximab, adalimumab, and etanercept, have been developed to treat these conditions. However, these drugs can also increase the risk of infections and other side effects, so their use must be carefully monitored.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

A portosystemic shunt is a surgical procedure that creates a connection between the portal vein (the blood vessel that carries blood from the digestive organs to the liver) and another systemic vein (a vein that carries blood away from the liver). This procedure is typically performed in animals, particularly dogs, to treat conditions such as portal hypertension or liver disease.

In a surgical portosystemic shunt, the surgeon creates a connection between the portal vein and a systemic vein, allowing blood from the digestive organs to bypass the liver. This can help to reduce the pressure in the portal vein and improve blood flow to the liver. The specific type of shunt created and the surgical approach used may vary depending on the individual patient's needs and the surgeon's preference.

It is important to note that while a surgical portosystemic shunt can be an effective treatment for certain conditions, it is not without risks and potential complications. As with any surgical procedure, there is always a risk of infection, bleeding, or other complications. Additionally, the creation of a portosystemic shunt can have long-term effects on the liver and overall health of the patient. It is important for pet owners to carefully consider the risks and benefits of this procedure and to discuss any questions or concerns they may have with their veterinarian.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

An antidote is a substance that can counteract the effects of a poison or toxin. It works by neutralizing, reducing, or eliminating the harmful effects of the toxic substance. Antidotes can be administered in various forms such as medications, vaccines, or treatments. They are often used in emergency situations to save lives and prevent serious complications from poisoning.

The effectiveness of an antidote depends on several factors, including the type and amount of toxin involved, the timing of administration, and the individual's response to treatment. In some cases, multiple antidotes may be required to treat a single poisoning incident. It is important to note that not all poisons have specific antidotes, and in such cases, supportive care and symptomatic treatment may be necessary.

Examples of common antidotes include:

* Naloxone for opioid overdose
* Activated charcoal for certain types of poisoning
* Digoxin-specific antibodies for digoxin toxicity
* Fomepizole for methanol or ethylene glycol poisoning
* Dimercaprol for heavy metal poisoning.

Vitamin D-Binding Protein (DBP), also known as Group-specific Component (Gc-globulin), is a protein that binds and transports vitamin D and its metabolites in the bloodstream. It plays a crucial role in maintaining the homeostasis of vitamin D by regulating the amount of free, active vitamin D available to cells. DBP also has other functions, including acting as an actin scavenger to prevent the formation of harmful actin aggregates in circulation and participating in immune responses.

Glutathione is a tripeptide composed of three amino acids: cysteine, glutamic acid, and glycine. It is a vital antioxidant that plays an essential role in maintaining cellular health and function. Glutathione helps protect cells from oxidative stress by neutralizing free radicals, which are unstable molecules that can damage cells and contribute to aging and diseases such as cancer, heart disease, and dementia. It also supports the immune system, detoxifies harmful substances, and regulates various cellular processes, including DNA synthesis and repair.

Glutathione is found in every cell of the body, with particularly high concentrations in the liver, lungs, and eyes. The body can produce its own glutathione, but levels may decline with age, illness, or exposure to toxins. As such, maintaining optimal glutathione levels through diet, supplementation, or other means is essential for overall health and well-being.

Bile acids and salts are naturally occurring steroidal compounds that play a crucial role in the digestion and absorption of lipids (fats) in the body. They are produced in the liver from cholesterol and then conjugated with glycine or taurine to form bile acids, which are subsequently converted into bile salts by the addition of a sodium or potassium ion.

Bile acids and salts are stored in the gallbladder and released into the small intestine during digestion, where they help emulsify fats, allowing them to be broken down into smaller molecules that can be absorbed by the body. They also aid in the elimination of waste products from the liver and help regulate cholesterol metabolism.

Abnormalities in bile acid synthesis or transport can lead to various medical conditions, such as cholestatic liver diseases, gallstones, and diarrhea. Therefore, understanding the role of bile acids and salts in the body is essential for diagnosing and treating these disorders.

A biopsy is a medical procedure in which a small sample of tissue is taken from the body to be examined under a microscope for the presence of disease. This can help doctors diagnose and monitor various medical conditions, such as cancer, infections, or autoimmune disorders. The type of biopsy performed will depend on the location and nature of the suspected condition. Some common types of biopsies include:

1. Incisional biopsy: In this procedure, a surgeon removes a piece of tissue from an abnormal area using a scalpel or other surgical instrument. This type of biopsy is often used when the lesion is too large to be removed entirely during the initial biopsy.

2. Excisional biopsy: An excisional biopsy involves removing the entire abnormal area, along with a margin of healthy tissue surrounding it. This technique is typically employed for smaller lesions or when cancer is suspected.

3. Needle biopsy: A needle biopsy uses a thin, hollow needle to extract cells or fluid from the body. There are two main types of needle biopsies: fine-needle aspiration (FNA) and core needle biopsy. FNA extracts loose cells, while a core needle biopsy removes a small piece of tissue.

4. Punch biopsy: In a punch biopsy, a round, sharp tool is used to remove a small cylindrical sample of skin tissue. This type of biopsy is often used for evaluating rashes or other skin abnormalities.

5. Shave biopsy: During a shave biopsy, a thin slice of tissue is removed from the surface of the skin using a sharp razor-like instrument. This technique is typically used for superficial lesions or growths on the skin.

After the biopsy sample has been collected, it is sent to a laboratory where a pathologist will examine the tissue under a microscope and provide a diagnosis based on their findings. The results of the biopsy can help guide further treatment decisions and determine the best course of action for managing the patient's condition.

Prosthesis failure is a term used to describe a situation where a prosthetic device, such as an artificial joint or limb, has stopped functioning or failed to meet its intended purpose. This can be due to various reasons, including mechanical failure, infection, loosening of the device, or a reaction to the materials used in the prosthesis.

Mechanical failure can occur due to wear and tear, manufacturing defects, or improper use of the prosthetic device. Infection can also lead to prosthesis failure, particularly in cases where the prosthesis is implanted inside the body. The immune system may react to the presence of the foreign material, leading to inflammation and infection.

Loosening of the prosthesis can also cause it to fail over time, as the device becomes less stable and eventually stops working properly. Additionally, some people may have a reaction to the materials used in the prosthesis, leading to tissue damage or other complications that can result in prosthesis failure.

In general, prosthesis failure can lead to decreased mobility, pain, and the need for additional surgeries or treatments to correct the problem. It is important for individuals with prosthetic devices to follow their healthcare provider's instructions carefully to minimize the risk of prosthesis failure and ensure that the device continues to function properly over time.

Cholangitis is a medical condition characterized by inflammation of the bile ducts, which are the tubes that carry bile from the liver to the small intestine. Bile is a digestive juice produced by the liver that helps break down fats in food.

There are two types of cholangitis: acute and chronic. Acute cholangitis is a sudden and severe infection that can cause symptoms such as abdominal pain, fever, jaundice (yellowing of the skin and eyes), and dark urine. It is usually caused by a bacterial infection that enters the bile ducts through a blockage or obstruction.

Chronic cholangitis, on the other hand, is a long-term inflammation of the bile ducts that can lead to scarring and narrowing of the ducts. This can cause symptoms such as abdominal pain, itching, and jaundice. Chronic cholangitis can be caused by various factors, including primary sclerosing cholangitis (an autoimmune disease), bile duct stones, or tumors in the bile ducts.

Treatment for cholangitis depends on the underlying cause of the condition. Antibiotics may be used to treat bacterial infections, and surgery may be necessary to remove blockages or obstructions in the bile ducts. In some cases, medications may be prescribed to manage symptoms and prevent further complications.

BALB/c is an inbred strain of laboratory mouse that is widely used in biomedical research. The strain was developed at the Institute of Cancer Research in London by Henry Baldwin and his colleagues in the 1920s, and it has since become one of the most commonly used inbred strains in the world.

BALB/c mice are characterized by their black coat color, which is determined by a recessive allele at the tyrosinase locus. They are also known for their docile and friendly temperament, making them easy to handle and work with in the laboratory.

One of the key features of BALB/c mice that makes them useful for research is their susceptibility to certain types of tumors and immune responses. For example, they are highly susceptible to developing mammary tumors, which can be induced by chemical carcinogens or viral infection. They also have a strong Th2-biased immune response, which makes them useful models for studying allergic diseases and asthma.

BALB/c mice are also commonly used in studies of genetics, neuroscience, behavior, and infectious diseases. Because they are an inbred strain, they have a uniform genetic background, which makes it easier to control for genetic factors in experiments. Additionally, because they have been bred in the laboratory for many generations, they are highly standardized and reproducible, making them ideal subjects for scientific research.

Patient selection, in the context of medical treatment or clinical research, refers to the process of identifying and choosing appropriate individuals who are most likely to benefit from a particular medical intervention or who meet specific criteria to participate in a study. This decision is based on various factors such as the patient's diagnosis, stage of disease, overall health status, potential risks, and expected benefits. The goal of patient selection is to ensure that the selected individuals will receive the most effective and safe care possible while also contributing to meaningful research outcomes.

Heterophile antibodies are a type of antibody that can react with antigens from more than one source, rather than being specific to a single antigen. They are produced in response to an initial infection or immunization, but can also cross-react with antigens from unrelated organisms or substances. A common example of heterophile antibodies are those that are produced in response to Epstein-Barr virus (EBV) infection, which can cause infectious mononucleosis. These antibodies, known as Paul-Bunnell antibodies, can agglutinate (clump together) sheep or horse red blood cells, which is the basis for a diagnostic test for EBV infection called the Monospot test. However, it's important to note that not all cases of infectious mononucleosis are caused by EBV, and other infections or conditions can also cause the production of heterophile antibodies, leading to false-positive results.

Lipopolysaccharides (LPS) are large molecules found in the outer membrane of Gram-negative bacteria. They consist of a hydrophilic polysaccharide called the O-antigen, a core oligosaccharide, and a lipid portion known as Lipid A. The Lipid A component is responsible for the endotoxic activity of LPS, which can trigger a powerful immune response in animals, including humans. This response can lead to symptoms such as fever, inflammation, and septic shock, especially when large amounts of LPS are introduced into the bloodstream.

Gene expression is the process by which the information encoded in a gene is used to synthesize a functional gene product, such as a protein or RNA molecule. This process involves several steps: transcription, RNA processing, and translation. During transcription, the genetic information in DNA is copied into a complementary RNA molecule, known as messenger RNA (mRNA). The mRNA then undergoes RNA processing, which includes adding a cap and tail to the mRNA and splicing out non-coding regions called introns. The resulting mature mRNA is then translated into a protein on ribosomes in the cytoplasm through the process of translation.

The regulation of gene expression is a complex and highly controlled process that allows cells to respond to changes in their environment, such as growth factors, hormones, and stress signals. This regulation can occur at various stages of gene expression, including transcriptional activation or repression, RNA processing, mRNA stability, and translation. Dysregulation of gene expression has been implicated in many diseases, including cancer, genetic disorders, and neurological conditions.

'Gene expression regulation' refers to the processes that control whether, when, and where a particular gene is expressed, meaning the production of a specific protein or functional RNA encoded by that gene. This complex mechanism can be influenced by various factors such as transcription factors, chromatin remodeling, DNA methylation, non-coding RNAs, and post-transcriptional modifications, among others. Proper regulation of gene expression is crucial for normal cellular function, development, and maintaining homeostasis in living organisms. Dysregulation of gene expression can lead to various diseases, including cancer and genetic disorders.

Hemofiltration is a type of renal replacement therapy used for treating acute or chronic renal failure. It is a convective process that utilizes a semipermeable membrane to remove waste solutes and water from the blood. In this process, blood is passed through a filter, called a hemofilter, which contains hollow fibers with tiny pores. The pressure gradient across the membrane causes fluid and solutes to move from the blood into the filtrate compartment, based on their size and charge.

The filtrate, which contains waste products and water, is then discarded, while a replacement solution is infused back into the patient's bloodstream to maintain adequate fluid volume and electrolyte balance. Hemofiltration can be performed continuously (continuous hemofiltration) or intermittently (intermittent hemofiltration), depending on the clinical situation and the patient's needs.

Hemofiltration is particularly useful in critically ill patients with fluid overload, electrolyte imbalances, or acute kidney injury, as it can effectively remove large volumes of water and solutes, including inflammatory mediators and toxins, from the blood. It is also used in the management of drug overdoses and poisonings, where rapid removal of toxic substances is required.

The inferior vena cava (IVC) is the largest vein in the human body that carries deoxygenated blood from the lower extremities, pelvis, and abdomen to the right atrium of the heart. It is formed by the union of the left and right common iliac veins at the level of the fifth lumbar vertebra. The inferior vena cava is a retroperitoneal structure, meaning it lies behind the peritoneum, the lining that covers the abdominal cavity. It ascends through the posterior abdominal wall and passes through the central tendon of the diaphragm to enter the thoracic cavity.

The inferior vena cava is composed of three parts:

1. The infrarenal portion, which lies below the renal veins
2. The renal portion, which receives blood from the renal veins
3. The suprahepatic portion, which lies above the liver and receives blood from the hepatic veins before draining into the right atrium of the heart.

The inferior vena cava plays a crucial role in maintaining venous return to the heart and contributing to cardiovascular function.

Transgenic mice are genetically modified rodents that have incorporated foreign DNA (exogenous DNA) into their own genome. This is typically done through the use of recombinant DNA technology, where a specific gene or genetic sequence of interest is isolated and then introduced into the mouse embryo. The resulting transgenic mice can then express the protein encoded by the foreign gene, allowing researchers to study its function in a living organism.

The process of creating transgenic mice usually involves microinjecting the exogenous DNA into the pronucleus of a fertilized egg, which is then implanted into a surrogate mother. The offspring that result from this procedure are screened for the presence of the foreign DNA, and those that carry the desired genetic modification are used to establish a transgenic mouse line.

Transgenic mice have been widely used in biomedical research to model human diseases, study gene function, and test new therapies. They provide a valuable tool for understanding complex biological processes and developing new treatments for a variety of medical conditions.

Kupffer cells are specialized macrophages that reside in the liver, particularly in the sinusoids of the liver's blood circulation system. They play a crucial role in the immune system by engulfing and destroying bacteria, microorganisms, and other particles that enter the liver via the portal vein. Kupffer cells also contribute to the clearance of damaged red blood cells, iron metabolism, and the regulation of inflammation in the liver. They are named after the German pathologist Karl Wilhelm von Kupffer who first described them in 1876.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Oxidative stress is defined as an imbalance between the production of reactive oxygen species (free radicals) and the body's ability to detoxify them or repair the damage they cause. This imbalance can lead to cellular damage, oxidation of proteins, lipids, and DNA, disruption of cellular functions, and activation of inflammatory responses. Prolonged or excessive oxidative stress has been linked to various health conditions, including cancer, cardiovascular diseases, neurodegenerative disorders, and aging-related diseases.

Lamivudine is an antiretroviral medication used in the treatment and management of HIV (Human Immunodeficiency Virus) infection and HBV (Hepatitis B Virus) infection. It is a nucleoside reverse transcriptase inhibitor (NRTI), which means it works by blocking the action of the reverse transcriptase enzyme that the viruses need to multiply. By doing this, Lamivudine helps to reduce the amount of the virus in the body, which in turn helps to slow down or prevent the damage that the virus can cause to the immune system and improve the patient's quality of life.

The medical definition of Lamivudine is: "A synthetic nucleoside analogue with activity against both HIV-1 and HBV. It is used in the treatment of HIV infection and AIDS, as well as chronic hepatitis B."

"Miniature Swine" is not a medical term per se, but it is commonly used in the field of biomedical research to refer to certain breeds or types of pigs that are smaller in size compared to traditional farm pigs. These miniature swine are often used as animal models for human diseases due to their similarities with humans in terms of anatomy, genetics, and physiology. Examples of commonly used miniature swine include the Yucatan, Sinclair, and Göttingen breeds. It is important to note that while these animals are often called "miniature," they can still weigh between 50-200 pounds depending on the specific breed or age.

A coma is a deep state of unconsciousness in which an individual cannot be awakened, cannot respond to stimuli, and does not exhibit any sleep-wake cycles. It is typically caused by severe brain injury, illness, or toxic exposure that impairs the function of the brainstem and cerebral cortex.

In a coma, the person may appear to be asleep, but they are not aware of their surroundings or able to communicate or respond to stimuli. Comas can last for varying lengths of time, from days to weeks or even months, and some people may emerge from a coma with varying degrees of brain function and disability.

Medical professionals use various diagnostic tools and assessments to evaluate the level of consciousness and brain function in individuals who are in a coma, including the Glasgow Coma Scale (GCS), which measures eye opening, verbal response, and motor response. Treatment for coma typically involves supportive care to maintain vital functions, manage any underlying medical conditions, and prevent further complications.

Intensive care is a specialized level of medical care that is provided to critically ill patients. It's usually given in a dedicated unit of a hospital called the Intensive Care Unit (ICU) or Critical Care Unit (CCU). The goal of intensive care is to closely monitor and manage life-threatening conditions, stabilize vital functions, and support organs until they recover or the patient can be moved to a less acute level of care.

Intensive care involves advanced medical equipment and technologies, such as ventilators to assist with breathing, dialysis machines for kidney support, intravenous lines for medication administration, and continuous monitoring devices for heart rate, blood pressure, oxygen levels, and other vital signs.

The ICU team typically includes intensive care specialists (intensivists), critical care nurses, respiratory therapists, and other healthcare professionals who work together to provide comprehensive, round-the-clock care for critically ill patients.

The Cytochrome P-450 (CYP450) enzyme system is a group of enzymes found primarily in the liver, but also in other organs such as the intestines, lungs, and skin. These enzymes play a crucial role in the metabolism and biotransformation of various substances, including drugs, environmental toxins, and endogenous compounds like hormones and fatty acids.

The name "Cytochrome P-450" refers to the unique property of these enzymes to bind to carbon monoxide (CO) and form a complex that absorbs light at a wavelength of 450 nm, which can be detected spectrophotometrically.

The CYP450 enzyme system is involved in Phase I metabolism of xenobiotics, where it catalyzes oxidation reactions such as hydroxylation, dealkylation, and epoxidation. These reactions introduce functional groups into the substrate molecule, which can then undergo further modifications by other enzymes during Phase II metabolism.

There are several families and subfamilies of CYP450 enzymes, each with distinct substrate specificities and functions. Some of the most important CYP450 enzymes include:

1. CYP3A4: This is the most abundant CYP450 enzyme in the human liver and is involved in the metabolism of approximately 50% of all drugs. It also metabolizes various endogenous compounds like steroids, bile acids, and vitamin D.
2. CYP2D6: This enzyme is responsible for the metabolism of many psychotropic drugs, including antidepressants, antipsychotics, and beta-blockers. It also metabolizes some endogenous compounds like dopamine and serotonin.
3. CYP2C9: This enzyme plays a significant role in the metabolism of warfarin, phenytoin, and nonsteroidal anti-inflammatory drugs (NSAIDs).
4. CYP2C19: This enzyme is involved in the metabolism of proton pump inhibitors, antidepressants, and clopidogrel.
5. CYP2E1: This enzyme metabolizes various xenobiotics like alcohol, acetaminophen, and carbon tetrachloride, as well as some endogenous compounds like fatty acids and prostaglandins.

Genetic polymorphisms in CYP450 enzymes can significantly affect drug metabolism and response, leading to interindividual variability in drug efficacy and toxicity. Understanding the role of CYP450 enzymes in drug metabolism is crucial for optimizing pharmacotherapy and minimizing adverse effects.

Wilson's disease (hereditary copper accumulation) may infrequently present with acute liver failure. Acute liver failure also ... acute fatty liver of pregnancy, and idiopathic (without an obvious cause). Reye syndrome is acute liver failure in a child with ... Acute liver failure is the appearance of severe complications rapidly after the first signs (such as jaundice) of liver disease ... "Acute Liver Failure", LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Bethesda (MD): National ...
Koroshi A, Babameto A (2002). "Acute renal failure during acute fatty liver of pregnancy". Nephrology Dialysis Transplantation ... Pang WW, Lei CH, Chang DP, Yang TF, Chung YT, Huang MH (1999). "Acute jaundice in pregnancy: acute fatty liver or acute viral ... The diagnosis of acute fatty liver of pregnancy is suggested by jaundice with a lesser elevation of liver enzymes, elevated ... Riely CA (1987). "Acute fatty liver of pregnancy". Seminars in Liver Disease. 7 (1): 47-54. doi:10.1055/s-2008-1040563. PMID ...
However, neither a 2005 American Association for the Study of the Liver position paper on the management of acute liver failure ... This paper examined the connection between Herbalife slimming products and a case of fatal acute liver failure in one patient ... Polson J, Lee WM (May 2005). "AASLD position paper: the management of acute liver failure". Hepatology. 41 (5): 1179-97. doi: ... Bernal W, Auzinger G, Dhawan A, Wendon J (July 2010). "Acute liver failure". Lancet. 376 (9736): 190-201. doi:10.1016/S0140- ...
... patients with acute liver failure have the highest priority over patients with only cirrhosis. Acute liver failure patients ... Lee, W. M. (16 December 1993). "Acute liver failure". The New England Journal of Medicine. 329 (25): 1862-1872. doi:10.1056/ ... "Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States". Annals of Internal ... Hospice patients are also able to live at peace away from a hospital setting; they may live at home with a hospice provider or ...
... a third form of liver failure known as acute-on-chronic liver failure (ACLF) is increasingly being recognized. Acute liver ... "Acute on chronic liver failure (ACLF)" is said to exist when someone with chronic liver disease develops features of liver ... "Acute-on-Chronic Liver Failure: A Distinct Clinical Condition". Seminars in Liver Disease. 36 (2): 107-108. doi:10.1055/s-0036- ... "Coagulopathy of acute liver failure". Clinics in Liver Disease. 13 (1): 95-107. doi:10.1016/j.cld.2008.10.001. ISSN 1089-3261. ...
Higher doses may lead to toxicity, including liver failure. Paracetamol poisoning is the foremost cause of acute liver failure ... Lee WM (2004). "Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure". Hepatology ... but even without overdose those who take this drug may develop acute liver failure requiring liver transplantation more ... Paracetamol toxicity is the foremost cause of acute liver failure in the Western world, and accounts for most drug overdoses in ...
Chertoff J, Alam S, Clark V (July 2014). "Cyproheptadine-Induced Acute Liver Failure". ACG Case Reports Journal. 1 (4): 212-213 ... liver) side effects such as: Hepatitis Jaundice Liver failure Hepatic function abnormality Epigastric distress Anorexia Nausea ... Hallucinations Hysteria Faintness Allergic manifestation of rash and edema Diaphoresis Urticaria Photosensitivity Acute ...
Binder D, Jost R, Flury R, Salomon F (May 1995). "[Acute liver failure following tetrabamate]". Schweizerische Medizinische ... after over 30 years of use due to reports of hepatitis and acute liver failure. The decision to restrict the use of the drug ... Eugene R. Schiff; Willis C. Maddrey; Michael F. Sorrell (19 October 2011). Schiff's Diseases of the Liver. John Wiley and Sons ...
... bioartificial liver device). This system is in trial to help people with acute liver failure (ALF) or acute-on-chronic liver ... system for an individual who is suffering from acute liver failure (ALF) or acute-on-chronic liver failure (ACLF). The ... either allowing the liver to regenerate properly upon acute liver failure, or to bridge the individual's liver functions until ... "Artificial liver support system in acute liver failure patients waiting liver transplantation". Hepato-gastroenterology. 56 (90 ...
Some symptoms of liver injury or acute liver failure can include jaundice, pain in the upper right abdomen, ascites, nausea/ ... "Acute liver failure - Symptoms and causes". Mayo Clinic. Archived from the original on 27 June 2022. Retrieved 4 August 2022. ... Serious adverse reactions in >2% of patients included sepsis, acute kidney injury, urinary tract infection, abdominal pain, and ... Some people treated with dostarlimab can develop immune related liver injury. ...
A rare cause of acute liver failure". Clinics and Research in Hepatology and Gastroenterology. 44 (1): e14-e16. doi:10.1016/j. ... Liver angiosarcoma may also result in liver failure, a potentially fatal complication. Like many cancers, liver angiosarcoma ... The European Liver Transplant Registry considers liver angiosarcoma an absolute contraindication to liver transplantation, ... Liver angiosarcoma also known as angiosarcoma of the liver or hepatic angiosarcoma is a rare and rapidly fatal cancer arising ...
Depla AC, Vermeersch PH, van Gorp LH, Nadorp JH (August 1990). "Fatal acute liver failure associated with pirprofen. Report of ... Its label was restricted after adverse events arose, including some cases of fatal liver toxicity. Ciba-Geigy voluntarily ...
Death occurs by acute liver failure (ALF). In the last phase, neurological symptoms such as agitation, delirium, convulsions ... These complications include a greater likelihood of experiencing liver failure in acute infections and a rapid progression to ... Non-invasive measures of liver fibrosis, such as the biomarker based FibroTest or non-invasive liver imaging such as transient ... In those with whom liver fibrosis or cirrhosis is suspected, a liver biopsy is usually needed. Current established treatments ...
"Serum acute-phase protein level as indicator for liver failure after liver resection". Hepatogastroenterology. 52 (63): 857-61 ... This response is called the acute-phase reaction (also called acute-phase response). The acute-phase reaction ... They may also indicate liver failure. Jain S, Gautam V, Naseem S (January 2011). "Acute-phase proteins: As diagnostic tool". ... acute-phase reactants. Increased acute-phase proteins from the liver may also contribute to the promotion of sepsis. TNF-α, IL- ...
Kidney failure* is common in dogs and may be found in acute or chronic forms. It is defined by a loss of function of about 75 ... Symptoms include liver and kidney failure and vasculitis. Lyme disease* is a disease caused by Borrelia burgdorferi, a ... Right-sided heart failure results in a large liver (congestion) and build-up of fluid in the abdomen (ascites), uncommonly ... Left-sided heart failure results in rapid and/or difficulty breathing and sometimes coughing from a build-up of fluid in the ...
Pannu HK, Gottlieb L, Fishman EK (2001). "Acute liver failure due to trovafloxacin: CT findings". Emergency Radiology. 8 (2): ... or the European Union due to association with cases of acute liver failure and death. The key reaction in building the ring ... over 100 cases of acute liver injury reported to FDA). In May 2000, the FDA withdrew marketing authorisation for trovafloxacin ... Trovafloxacin use is significantly restricted due to its high potential for inducing serious and sometimes fatal liver damage. ...
Papilledema at eMedicine Polson J, Lee WM (2005). "AASLD position paper: the management of acute liver failure". Hepatology. 41 ... acute liver failure, hypertensive encephalopathy, hypercarbia (hypercapnia), and Reye hepatocerebral syndrome. These conditions ... In people who have high ICP due to an acute injury, it is particularly important to ensure adequate airway, breathing, and ... Increase in venous pressure can be due to venous sinus thrombosis, heart failure, or obstruction of superior mediastinal or ...
Chinese herbal medicine has been a major cause of acute liver failure in China. Most Chinese herbs are safe but some have shown ... "Causes and Outcomes of Acute Liver Failure in China". PLOS ONE. 8 (11): e80991. Bibcode:2013PLoSO...880991Z. doi:10.1371/ ... calming the Liver and expelling wind or liver-calming and wind-extinguishing orifice-opening supplementing or tonifying: this ... Divine Farmer'), a mythical god-like figure, who is said to have lived around 2800 BCE. He allegedly tasted hundreds of herbs ...
Graziadei, IW (September 2011). "The clinical challenges of acute on chronic liver failure". Liver International. 31 (Suppl 3 ... "A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality". Liver ... such as severe acute respiratory syndrome, acute leukaemia, acute myocardial infarction, and acute hepatitis. This is often to ... A mild stubbed toe is an acute injury. Similarly, many acute upper respiratory infections and acute gastroenteritis cases in ...
Fagan, E. A. (1994). "Acute Liver Failure of Unknown Pathogenesis: The Hidden Agenda". Hepatology. 19 (5): 1307-12. doi:10.1002 ...
Chinese herbal medicine has been a major cause of acute liver failure in China. The harvesting of guano from bat caves ( ... 2013). Avila MA (ed.). "Causes and outcomes of acute liver failure in China". PLOS ONE. 8 (11): e80991. Bibcode:2013PLoSO... ... calming the liver and expelling wind or liver-calming and wind-extinguishing orifice-opening supplementing which includes qi- ... The term zang refers to the five considered to be yin in nature-Heart, Liver, Spleen, Lung, Kidney-while fu refers to the six ...
He subsequently suffered from organ and liver failure. On February 18, it was decided to take Mullica off life support. He was ... In 2010, Mullica was diagnosed with acute myelogenous leukemia. In July 2013, Mullica helped dedicate the Red Skelton Museum & ...
Allen died in 1970 of liver failure from acute alcoholism. Leroy Jenkins spent several years in prison for arson and conspiracy ... When accused of living a lavish lifestyle he provided a cryptic justification to his followers. He claims to have begun his ... They lived a lavish lifestyle. His performance tricks were exposed by Randi on the Johnny Carson show in February 1986. This ... His father, also a preacher, once claimed that men would not land on the moon because Lucifer lives there. Grant lied about his ...
Paracetamol poisoning is a common cause of acute liver failure. In the United States about 60% of suicide attempts and 14% of ... A suicide method is any means by which a person may choose to end their lives. Suicide attempts do not always result in death, ... Gun control is a primary method of reducing suicide by people who live in a home with guns. Prevention measures include simple ... Overall suicide deaths were cut by 70%, with 93,000 lives saved over 20 years as a result of banning these pesticides. In Korea ...
2-Oxo-glutarate dehydrogenase is an autoantigen recognized in primary biliary cirrhosis, a form of acute liver failure. These ... November 2007). "Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis". Hepatology. ... allowing an increased level of oxoglutarate dehydrogenase activity to compensate for the acute stress exposure. Acute exposures ... The up-regulation response that occurs after acute exposure can become exhausted if the inhibition of the enzyme complex ...
"Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis". Hepatology. 46 (5): 1436-42. ... although some may live into adolescence or adulthood. Click on genes, proteins and metabolites below to link to respective ...
Serious side effects may include liver inflammation and acute liver failure. It is unclear if use during pregnancy is safe for ... People with liver dysfunction are at a higher risk for hepatitis caused by INH, and may need a lower dose. Levels of liver ... Asymptomatic elevation of serum liver enzyme concentrations occurs in 10% to 20% of people taking INH, and liver enzyme ... Some recommend that liver function should be monitored carefully in all people receiving it, but others recommend monitoring ...
Tatsuzō Shimaoka, 88, Japanese potter, living national treasure, acute liver failure. Terry Yates, 57, American biologist, ... Bierman, Noah; Oster, Alex I. (December 13, 2007). "Death comes for a musician who lived the blues". The Boston Globe. ... Carlos Valdes, 81, Cuban conga player, respiratory failure. M. V. Dhond, 93, Indian literary and art critic. Christine Finn, 78 ... "Footballer died of heart failure". BBC News. January 1, 2008. Retrieved June 23, 2018. Thurber, Jon (January 2, 2008). "H.D. ...
Carbon tetrachloride has since been found to cause acute liver failure. In 1925, Hall ingested tetrachloroethylene (the most ... Carrión developed an acute form of bartonellosis now known as Carrion's disease or Oroya fever. This is a rare disease found ... A follow-up report released a year later confirmed that he was in good health, and he lived to the age of 75. Clinical ... Likewise, a single failure does not absolutely prove that a procedure is worthless. Psychological issues such as confirmation ...
2005). "Serum LECT2 level as a prognostic indicator in acute liver failure". Transplant. Proc. 36 (8): 2359-61. doi:10.1016/j. ... 2005). "Changes in serum LECT 2 levels during the early period of liver regeneration after adult living related donor liver ... The liver hepatocyte is considered to be the source of the LECT2 circulating in blood. However, its expression in these cells ... mRNA for LECT2 is highly expressed in liver tissue and expressed at far lower levels in a wide range of other tssues. Human ...
... behind the recently published recommendations on how to manage this major cause of mortality in patients with chronic liver ... drug-induced liver injury), which is termed acute-on-chronic liver failure (ACLF). Although ACLF has been described only ... Patients with acute kidney injury can easily morph into kidney failure, defined either by stage 2 and 3 acute kidney injury or ... Cite this: ACG Offers Guidelines for Acute-on-Chronic Liver Failure - Medscape - Mar 07, 2022. ...
Acute liver failure often affects young people and carries a very high mortality. ... is an uncommon condition in which rapid deterioration of liver function results in coagulopathy and alteration in the mental ... Racial distribution of acute liver failure. Acute liver failure is seen among all races. In a US multicenter study of acute ... for the Acute Liver Failure Study Group. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute ...
Wilsons disease (hereditary copper accumulation) may infrequently present with acute liver failure. Acute liver failure also ... acute fatty liver of pregnancy, and idiopathic (without an obvious cause). Reye syndrome is acute liver failure in a child with ... Acute liver failure is the appearance of severe complications rapidly after the first signs (such as jaundice) of liver disease ... "Acute Liver Failure", LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Bethesda (MD): National ...
Management of ACLF is broadly focused on supportive care often in an intensive care setting with liver transplantation proving ... Acute-on-chronic liver failure; Inflammatory response; acute decompensation; liver transplantation; multiorgan failure. ... Acute-on-chronic failure (ACLF) is a recognized syndrome in patients with chronic liver disease and is characterized by acute ... Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived? Expert Rev Gastroenterol Hepatol ...
They found 34 reports of liver damage, ranging from acute hepatitis to fulminant liver failure requiring transplant, following ... he was admitted for work-up of acute liver injury and possible impending liver failure. During his hospitalization his peak INR ... Green tea extract: A potential cause of acute liver failure Shreena S Patel, Stacey Beer, Debra L Kearney, Garrett Phillips, ... We present a case of acute impending liver failure in an adolescent male using a weight-loss product containing green tea ...
The only curative treatment for acute liver failure is liver transplantation, but there are many restrictions on the ... In recent years, a growing number of studies have shown that stem cells can effectively treat acute liver failure. Several ... Numerous treatment strategies for acute liver failure simply prevent complications and decelerate disease progression. ... article are to review the current knowledge regarding therapeutic mechanisms of mesenchymal stem cells in acute liver failure, ...
acute liver failure. A Bit of Irony: J&J Developing Drug to Undo Liver Damage ... From Its Own Tylenol. ... Johnson & Johnson is working on a drug to repair liver damage caused by Tylenol, which has made the company billions since it ...
Retrieved from "https://www.wikidoc.org/index.php/Acute_liver_failure_surgery" ...
... but also in liver tissue repair after APAP-induced liver injury. In fact, while neutrophil depletion led to reduced hepatic ... Liver injury and repair kinetics were evaluated by a novel combination of enzyme quantifications, ELISA, specific antagonists ... In this work, drug-induced liver injury was induced by oral administration of APAP and pharmacological intervention was made 12 ... During the course of hepatocyte necrosis, an intense accumulation of neutrophils is often observed within the liver ...
Hemostatic changes in acute-on-chronic liver failure (ACLF) may in part reflect critical illness. Hemostatic changes in ACLF ... Essentials Liver diseases are associated with profound hemostatic changes proportional to severity of illness. ... Global hemostatic status in patients with acute-on-chronic liver failure and septics without underlying liver disease J Thromb ... Hemostatic changes in acute-on-chronic liver failure (ACLF) may in part reflect critical illness. Hemostatic changes in ACLF ...
Williams R Auxiliary partial orthotopic liver transplantation for acute liver failure J Hepatol 1997 26(5):1010-7 ... "Auxiliary partial orthotopic liver transplantation for acute liver failure" J Hepatol. 1997;26(5):1010-7. ... auxiliary partial orthotopic liver transplantation in acute liver failure is technically feasible and, in some patients, allows ... but experience with the technique in acute liver failure is limited. METHODS: We describe our initial experience in seven ...
About 70% in each group had alcoholic hepatitis (the reason for acute liver failure in most). Mean Model for End-Stage Liver ... A total of 136 patients with acute-on-chronic liver failure with small or no esophageal varices and a hepatic venous pressure ... Morbidity and mortality were high, as is expected with acute-on-chronic liver failure, he noted. A total of 36 patients died ... Carvedilol fails to reduce variceal bleeds in acute-on-chronic liver failure. *By ...
Acute liver failure secondary to severe systemic disease from fatal hemophagocytic lymphohistiocytosis: Case report and ... Acute liver failure secondary to severe systemic disease from fatal hemophagocytic lymphohistiocytosis: Case report and ... Acute liver failure secondary to severe systemic disease from fatal hemophagocytic lymphohistiocytosis: Case report and ... Cappell MS, Hader I, Amin M. Acute liver failure secondary to severe systemic disease from fatal hemophagocytic ...
Patients with hepatitis B virus-associated acute-on-chronic liver failure (HBV-ACLF) present a complex and poor prognosis. ... High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure ... High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure. World J ... Keywords: Hepatitis B virus, Liver failure, Prognosis, Interleukin-6 Core tip: To triage and prognosticate the outcome is vital ...
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure. Publikation: Bidrag til tidsskrift ... common end stage of liver disease is decompensated cirrhosis and the further development towards acute-on-chronic liver failure ... common end stage of liver disease is decompensated cirrhosis and the further development towards acute-on-chronic liver failure ... and therapeutic role of the gut microbiota in decompensation of cirrhosis and progression to acute-on-chronic liver failure. ...
... who present with non-A-E fulminant liver hepatitis also develop aplastic anemia either before or shortly after liver ... Greater understanding of mechanisms of liver and bone marrow injury, elucidation of etiologic factors may result in new ... clinical presentation and treatment of acute liver failure and acquired aplastic anemia in children. They are both rare, but ... Acute liver failure and acquired aplastic anaemia in children - life - threatening clinical entities of common etiopathogenesis ...
D008107 - Liver Diseases, D017114 - Liver Failure, Acute, D017093 - Liver Failure. Keywords. liver disease, acute liver failure ... Summary of Recommendations of the AGA Clinical Guidelines for the Diagnosis and Management of Acute Liver Failure (ALF). ... Summary of Recommendations of the AGA Clinical Guidelines for the Diagnosis and Management of Acute Liver Failure (ALF). ... Comment: A Model for End-Stage Liver Disease (MELD score of 30.5 (fixed cut-off level) should be used for prognosis; higher ...
Acute liver failure often affects young people and carries a very high mortality. ... is an uncommon condition in which rapid deterioration of liver function results in coagulopathy and alteration in the mental ... Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med ... encoded search term (Acute Liver Failure) and Acute Liver Failure What to Read Next on Medscape ...
Acute Liver Failure - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - Medical ... Acute liver failure Acute Liver Failure Acute liver failure is caused most often by drugs and hepatitis viruses. Cardinal ... Etiology of Acute Liver Failure Overall, the most common causes of acute liver failure are ... Pathophysiology of Acute Liver Failure In acute liver failure, multiple organ systems malfunction, often for unknown reasons ...
Elevated ICP secondary to cerebral edema accounts for approximately 25% of all deaths in acute liver failure. Cerebral edema ... Seizures have also been associated with patients in acute liver failure. Persistent seizure activity can cause cerebral hypoxia ... Neurological manifestations of both acute and chronic liver disease include hepatic encephalopathy, cerebral edema and seizures ... as well as other causes that may be present in a patient with liver disease such as hypoglycemia or intracranial bleeding. ...
... among patients with acute-on-chronic liver failure grade 3 (ACL... ... p>Background & Aims Uncertainties exist surrounding the timing of liver transplantation (LT) ... treatment Liver transplantation Model for End-Stage Liver Disease Survival probability Medicine Acute on chronic liver failure ... treatment Liver transplantation Model for End-Stage Liver Disease Survival probability Medicine Acute on chronic liver failure ...
Access this presentation on ESC 365 from HEART FAILURE 2016 on Prognosis by Doctor M. Talavera (Argentina,AR) on ESC 365. ... Abnormal liver function predicts death and readmissions after acute decompensated cardiac failure ... Heart failure as a factor of unfavorable prognosis for women with myocardial infarction ... Serum markers of endothelial dysfunction and long-term prognosis in patients, hospitalized with acute decompensated chronic ...
... The antidote for acute liver failure caused by acetaminophen poisoning also ... The antidote for acute liver failure caused by acetaminophen poisoning also can treat acute liver failure due to most other ... Acute liver failure occurs when cells in the liver die quickly, resulting in toxins being released into the bloodstream and ... Known causes of acute liver failure include autoimmune hepatitis, drug-induced liver injury, hepatitis A and B, and ...
US Acute Liver Failure Study Group. Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and ... What factors determine the severity of hepatitis A-related acute liver failure? J Viral Hepat 2011;18(7):e167-74. ... Virtually all patients with acute hepatitis A have detectable IgM anti-HAV. Acute HAV infection is confirmed during the acute ... Persons with Chronic Liver Disease. Persons with chronic liver disease are at increased risk for fulminant hepatitis A should ...
Development of acute myelogenous leukemia. *Infections. *Bleeding. *Blood clots. *Liver failure When to Contact a Medical ... As a result, the liver and spleen try to make some of these blood cells. This causes these organs to swell. ...
Liver failure *Lung scarring (evolves more quickly than when small to medium amounts have been ingested) ... Other long-term effects may also occur, including kidney failure, heart failure, and esophageal strictures (scarring of the ... Acute Kidney failure *Confusion *Coma *Fast heart rate *Injury to the heart ... Paraquat causes toxic chemical reactions to occur throughout many parts of the body, primarily the lungs, liver, and kidneys. ...
She progressed to haemodynamic and hepatic failure, with clinical features of acute-on-chronic liver failure (ACLF). Despite ... Massive iron overload and acute-on-chronic liver failure in a patient with Diamond-Blackfan anaemia: a case report.. Assis- ... acute damage), supporting the hypothesis of ACLF. The main feature responsible for acute liver decompensation seemed to be ... this congestive condition led to an acute liver injury overlapping pre-existing hepatic fibrosis. ...
Acute liver failure is when your liver suddenly starts to not work. This often happens right after an overdose of medicine or ... Acute Liver Failure. What is acute liver failure?. Acute liver failure is a rare condition. It happens when your liver suddenly ... Key points about acute liver failure. * Acute liver failure happens when your liver suddenly starts to not work. ... Can acute liver failure be prevented?. You can prevent some of the underlying causes of acute liver failure. Make sure you: * ...
Acute Liver Failure. Acute liver failure can be caused due to an infection, drugs, or other factors. It is comparatively less ... According to research, around 1% to 2% of people with viral hepatitis suffer from acute liver failure. Acute liver failure is ... Acute liver failure refers to the rapid loss of liver functioning due to an underlying cause. Your liver gets damaged and ... It is also known as a fulminant hepatic failure. Acute liver failure can be caused due to an infection, drugs, or other factors ...
  • Chronic liver disease is a mounting problem worldwide, and one that is greatly compounded when combined with other precipitating events (eg, alcohol-related or viral hepatitis , drug-induced liver injury), which is termed acute-on-chronic liver failure (ACLF). (medscape.com)
  • For example, in Asia, there could be patients with chronic liver disease who have a hepatitis B flare - which would also be ACLF because the definitions are chronic liver disease, not just cirrhosis. (medscape.com)
  • All patients with clinical or laboratory evidence of moderate or severe acute hepatitis should have immediate measurement of prothrombin time (PT) and careful evaluation of the mental status. (medscape.com)
  • About 70% in each group had alcoholic hepatitis (the reason for acute liver failure in most). (the-hospitalist.org)
  • Approximately 28%-33% of pediatric patients, who present with non-A-E fulminant liver hepatitis also develop aplastic anemia either before or shortly after liver transplantation. (medscimonit.com)
  • Acute liver failure is caused most often by drugs and hepatitis viruses. (msdmanuals.com)
  • Hepatitis B, Acute Hepatitis B is caused by a DNA virus that is often parenterally transmitted. (msdmanuals.com)
  • It occurs uncommonly as a coinfection with acute hepatitis B or as. (msdmanuals.com)
  • Known causes of acute liver failure include autoimmune hepatitis, drug-induced liver injury, hepatitis A and B, and acetaminophen poisoning. (rejuvenation-science.com)
  • The clinical course of hepatitis A is indistinguishable from that of other types of acute viral hepatitis. (cdc.gov)
  • Certain diseases can also cause acute liver failure, such as hepatitis and Wilson disease. (touro.com)
  • If viral hepatitis is the cause of your acute liver failure, your healthcare provider may give you certain medicines depending on the type of hepatitis you have. (touro.com)
  • According to research, around 1% to 2% of people with viral hepatitis suffer from acute liver failure. (heprx.net)
  • These can include complete blood count (CBC), prothrombin time, liver function tests (LFTs), INR, hepatitis tests, and other suitable tests according to the suspected cause. (heprx.net)
  • These may include acute hepatitis, hemolytic jaundice, or cholestatic jaundice. (heprx.net)
  • Acute liver failure can be caused by hepatitis. (uchealth.com)
  • Diseases such as hepatitis and Wilson's disease, cytomegalovirus, Epstein-Barr virus, and herpes simplex virus also increase your risk for acute liver failure. (uchealth.com)
  • If autoimmune hepatitis is causing your liver failure, your healthcare provider can treat you with steroids. (uchealth.com)
  • A 52 year old male admitted with symptoms of jaundice followed by altered consciousness, developed ascites (accumulation of fluid in abdomen and decreased urine output (acute kidney injury) and the later investigation detected to be hepatitis B Virus positive and a diagnosis of with acute on chronic liver failure (ACLF). (medlarge.com)
  • Viruses like hepatitis A, B, and E can lead to acute liver failure if left untreated. (dzairblog.com)
  • Conditions like autoimmune hepatitis and Wilson's disease can result in acute liver failure. (dzairblog.com)
  • A detailed history of the patient's symptoms, recent medication use, and potential exposure to hepatitis or other liver-damaging agents. (dzairblog.com)
  • Avoiding excessive alcohol consumption, practicing safe sex to prevent viral hepatitis, and using medications responsibly can reduce the risk of acute liver failure. (dzairblog.com)
  • When something goes wrong-fatty liver disease, hepatitis C or too much alcohol-seek help right away. (sutterhealth.org)
  • Sutter care centers have a comprehensive liver disease research program that provides our patients access to many clinical trials focused on new therapies, devices and antiviral agents in the areas of viral hepatitis, liver cancer, gastroenterology and liver transplantation. (sutterhealth.org)
  • Too much acetaminophen, viral hepatitis and poisonous mushrooms all can result in acute liver failure. (sutterhealth.org)
  • We reported a case of 48-year-old male with acute liver failure due to acute hepatitis B infection and considered the possibility of concomitant zoonotic hepatitis E (HEV) infection to explain the severity of his presentation. (authorea.com)
  • Patients with chronic hepatitis B (CHB) and Hepatitis B virus (HBV)-related cirrhosis are also prone to develop hepatic or extrahepatic failures when they develop a superadded insult. (growthmarketreports.com)
  • whereas chronic liver disease is generally caused by cirrhosis, hepatitis B or C, and non-alcoholic steatohepatitis (NASH). (growthmarketreports.com)
  • In terms of indication, the global acute on chronic liver failure treatment market is bifurcated into hepatitis, autoimmune diseases, non-alcoholic fatty liver disease (NAFLD), and others. (growthmarketreports.com)
  • In the United States, acetaminophen toxicity has replaced viral hepatitis as the most common cause of acute liver failure. (medscape.com)
  • It is responsible for an estimated 1.4 million deaths per year globally, mostly from hepatitis-related liver cancer and cirrhosis. (who.int)
  • All five hepatitis viruses can cause acute disease, but the highest numbers of deaths result from liver cancer and cirrhosis which occur after decades of chronic hepatitis B or C infection. (who.int)
  • We believe the time was prime to move the needle forward and raise awareness, among not only hepatologists and intensive care unit (ICU) specialists but also the general gastrointestinal audience who may or may not deal with cirrhosis or will be dealing with chronic liver disease in the future. (medscape.com)
  • A pragmatic approach to a patient who has chronic liver disease or cirrhosis, and now has completely gone into ACLF, is to try and do everything in your power to reverse that ACLF if possible. (medscape.com)
  • Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived? (nih.gov)
  • Acute-on-chronic failure (ACLF) is a recognized syndrome in patients with chronic liver disease and is characterized by acute decompensation, organ failure(s), and a high short-term mortality. (nih.gov)
  • Hemostatic changes in acute-on-chronic liver failure (ACLF) may in part reflect critical illness. (nih.gov)
  • ABSTRACT: Background Even the sickest patients with chronic liver disease (CLD), such as those with acute-on-chronic liver failure (ACLF) remain in hemostatic balance due to a concomitant decline in pro- and antihemostatic factors. (nih.gov)
  • WASHINGTON - Treatment with carvedilol reduced the incidence of sepsis and acute kidney injury and improved survival at 28 days but did not significantly reduce the progression of esophageal varices in patients with acute-on-chronic liver failure. (the-hospitalist.org)
  • A total of 136 patients with acute-on-chronic liver failure with small or no esophageal varices and a hepatic venous pressure gradient (HVPG) of 12 mm Hg or greater were enrolled in a single center, prospective, open-label , randomized controlled trial: 66 were randomized to carvedilol and 70 to placebo, according to Sumeet Kainth , MD, of the Institute of Liver and Biliary Sciences in New Delhi. (the-hospitalist.org)
  • Morbidity and mortality were high, as is expected with acute-on-chronic liver failure, he noted. (the-hospitalist.org)
  • Patients with acute on chronic kidney disease fared the worst. (the-hospitalist.org)
  • The common end stage of liver disease is decompensated cirrhosis and the further development towards acute-on-chronic liver failure (ACLF). (ku.dk)
  • In this Review, the authors discuss the possible pathogenic, diagnostic and therapeutic role of the gut microbiota in decompensation of cirrhosis and progression to acute-on-chronic liver failure. (ku.dk)
  • Predisposing factors for acetaminophen -induced liver failure include preexisting liver disease, chronic alcohol use, and use of drugs that induce the cytochrome P-450 enzyme system (eg, anticonvulsants). (msdmanuals.com)
  • Neurological manifestations of both acute and chronic liver disease include hepatic encephalopathy, cerebral edema and seizures. (openanesthesia.org)
  • Background & Aims Uncertainties exist surrounding the timing of liver transplantation (LT) among patients with acute-on-chronic liver failure grade 3 (ACLF-3), regarding whether to accept a marginal quality donor organ to allow for earlier LT or wait for either an optimal organ offer or improvement in the number of organ failures, in order to increase post-LT survival. (openaire.eu)
  • Massive iron overload and acute-on-chronic liver failure in a patient with Diamond-Blackfan anaemia: a case report. (bvsalud.org)
  • She progressed to haemodynamic and hepatic failure , with clinical features of acute-on-chronic liver failure (ACLF) . (bvsalud.org)
  • We found marked advance of liver fibrosis (chronic damage), as well as necrosis of hepatocytes in zone 3 of the Rappaport acinus (acute damage), supporting the hypothesis of ACLF. (bvsalud.org)
  • Chronic liver failure happens over a long stretch of time. (touro.com)
  • It is comparatively less common than chronic liver failure, but if it occurs, it can lead to much severe symptoms. (heprx.net)
  • Alcohol consumption is usually associated with chronic liver disease, but excessive intake of alcohol in a short period may increase the risk of acute liver failure. (heprx.net)
  • The guidelines, Acute Liver Failure and Management of Decompensated Liver Disease , are intended to help with both the acute case and with the deterioration of chronic cases. (ggcmedicines.org.uk)
  • ACLF is a distinct clinical entity and different from acute liver failure or chronic liver disease as here two simultaneous but different insults are operating: acute insult and chronic insult. (medicinepaper.net)
  • Patients with acute-on-chronic liver failure (ACLF) admitted in Medicine or Hepatology ward were enrolled for the study. (medicinepaper.net)
  • Dr. Amasa Viswanatha Reddy, Dr. Sindhuja M. Clinical profile of patients with acute-on-chronic liver failure . (medicinepaper.net)
  • The present study aimed to examine alterations of serum ATX in acute-on-chronic liver failure (ACLF) and evaluate whether serum ATX could be useful as an early warning biomarker of ACLF. (xiahepublishing.com)
  • Acute-on-chronic liver failure (ACLF) encompasses a group of clinical syndromes based on chronic liver disease, acute intrahepatic and/or extrahepatic injury as the inducement, and accompanied by multiple organ failure and early high mortality. (xiahepublishing.com)
  • In recent years, the concept of acute-on-chronic pre-liver failure (pre-ACLF) was proposed. (xiahepublishing.com)
  • In chronic diseases, at some point the liver can suddenly stop functioning. (lisym.org)
  • This is called acute-on-chronic liver failure, or ACLF. (lisym.org)
  • Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome characterized by liver failure, due to an acute hepatic injury on an underlying chronic liver disease with high 28-day mortality. (growthmarketreports.com)
  • Based on type, the global acute on chronic liver failure treatment market is segregated into Type-A ACLF, Type-B ACLF, and Type-C ACLF. (growthmarketreports.com)
  • Type-A ACLF is an acute worsening of liver function in a patient with chronic liver disease. (growthmarketreports.com)
  • Some of these patients develop liver failure during such exacerbations and are labelled as acute-on-chronic liver failure. (growthmarketreports.com)
  • Based on treatment the global acute on chronic liver failure treatment market is segmented into surgery and medication. (growthmarketreports.com)
  • Data from the study from liver-chronic liver failure (EASL-CLIF) Consortium and called the EASL-CLIF Acute-on-Chronic Liver Failure in Cirrhosis (CANONIC) shows that 9% of patients satisfying the ACLF criteria can be transplanted within 28 days and 15% within 90 days after admission. (growthmarketreports.com)
  • In terms of application, the global acute on chronic liver failure treatment market is segmented into hospitals, ambulatory surgical centers, and others. (growthmarketreports.com)
  • Organ transplantation is often the best, if not the only, treatment for acute and chronic organ failure. (who.int)
  • Noncommunicable diseases such as diabetes and arterial hypertension, combined with various social determinants (e.g. alcoholism, obesity), may lead to chronic kidney disease and liver cirrhosis, conditions that are among the top 10 causes of death worldwide. (who.int)
  • For chronic or acute liver failure, as well as some cardiorespiratory conditions, the only alternative to transplantation is death. (who.int)
  • It's a little difficult to thread this needle, but we hope we've done it, because ACLF is clearly a distinct entity from acute decompensation, and it has a much worse prognosis. (medscape.com)
  • Management of ACLF is broadly focused on supportive care often in an intensive care setting with liver transplantation proving to be an increasingly relevant and effective rescue therapy. (nih.gov)
  • This is the first case reporting the sequence DBA, multiple blood transfusions , secondary haemochromatosis , advanced liver fibrosis , heart failure , ACLF and death . (bvsalud.org)
  • Like acute liver failure ACLF is also associated with high mortality rate, liver support device are important therapeutic options for these patients to provide them additional time for recovery or to serve as a "bridge" to transplantation, whereas orthotopic liver transplantation remains the only definitive therapy who do not improve with supportive measures. (medicinepaper.net)
  • 1 , 2 Although liver transplantation is considered to be the most effective treatment for ACLF, donor organ shortages pose a major obstacle. (xiahepublishing.com)
  • The early warning indicators of ACLF are currently lacking in clinical practice, and the specificity and sensitivity of traditional end-stage liver disease model scores, including the model for end-stage liver disease (MELD) and MELD-Na, and Child-Pugh scores can hardly meet the clinical needs of prognostic assessment. (xiahepublishing.com)
  • Can the liver be repaired or regenerated after ACLF? (lisym.org)
  • The Type-C ACLF segment is expected to hold a significant share of the market during the forecast period, due to increasing diagnosis of the liver disease and ACLF at this stage. (growthmarketreports.com)
  • Type-B ACLF happens when acute decompensation occurs in patients with cirrhosis. (growthmarketreports.com)
  • Type-C ACLF is acute worsening of liver function in decompensated cirrhotic. (growthmarketreports.com)
  • Type-C ACLF is diagnosed when there are three or more organ failures of any combination. (growthmarketreports.com)
  • Acetaminophen (APAP) poisoning is one of the leading causes of acute hepatic failure and liver transplantation is often the only lifesaving alternative. (mdpi.com)
  • Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. (medscape.com)
  • Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. (medscape.com)
  • Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. (medscape.com)
  • Treatment is mainly supportive, sometimes with liver transplantation and/or specific therapies (eg, N - acetylcysteine for acetaminophen toxicity). (msdmanuals.com)
  • The antidote for acute liver failure caused by acetaminophen poisoning also can treat acute liver failure due to most other causes if given before severe injury occurs, UT Southwestern Medical Center researchers and their colleagues at 21 other institutions have found. (rejuvenation-science.com)
  • NAC is an excellent treatment for non-acetaminophen acute liver failure if the disease is caught early. (rejuvenation-science.com)
  • Acute liver failure affects about 2,000 people annually in the U.S., and 50 percent of those cases are caused by acetaminophen poisoning. (rejuvenation-science.com)
  • Until this study, liver transplantation was the only treatment if the failure was from non-acetaminophen causes. (rejuvenation-science.com)
  • To test NAC's use in non-acetaminophen cases, researchers at 22 sites randomly assigned non-acetaminophen acute liver failure patients by the level of their coma, with those with mild to moderate coma in one group, and patients with more severe coma in the other group. (rejuvenation-science.com)
  • This study establishes NAC as a treatment for non-acetaminophen acute liver failure patients in mild to moderate coma and provides the first glimmer of hope that something can help these direly ill patients," Dr. Lee said. (rejuvenation-science.com)
  • He said he will continue to study NAC as a therapy for acute liver failure not caused by acetaminophen poisoning to determine optimal dosing and duration. (rejuvenation-science.com)
  • Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. (rejuvenation-science.com)
  • Taking too much acetaminophen causes most cases of acute liver failure. (touro.com)
  • It's also sometimes helpful to people with acute liver failure that was not caused by too much acetaminophen. (touro.com)
  • Paracetamol or acetaminophen can damage the liver tissues if taken too much at once or more than necessary every day. (heprx.net)
  • Certain medications and toxins, such as acetaminophen (paracetamol) overdose, can damage the liver and cause ALF. (dzairblog.com)
  • Acetaminophen (APAP) toxicity is the number one cause of acute liver failure (ALF) and treatment options are limited. (pcom.edu)
  • Acetaminophen metabolism occurs primarily in the liver and is illustrated in the image below. (medscape.com)
  • Most patients who overdose on acetaminophen will initially be asymptomatic, as clinical symptoms of end-organ toxicity do not manifest until 24-48 hours after an acute ingestion. (medscape.com)
  • The Rumack-Matthew nomogram interprets the acetaminophen concentration (in micrograms per mL), in relation to time (in hours) after ingestion, and is predictive of possible hepatotoxicity after single, acute ingestions of acetaminophen. (medscape.com)
  • The surgery segment is expected to hold a significant share of the market, as the high and increasing cirrhosis burden heightens the need for liver transplantation (LT). In 2021, 34,694 liver transplants were performed globally, an increase of 6.5% from 2020 and a 20% increase from 2015 (living or deceased). (growthmarketreports.com)
  • When she faced heart decompensation , this congestive condition led to an acute liver injury overlapping pre-existing hepatic fibrosis . (bvsalud.org)
  • The main feature responsible for acute liver decompensation seemed to be heart insufficiency. (bvsalud.org)
  • but, if you have a patient with multiorgan failure, this is not always going to be a patient where the answer is clearly transplant or treat with x . (medscape.com)
  • They strongly appreciate when the transplant service or the liver service gets involved early to help with the transition, so the family is aware. (medscape.com)
  • Another 23 experienced adverse events and 2 progressed to liver transplant. (the-hospitalist.org)
  • For a discussion of acute liver failure and other diagnostic considerations in liver transplant recipients, see the Medscape article Liver Transplants . (medscape.com)
  • That makes sense because patients with advanced comas typically die or get a transplant within a few days," said Dr. Lee, principal investigator of the Acute Liver Failure Study Group, a national consortium of liver centers formed in 1997 to increase research into the rare disease. (rejuvenation-science.com)
  • If treatment can't get your liver working again, you may need a liver transplant. (touro.com)
  • But people with controlled HIV can get a liver transplant. (touro.com)
  • If you are approved for a liver transplant, your name will be put on a waiting list to get a donated organ. (touro.com)
  • If the liver is unable to revive despite supportive measures, a liver transplant will be the last option to save your life. (heprx.net)
  • Your consultant should be aware of the patient on the day of admission so that early discussions can take place with relatives and the Liver Transplant Unit if needed. (ggcmedicines.org.uk)
  • Rather than waiting until the strict criteria for transplantation are met, patients with severe acute liver failure should be discussed with the Scottish Liver Transplant Unit (see Appendix 6 for contact details) at an early stage. (ggcmedicines.org.uk)
  • To schedule an appointment, please call the Liver Transplant team at 513-584-9999 . (uchealth.com)
  • At this juncture dialysis was considered and patient was offered an option of liver transplant by the Doctors of Sir Ganga Ram hospital where he was admitted, as his parameters indicated one month probability of survival to be around 50 per cent. (medlarge.com)
  • The Plasmapheresis is increasingly being used as a bridge for liver transplant and in many cases a large proportion of these patients may recover by the control of other factors. (medlarge.com)
  • In severe cases where the liver is extensively damaged, a liver transplant may be the only option for survival. (dzairblog.com)
  • However, without a liver transplant, the mortality rate for ALF can be high. (dzairblog.com)
  • Recognized by the Scientific Registry of Transplant Recipients in 2014 as the only liver and kidney transplant program in the nation to exceed better-than-expected patient outcomes. (sutterhealth.org)
  • Awarded the U.S. Department of Health and Human Services Transplant Program Award at Silver level in 2012, one of five out of 137 recognized as an exemplary liver transplant program. (sutterhealth.org)
  • Data were analyzed with and without accounting for the following confounding factors: liver transplantation, time to transplant, disease etiology, disease severity, and treatment site. (elsevierpure.com)
  • CONCLUSIONS: Although patient selection remains poorly defined, auxiliary partial orthotopic liver transplantation in acute liver failure is technically feasible and, in some patients, allows native liver regeneration and eventual immunosuppression withdrawal. (erowid.org)
  • Greater understanding of mechanisms of liver and bone marrow injury, elucidation of etiologic factors may result in new therapeutical approach and in improvement of the final outcome. (medscimonit.com)
  • Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study. (medscape.com)
  • Liver Injury Caused by Drugs Many medications (eg, statins) commonly cause asymptomatic elevation of hepatic enzymes (alanine aminotransferase [ALT], aspartate aminotransferase [AST], alkaline phosphatase). (msdmanuals.com)
  • What is acute liver injury/failure? (medtalks.in)
  • Any patient with encephalopathy, coagulopathy or renal impairment complicating acute liver injury should be discussed with SLTU. (ggcmedicines.org.uk)
  • LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. (nih.gov)
  • Simvastatin is a commonly used cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy, and rarely with clinically apparent acute liver injury. (nih.gov)
  • Rare but potentially severe adverse events include liver injury, myopathy, rhabdomyolysis, and immune-mediated necrotizing myopathy. (nih.gov)
  • Clinically apparent liver injury due to simvastatin is rare. (nih.gov)
  • But in view of the wide use of simvastatin, clinically apparent liver injury is exceeding rare and is estimated to occur in 1 per 100,000 patient years of exposure. (nih.gov)
  • A (well known but rare cause of clinically apparent liver injury). (nih.gov)
  • Doctor said that the plasma contains a lot of toxic products which are being produced the injury to liver. (medlarge.com)
  • Liver and serum were harvested at each time point and the extent of injury was assessed via ALT/AST. (pcom.edu)
  • At 2 weeks, four of six patients had partial regeneration of the native liver, which became complete in two of the survivors by 1 year. (erowid.org)
  • The role of Lcn2 in a drug-induced acute liver failure model, when regeneration is inhibited, has not yet been investigated. (pcom.edu)
  • Acute liver failure (ALF) is a life-threatening clinical syndrome characterized by rapid hepatocellular necrosis due to various acute injuries induced by hepatotoxic drugs, immune-mediated attack, or viral infections. (springer.com)
  • Viral infections can cause acute liver failure. (heprx.net)
  • In part because the liver disease severity we see at baseline is different around the world. (medscape.com)
  • The term subfulminant hepatic failure is reserved for patients with liver disease for up to 26 weeks before the development of hepatic encephalopathy. (medscape.com)
  • Acute liver failure is the appearance of severe complications rapidly after the first signs (such as jaundice) of liver disease, and indicates that the liver has sustained severe damage (loss of function of 80-90% of liver cells). (wikipedia.org)
  • Numerous treatment strategies for acute liver failure simply prevent complications and decelerate disease progression. (springer.com)
  • Mean Model for End-Stage Liver Disease (MELD) scores were about 25. (the-hospitalist.org)
  • Additionally, a postictal state should be on your differential for AMS when working up a patient with potential hepatic encephalopathy, as well as other causes that may be present in a patient with liver disease such as hypoglycemia or intracranial bleeding. (openanesthesia.org)
  • The purpose of treatment is to slow down the progression of this disease and give enough time to your liver to heal itself. (heprx.net)
  • Most acute admissions for liver failure occur in patients with pre-existing liver disease. (ggcmedicines.org.uk)
  • A diagnosis of liver disease can feel overwhelming. (uchealth.com)
  • Autoimmune disease and Wilson's disease can also cause acute liver failure. (uchealth.com)
  • The usual latency to onset of symptoms of liver disease ranges from one week to as long as 3 years, but most cases have a latency of 1 to 6 months. (nih.gov)
  • Recent accumulating evidence indicates the biological actions of autotaxin (ATX) in liver disease. (xiahepublishing.com)
  • Serum ATX levels were well correlated with serum biochemical parameters of liver function and model for end-stage liver disease score. (xiahepublishing.com)
  • Seminars in liver disease , 36 (2), 107. (elsevierpure.com)
  • Sutter's nationally recognized Center for Liver Disease Management and Transplantation serves as a collaborative hub for liver disease care and research, providing access to internationally known liver specialists and investigational therapies. (sutterhealth.org)
  • 75% of these cases are in Asia Pacific alone, where CHB is a leading cause of liver disease-related mortality. (growthmarketreports.com)
  • The non-alcoholic fatty liver disease (NAFLD) segment is projected to expand at a significant CAGR during the forecast period, due rapidly increasing prevalence of NAFLD in North America and Europe. (growthmarketreports.com)
  • Lipocalin-2 is an acute phase protein known to be upregulated in various disease models and has been observed to have a protective as well as a destructive role dependent on the model analyzed, via modulation of pro/anti-inflammatory signalling. (pcom.edu)
  • Corneal disease (scarring or perforation) can be successfully addressed through transplantation in 80% of affected individuals.3 Tissue transplantation allows many recipients to return to economically productive lives and promotes their independence. (who.int)
  • Kidney failure is common, present in more than 50% of ALF patients, either due to original insult such as paracetamol resulting in acute tubular necrosis or from hyperdynamic circulation leading to hepatorenal syndrome or functional kidney failure. (wikipedia.org)
  • mean age 28, range 14-35 years) with acute liver failure (paracetamol 3, non A-E 2, autoimmune 1, Ecstasy 1) who fulfilled criteria for emergency transplantation. (erowid.org)
  • Acute liver failure is an uncommon condition in which rapid deterioration of liver function results in coagulopathy, usually with an international normalized ratio (INR) of greater than 1.5, and alteration in the mental status (encephalopathy) of a previously healthy individual. (medscape.com)
  • A wide variety of conditions can cause acute liver failure or produce mental status changes and coagulopathy resembling acute liver failure. (medscape.com)
  • Severity of hepatotoxicity after a single acute overdose is predicted by serum. (msdmanuals.com)
  • The only curative treatment for ALF is liver transplantation, but there are many restrictions on the application of liver transplantation because of financial considerations, a shortage of donor livers, and immunosuppression-related complications [ 3 ]. (springer.com)
  • Ocular complications associated cases with onset dates after October 2021 were report- with acute monkeypox virus infection, DRC. (cdc.gov)
  • What are possible complications of acute liver failure? (touro.com)
  • Acute liver failure is a medical emergency and must be treated immediately before complications arise. (heprx.net)
  • Majority of these medications are metabolized by the liver, so an overdose can cause complications. (heprx.net)
  • If you have acute liver failure, common complications include bacterial and fungal infection and low blood sugar. (uchealth.com)
  • There are also other things that can lead to acute liver failure. (uchealth.com)
  • Who is at risk for acute liver failure? (touro.com)
  • Rare cases of acute liver failure and death have been attributed to simvastatin. (nih.gov)
  • The safety and efficacy of the BAL were evaluated in a prospective, randomized, controlled, multicenter trial in patients with severe acute liver failure. (elsevierpure.com)
  • Essentials Liver diseases are associated with profound hemostatic changes proportional to severity of illness. (nih.gov)
  • Hemodynamic parameters also were comparable, with a mean HVPG of about 19, Dr. Kainth said at the annual meeting of the American Association for the Study of Liver Diseases. (the-hospitalist.org)
  • Thus, the gut microbiome might play a major part in the development of liver diseases. (ku.dk)
  • A family history of rare genetic diseases that affect your liver can also increase your risk. (heprx.net)
  • Several innovations and technologies associated with hospitals are expected to improve the pain management of patients suffering from end-stage liver diseases in the hospital. (growthmarketreports.com)
  • In recent years, a growing number of studies have shown that stem cells can effectively treat acute liver failure. (springer.com)
  • Rare metabolic disorders, such as acute fatty liver of pregnancy, can lead to ALF, particularly in pregnant women. (dzairblog.com)
  • In a study published in the September issue of Gastroenterology, researchers found that acute liver failure patients in early stages of hepatic comas, when treated with N-acetylcysteine (NAC) , were nearly 2.5 times more likely to survive than those treated only with a placebo. (rejuvenation-science.com)
  • Acute liver failure occurs when cells in the liver die quickly, resulting in toxins being released into the bloodstream and brain. (rejuvenation-science.com)
  • When the liver suddenly loses its ability to function, a condition known as acute liver failure (ALF) occurs. (dzairblog.com)
  • Acute Liver Failure Acute liver failure is a medical condition that occurs when the liver suddenly stops working properly, usually within a few days or weeks. (agrawalgastrocarecenterindore.com)
  • If your healthcare provider can't find the cause of your acute liver failure, you may need a liver biopsy. (touro.com)
  • A liver biopsy can be done if there is a risk of liver cancer. (heprx.net)
  • In some cases, a liver biopsy may be necessary to determine the extent of liver damage. (dzairblog.com)
  • The recipient had a fever 8 days after receiving the renal allograft, and a biopsy of it showed acute rejection. (cdc.gov)
  • Even if you take out all the minutiae of the guidelines, it's largely characterized by liver failure plus a few extrahepatic organ failures. (medscape.com)
  • BACKGROUND/AIMS: Auxiliary partial orthotopic liver transplantation holds potential advantages over conventional orthotopic liver transplantation, but experience with the technique in acute liver failure is limited. (erowid.org)
  • Another common cause of acute liver failure is drug overdose. (heprx.net)
  • The conformational diagnosis of acute liver failure is made on the basis of multiple tests. (heprx.net)
  • A diagnosis like acute liver failure can be scary, but with science and research advancing treatment every day, we can offer more hope than ever before. (uchealth.com)
  • Co-Editor-in-Chief Jasmohan S. Bajaj, MD, MS, FACG interviews Alexandra Shingina, MD, MSc about the recently published ACG Guideline on the diagnosis and management of acute liver failure. (gi.org)
  • The main features of acute liver failure are rapid-onset jaundice, weakness, and eventually, changes in mental status that can begin as mild confusion but progress to coma, known as hepatic encephalopathy. (wikipedia.org)
  • Acute liver failure should be differentiated from other conditions that can cause abdominal pain, jaundice, and hepatic encephalopathy. (heprx.net)
  • Encephalopathy developing in a person with acute hepatic dysfunction within 8 weeks of the onset of jaundice. (ggcmedicines.org.uk)
  • Although liver failure can be treated via hepatocyte transplantation, it also faces multiple problems comprising the shortage of high-quality hepatocytes sources, rejection of allogeneic transplants, difficulty to expand, and losing hepatic characteristics in vitro [ 7 , 8 ]. (springer.com)
  • https://doi.org/ liver transplants, and 22 (2%) children died ( 1 ). (cdc.gov)
  • Three patients received liver transplants and all but one recovered completely. (cdc.gov)
  • Acute liver failure can be caused due to an infection, drugs, or other factors. (heprx.net)
  • Research studies suggest that between 15% and 37% of patients with HBV infection have spontaneous acute exacerbations within 4 years. (growthmarketreports.com)
  • The most important step in the assessment of patients with acute liver failure is to identify the cause, because certain conditions necessitate immediate and specific treatment and affect prognosis. (medscape.com)
  • The prognosis for acute liver failure varies depending on the underlying cause, the severity of liver damage, and the promptness of treatment. (dzairblog.com)
  • Acute liver failure is a broad term that encompasses both fulminant hepatic failure and subfulminant hepatic failure (or late-onset hepatic failure). (medscape.com)
  • The term fulminant hepatic failure is generally used to describe the development of encephalopathy within 8 weeks of the onset of symptoms in a patient with a previously healthy liver. (medscape.com)
  • Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. (medscape.com)
  • Fulminant hepatic failure. (medscape.com)
  • Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. (medscape.com)
  • It is also known as a fulminant hepatic failure. (heprx.net)
  • Acute liver failure (ALF) is a sudden loss of liver functioning, also known as fulminant hepatic failure (FHF). (topbookmarkingwebsite.com)
  • Patients with fulminant/subfulminant hepatic failure and primary nonfunction following liver transplantation were included. (elsevierpure.com)
  • Conclusions: This is the first prospective, randomized, controlled trial of an extracorporeal liver support system, demonstrating safety and improved survival in patients with fulminant/subfulminant hepatic failure. (elsevierpure.com)
  • Acute liver failure often affects young people and carries a very high mortality. (medscape.com)
  • Acute liver failure is a life-threatening clinical syndrome characterized by rapid development of hepatocellular necrosis leading to high mortality and resource costs. (springer.com)
  • Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. (medscape.com)
  • Objective: The HepatAssist liver support system is an extracorporeal porcine hepatocyte-based bioartificial liver (BAL). (elsevierpure.com)
  • HAV is typically acquired through ingestion (through fecal-oral transmission) and replicates in the liver. (cdc.gov)
  • These tests will check your liver enzymes, bilirubin levels, and prothrombin time. (uchealth.com)
  • Liver Systems Medicine : striving to develop non-invasive methods for diagnosing and treating NAFLD by combining mathematical modeling and biological research. (lisym.org)
  • Abstract Background: Intracranial hypertension is a serious complication in patients with acute liver failure (ALF) which leads to brain herniation and 30% mortality. (uit.no)
  • The most important aspect of treatment for acute liver failure is to provide good intensive care support, including the protection of the airways. (medscape.com)
  • The only curative treatment for acute liver failure is liver transplantation, but there are many restrictions on the application of liver transplantation. (springer.com)
  • The aims of this article are to review the current knowledge regarding therapeutic mechanisms of mesenchymal stem cells in acute liver failure, to discuss recent advancements in preclinical and clinical studies in the treatment of mesenchymal stem cells, and to summarize the methodological improvement of mesenchymal stem cell transplantation in treating liver failure. (springer.com)
  • Previous studies have proven that rodent and human MSCs can differentiate into HLCs in vitro and in vivo , which is one of the mechanisms of MSCs in the treatment of liver failure. (springer.com)
  • The review presents etiopathogenesis, clinical presentation and treatment of acute liver failure and acquired aplastic anemia in children. (medscimonit.com)
  • The treatment for acute liver failure is often carried out in an intensive care unit (ICU). (heprx.net)
  • Liver specialists at Sutter Solano Medical Center provide evaluations, treatment and access to clinical trials. (sutterhealth.org)
  • Case Report: A 50-year-old patient with an unresectable small intestinal stromal tumor resistant to prior treatment with imatinib and sunitinib was started on regorafenib, but experienced acute liver failure 10 days later. (elsevierpure.com)
  • Plasma exchange and steroid pulse treatment improved her liver function. (elsevierpure.com)
  • Patients presenting as acute and hyperacute liver failure are at greater risk of developing cerebral edema and grade IV encephalopathy. (wikipedia.org)
  • Hypothermia attenuates oxidative/nitrosative stress, encephalopathy and brain edema in acute (ischemic) liver failure. (medscape.com)
  • ITU admission will be required for all grades of encephalopathy in the acute patient. (ggcmedicines.org.uk)
  • Smash Mouth released a statement at the time saying Harwell had been diagnosed with cardiomyopathy eight years earlier and had suffered "nonstop serious medical setbacks including heart failure as well as acute Wernicke Encephalopathy. (barrie360.com)
  • During the course of hepatocyte necrosis, an intense accumulation of neutrophils is often observed within the liver microenvironment. (mdpi.com)
  • Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. (medscape.com)